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1. Introduction 
 
1.1 - Thermodynamics of Protein Aggregation 
 
Proteins are unbranched heteropolymers formed from different naturally occurring ?-L-
amino acids connected by amide bonds. In order to perform their biological function, 
almost all proteins adopt a three dimensional structure, which is determined by the 
primary amino acid sequence and the local environment
1
. Despite the large configurational 
space available, proteins show a remarkable propensity to adopt unique, well-defined 
conformation. Many small proteins fold into their native stable ordered forms readily in 
solution, but it is also true that under some conditions proteins can interconvert among 
various ordered states, as well as between ordered and random forms. Such 
conformational changes generally occur in response to variations in an external parameter 
such as temperature, pH or solvent. 
The conformational stability of a protein is generally defined as the free energy change 
(?G0 ) for the reaction between the folded or native (N) and unfolded or denatured  (U) 
state of the protein
2, 3
 
 
U? N  (1) 
in an aqueous solution at ambient temperature and pressure. For the characterization of 
folding thermodynamics and thus the structural stability it is sufficient to characterize the 
folded and unfolded states under different conditions, as the free energy difference 
between them determines the macroscopic state observed at equilibrium. The analysis of 
the folding and unfolding reactions of various proteins by spectroscopic and calorimetric 
techniques
4
 has shown that a multitude of noncovalent intramolecular interactions as well 
as intermolecular protein-solvent contacts stabilize the protein structure. Specific 
electrostatic interactions, hydrogen bonds and van-der-Waals forces contributing to 
protein stability
5
, but the major driving force of protein folding is thought to result from 
the hydrophobic effect or hydrophobic free energy
6
. At ambient temperature the 
hydrophobic free energy is mainly entropic and can be explained by ordering of the 
solvent molecules around the protein surface, which is accompanied by the loss of 
orientational freedom. Thus, the hydrophobic effect favors the burial of protein surface in 
  1. Introduction 
 
2 
order to minimize the solvent accessible surface area. Multiple interactions between 
protein residues well separated in primary structure cause the overall compaction and 
defined fold of the native protein
7
. 
The fact that the native protein structure is thermodynamically stable does not necessarily 
imply that there is no other conformation, which exhibits a lower free energy state than the 
native state
8, 9
. In many cases, only small variations in an external variable are required to 
disturb the natural folding equilibrium and as a consequence protein misfolding and finally 
aggregation can be observed. Furthermore, the formation of proteins in an aggregated 
state, A, is today considered as a process that compete with the natural folding reaction
10
.  
 
(2) 
Through environmental changes, e.g. pH or temperature
11, 12
, proteins can sacrifice 
stabilizing intrachain contacts in favor of configurations that promote intermolecular 
interactions leading to the formation of aggregates. These aggregates range from 
amorphous structures without order to highly structured fibrils, each arising by distinct 
aggregation pathways. In a globular protein, for example, the polypeptide main chain and 
the hydrophobic side chains are largely buried within the folded structure. Therefore 
proteins have to unfold at least partially to expose hydrophobic patches
13
. In contrast to 
native proteins relative little is known about interactions, which stabilize protein 
aggregates. Direct comparison of the native state, with the aggregated state is impossible 
due to insolubility, heterogeneity, and high degree of polymerization of the protein 
aggregates. Quite often, the aggregated states of a protein are not in equilibrium with the 
unfolded state, which further complicates the analysis. On the other hand, the high 
resistance of the aggregated form to denaturation by detergents and to thermal and 
solvent-induced denaturations serves as an illustration of the extremely high 
thermodynamic stability compared to the metastability of the native state of proteins
14
. 
From these considerations the question arises, why the protein aggregation pathway is 
generally not accessible during folding under native condition? It has been argued that the 
rate of protein aggregation is slower by several orders of magnitude than the rate of 
folding into the native protein conformation
13, 15
. 
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1.2 - Formation of Protein Aggregates  
 
The formation of aggregates with similar structural features by proteins and peptides of 
unrelated primary sequence, suggests a generic mechanism governing the process
13, 16
. 
Proteins can aggregate either in an unordered or highly ordered fashion but relatively little 
is known about the conditions that favor one aggregation pathway over the other. 
Generally, both aggregation types are rich in extended ?-sheet structures17, 18. 
Nevertheless, the typical phenotype of ordered protein aggregation is the protein fibril. 
Protein fibrils are straight, unbranched fibers, 7-12 nm in diameter and of indeterminate 
length
19
. X-ray diffraction and solid state NMR spectroscopy studies
20-22
 revealed a 
repeating core structure for so called amyloid fibrils (see below). This structure consists 
predominantly of ?-sheets, which is orientated perpendicular to the fiber axis. The ?-sheet 
structure within the amyloid fibrils are stabilized by backbone hydrogen bonding and 
hydrophobic interactions, rather than through specific interactions of different side 
chains
23
. The fact that unordered protein aggregates are often found next to in vitro 
synthesized ordered aggregates, suggests that an interconversion between both types can 
take place
24-26
. Structural information of amorphous protein aggregates is rare because of 
their heterogeneity. 
Several models have been proposed to quantitatively describe protein fibrillization
16, 27-29
. 
Generally, the nucleation dependent polymerization model can describe the 
experimentally observed kinetics of fibrillogenesis
30
. This process is characterized by (a) a 
slow nucleation phase, in which the protein undergoes a series of unfavorable association 
steps to form a partially ordered oligomeric nucleus, (b) a growth phase, in which the 
nucleus rapidly grows to form larger polymers, and (c) a steady state phase, in which the 
ordered aggregate and the monomer appear to be at equilibrium (see Figure 1)
30, 31
. In a 
typical nucleation-dependent polymerization, polymers are not observed until the 
monomer concentration exceeds a certain level known as the critical concentration. Below 
this critical concentration the monomer is the predominant species. Raising the monomer 
concentration above the critical concentration leads to formation of polymer but the 
monomer concentration remains the same. Fibril nucleation is slow and as consequence 
supersaturated peptide solutions are metastable, or kinetically soluble
30
. However, the 
kinetically soluble monomer is time dependent. The length of time during which a 
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supersaturated solution remains kinetically soluble before fibril formation occurs is called 
the lag time. During the lag time prenuclei are sequentially formed in a dynamic 
equilibrium. The length of the lag time can be extremely sensitive to protein 
concentration, depending on the oligomer size of the nucleus
32
. 
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Figure 1. The nucleation-dependent mechanism of fibril formation shows a series of unfavourable peptide-
peptide association equilibriums (Kn) accompanied by a structural transition for the peptide monomers, 
followed by a series of favourable equilibriums (kg) that lead to fibril formation. The critical concentration 
phenomenon results from a shift from unfavourable to favourable equilibriums.  
 
This is in line with the findings that the nucleation process exhibits an apparent reaction 
order ? 2 , whereas the folding reaction of a protein into its native structure is generally a 
first-order reaction
4, 33
. The slow nucleation step can be bypassed by introduction of 
exogenous nucleus or seeds
31, 34, 35
, thus eliminating the lag time. Aggregation seeds for 
fibrils are also considered as modulators
36
. A vast variety of modulators of fibril formation 
is known to date, for example: lipids
37
, carbohydrates
38
, and metal ions
39
. Once a nucleus 
is formed, it elongates via end growth. Monomer addition to the fiber ends coincides with 
a conformational rearrangement. Theoretically this process lasts until a steady-state- 
equilibrium between monomer and a precursor of the fibrils is reached. The precursors 
leading to mature fibrils are named protofibrils
15, 40
. The conversion of protofibrils to 
fibrils involves inter- and intrafibrillar changes
15, 41
. In particular, end-to-end annealing 
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and lateral association mechanisms are thought to take place during the maturation of 
fibrils
42
. 
Even though a simple nucleation dependent polymerization model can describe the overall 
process of fibril assembling, most of the sub-processes are not understood at the molecular 
level. The key for a better understanding of fibril formation the identification and 
characterization of the slowest, or rate-limiting step in the overall process. As discussed 
above, the rate of nucleus formation is slow, owing primarily to the unfavorable 
association equilibriums rather than to the intrinsically slow association rates
43
. It is 
therefore critical to distinguish thermodynamic effects (structure, stability, solubility) from 
kinetic effects. Nucleus formation has to overcome two great entropy barriers, namely the 
protein conformation and association. 
 
1.3 - Protein Aggregation at Lipid Membrane surfaces 
 
Most proteins are surface active molecules, a property that is demonstrated by the 
spontaneous accumulation or adsorption of proteins at interfaces
44, 45
. This property results 
from the amphiphilic amino acid composition of proteins. Many theoretical approaches of 
protein adsorption from aqueous solution to solid-liquid interfaces have been described
46, 
47
, still this process is poorly understood. 
Lipid membranes constitute a biological interface and therefore lipid-protein interactions 
are of special interest. The adsorption of protein to membranes involves electrostatic and 
hydrophobic interactions, protonation reactions and dehydration effects. Minimization of 
the free energy of a protein-interface-system can lead to a shift in the folding equilibrium, 
i.e. surfaces can promote folding or unfolding of proteins
48-52
. Perturbation of the folding 
equilibrium has inevitable consequences on the protein aggregation reaction. Indeed 
protein aggregation is frequently observed upon membrane binding. The mechanism of 
membrane-induced aggregation differs from that occurring in bulk solution because of the 
restrictions imposed by (a) the physicochemical and dynamic properties of the lipid 
membrane surface, (b) concentration differences due to accumulation of proteins at the 
lipid-water interface
37
 
53
 
54
, and (c) dimensional restrictions and orientation effects of the 
membrane
55
 
56
. 
Aggregation of proteins at the membrane surface is frequently but not always initialized 
by electrostatic attraction between the protein and the membrane
53, 57-60
. Negatively and 
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positively charged lipids produce an electrostatic potential in the aqueous phase, 
immediately adjacent to the membrane, which leads to the repulsion or attraction of the 
proteins and ions. Electrostatic membrane potentials are also found at neutral membrane 
surfaces, due to preferential absorption of ions
61
. Such a membrane potential can be 
described quantitatively as diffuse double layer by the Gouy-Chapman theory
62, 63
. For a 
lipid membrane with surface potential of -60 mV the theory with physiological boundary 
conditions predicts that the concentration of monovalent ions or proteins at the lipid 
membrane surface is one order of magnitude higher than their bulk concentrations
64
. In 
parallel, the local pH will be one unit lower than in the bulk. The effect of ion 
accumulation at the membrane surface due to a membrane potential is illustrated in figure. 
2. 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2. (A) Surface membrane potential and ionic density profiles for a 0.1 M monovalent electrolyte near 
a membrane surface of charge density,? = -0.0621 Cm-2 (1 electronic charge per 2.6 nm2). The profiles were 
calculated from the Gouy-Chapman theory with a ? 0 = -60 mV. 
 
These surface effects are able to induce conformational transitions of proteins at the 
membrane surface. The higher charge state of the protein at lower pH may enhance side 
chain repulsion on the protein surface and thereby support aggregation. On the other hand 
screening of protein charges through lipid molecules or ions in the close vicinity of the 
membrane can lower repulsion forces between adsorbed proteins
65
. An important 
conclusion is that accumulation of proteins at the membrane surface can cause fibril 
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nucleation, when the local protein concentration exceeds the critical concentration. A 
number of studies have provided experimental evidence for this mechanism. It was 
concluded further that the lipid membrane lowers the energy barriers of nucleus formation 
(see Chapter 1.2)
60, 65-68
. It should be mentioned that fibril formation in aqueous solution is 
diffusion controlled. Membrane adsorbed proteins, however, are not freely diffusing and 
thus the dynamics of fibril formation at the membrane surface is changed compared to 
bulk dynamics. 
Because membranes can induce folding or unfolding upon adsorption of the protein, the 
resulting protein structure often differs from that in aqueous solution. The hierarchy of 
stabilizing interactions, which govern the folding reaction in aqueous solution, is changed 
due to the apolar properties of the membrane surface. For example hydrogen bonds take 
on a much greater significance in a hydrophobic milieu than in water, since the lipid 
solvent is unable to compete with intramolecular H-bonds. Thus hydrogen bonds between 
amino acid side chains and peptide backbone interactions are thought to dominate protein 
stabilization in the membrane surface environment
69, 70
. It is also obvious that lipid 
membrane surfaces can compete for the same hydrophobic interactions, which stabilize 
the native protein structure in aqueous solution
47
. Further, the transfer of nonpolar amino 
acid side chains from the polar water phase to the apolar membrane interface phase results 
in a free energy gain
71, 72
. This free energy of transfer is thought to be the major driving 
force for folding of membrane protein. 
After nucleus formation ordered or unordered aggregates are assembled. In contrast to this 
process occurs at the lipid-water interface. This means the association of monomers to the 
protein oligomers differs in the translational degree of freedom compared to the bulk 
aggregation process
73
 
56
. In addition, the grow axis of the fibril is restricted by the 
membrane surface
55
. The role of lipids is more versatile in terms of protein aggregation 
than it has been depicted in this introduction. Further effects include the lateral packing 
density, thickness and composition of the lipid membrane. Although, these effects might 
play an important role in protein aggregation, they are protein dependent (see examples in 
chapter 1.5). 
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1.4 - Diseases caused by Protein Aggregation 
 
The failure of a protein to fold correctly leads to a functional deficit, which can have 
serious consequences for cells. Therefore eukaryotic and prokaryotic cells have developed 
complex protein machineries for assisting protein folding
74, 75
, but also for recognition and 
degradation of misfolded proteins
76
. Nevertheless protein misfolding and finally 
aggregation occurs and has been connected to various diseases. Considerable attention is 
presently focused on a group of protein folding diseases known as amyloidoses. The 
amyloidoses have traditionally been defined as diseases in which normally soluble 
proteins accumulate in the extracellular space of various tissues as insoluble deposits of 
fibrils that are rich in ?-sheet structure and have characteristic dye-binding properties77. 
The fibril deposits were discovered first by Virchow in 1854
78
. He described the deposits 
as connote waxy, eosinophilic tissue and coined it in analogy to the comparable 
carbohydrate structure ‘amyloid’. The term amyloid persists up to the present day despite 
the fact that Friedrich and Kekulé found already in 1859, that amyloid deposits were 
formed from proteins
79
. Another general feature of these protein-folding disorders is the 
prolonged period before clinical manifestations appear. During the prolonged preclinical 
phase proteins misfold, build up and progressively compromise cellular and tissue 
function. About 30 diseases are known today which comply the typical characteristics of 
an amyloidoses (for a review see
80
). The most prominent diseases among of them are the 
Alzheimer’s-, Huntington’s-, and Creutzfeld-Jakob’s disease
81, 82
. In some aggressive 
amyloidoses protein-folding disorders can occur in young and early middle-aged 
individuals. In such cases, time still has a role but the fibrillogenic process requires less 
time overall because particular biochemical circumstances promote accelerated nucleation. 
The Down’s syndrome is one example for the early onset of an amylodosis. How protein 
aggregates emerge and are involved in the progress of the disease is shown in a case 
example in the next paragraph for the Alzheimer’s disease. 
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1.5 - The Amyloid Peptide: A Paradigm for Peptide Aggregation 
 
The Alzheimer disease is today explained on a molecular level by the "amyloid 
hypothesis", which states that the disease is initiated by the production, aggregation and 
deposition of the amyloid ?-peptide (A?). A? peptide is derived from the 170 kDa 
amyloid peptide precusor protein (APP), as a natural cleavage product
83, 84
. It is generated 
by cleavage of APP at two locations by proteases denoted as the ?- and ?-secretases. The 
initial proteolysis by the ?-secretase results in a residual C-terminal fragment containing 
the transmembrane and cytoplasmic domains of APP, which undergoes an additional, 
intramembranous cleavage by a ?-secretase to release A?. The ?-secretase cleavage site is 
heterogeneous and produces A? fragments that can vary in length from 39-42 residues85, 
86
. However, the two predominant species are peptides 1-40 (A?40) and 1-42 (A?42). 
Figure 3 shows the sequence of A?40 and A?42 and their amphipathic character. 
 
AD E F R H D S G Y E V H H Q K L V F F A E D V G S N K G A I I G L M
5 10 15 20 25 30 35
V G G V V
40
A I
42
 
 
Figure 3 Amino acid sequences of A?40 and A?42 in one letter code. Yellow and red marked amino acids 
denote positively and negatively charged residues, respectively under physiological conditions. Amino acids 
labelled in grey at the C-terminus indicate the former membrane domain of the A? peptides. 
 
The peptide A? fragments are found to circulate in nanomolar concentration in the blood 
and cerebrospinal fluid of AD patients but also in unaffected individuals
87, 88
. The soluble 
monomeric form of both peptides are generally considered to be non-toxic
89
. The hallmark 
of the Alzheimer’s disease is however the formation of A? fibrils. A? fibrils are visible in 
large plaques in the extracellular matrix of the neuronal tissue
89
. Therefore the prevailing 
explanation for the toxicity involves association of A? peptides and a structural transition 
of the polypeptide chain from the native to misfolded conformation. Several lines of 
evidence have converged recently to demonstrate that soluble oligomers of ?-sheet 
aggregated A?, may be responsible for synaptic dysfunction in the brains of AD patients. 
Metastable intermediates in the formation of fibrils by synthetic A?, referred to as AD
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 diffusible ligands (ADDLs) or protofibrils
90
, also cause injury to cultured neurons. But 
the most conspicuous form of the A? peptides is the mature amyloid fibril91. 
The amyloid hypothesis remains nevertheless controversial because a specific neurotoxic 
species of A? and the nature of its effects on neural function have not been defined in 
vivo. To shed light on the toxicity of A?, research focused on in vitro experiments to 
characterize the self-aggregation process of A?. Unfortunately, the attempt to quantify the 
self-aggregation process and the accompanied conformational change of A? were 
confounded by the range of apparently conflicted behaviors observed. A? peptides are 
polymorphic and the structure of these peptides are highly depending on the 
environmental conditions, such as pH, salt concentration, temperature or pressure
92-95
. 
Wile the natural conformation of A? within the APP is believed to be ?-helical96, the 
monomeric soluble form of A? adopts a random coil structure. In water/alcohol mixtures 
or in micellar solution, which are used as membrane mimicries, A? adopts an ?-helical 
conformation
97
. The position and length of the helical segments varies according to the 
media applied
98, 99
. A random coil conformation is observed in aqueous solution 
100, 101
. 
However, structural studies of protofibrils have shown that the prevailing structural 
element in these precursors of fibrils and matured fibrils is the ?-sheet (see chapter 1.2). 
Apart from the structural changes of A?, the discrepancy between the experimentally 
defined critical concentration of fibril formation (in the micromolar range in pure water)
28, 
53
 and the A? concentration in the blood and cerebrospinal fluid of AD patients (in the 
nanomolar range)
87, 88
 are thought to be a key hint for the understanding of A? 
aggregation. In order for A? amyloid formation to occur in the brain, a process must exist 
whereby a local A? concentration is created, which exceeds the naturally occurring 
concentration by three orders of magnitude. A simple way to explain the concentration 
difference is to assume that an endogenous substance could lower the in vivo critical 
concentration. This theory is supported by the finding that amyloid plaques consist not 
only of A? fibrils but contain also of non-fibrillar components including 
glycosaminoglycans
102
 
103
, apolipoprotein  E
104
, metal ions
39, 105
 and serum amyloid P 
component (SAP)
106
. Most of these substances accelerate fibril formation in AD but not all 
of them promote ordered aggregation in vitro. Another mechanism for achieving a high 
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local A? concentration is the binding of A? to proteoglycans or directly to the cell 
membrane surface (see also chapter 1.3). 
The cell membrane surface is of special interest not only due to its capability to assist 
fibril formation but also because it is the target of A? mediated cell death107. Oligomers, 
which are formed in the close vicinity of the membrane, are suspected to alter the 
membrane structure, which then leads to cell death. Several experiments give rise to 
speculations how A? is influencing the lipid membranes. For example, the possibilities of 
membrane channel formation
108
 and the disruption
109
 of neuronal cell membrane by A?  
have been pointed out. In both cases partitioning of the peptide into the cell membrane is 
stipulated. On the other hand, A? can cause changes of the lipid membrane mobility, 
integrity or simply insulation by absorption to lipid membrane surface
110, 111
. 
Specific interaction of A? with gangliosides112, a major lipid component in neural cell 
membranes, with cholesterol
113, 114
 or with phosphatidylinositol
115
 have been proposed. A 
more general mechanism for the binding of A? to lipid membranes is described by 
electrostatic interactions A?  to negatively charged phospholipids membranes (containing 
phosphatidylserin or phosphatidylgycerol)
53
. Interaction of A? with membrane surfaces 
promotes a conformational transition in favor of the ?-sheet structure at low lipid to 
peptide ratio, but at high lipid peptide ratios also the ?-helical structure is observed53. 
Deuterium NMR studies have shown that interactions of A? with the lipid membrane are 
exclusively localized to the membrane surface, with no significant insertion of the peptide 
into the lipid bilayer
101
. Similar, studies of lipid monolayers found insertion of A? only at 
lateral pressure below those found in lipid bilayers
101
. In contrast, a number of studies has 
demonstrated a disruption of membrane integrity caused by A? which presumably implies 
the penetration of the peptide into the hydrophobic core of the bilayer
109, 116
. All of the 
studies worked with the hypothesis that A? peptides might stay in the lipid membrane 
upon its cleavage from the amyloid precursor protein. However, to observe insertion of 
A? into lipid membranes the peptides has to be co-solubilized with lipids in organic 
solvents, before both components are transferred to aqueous solution
117-119
. The anchored 
form of A? has been shown to alter the fluidity of phospholipid membranes. All of these 
studies have not yet led to a comprehensive understanding of the structural detail of the 
A? interaction with the lipid membrane. 
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1.6 - The KIGAKI Peptide as Model System of Protein Aggregation 
 
The previous sections have demonstrated the complexity of protein aggregation. The 
studies of A? or other amyloid forming peptides suffer from a major experimental 
problem: the lack of a method to quantify aggregation. The drawbacks of using naturally 
derived proteins or peptides as model systems for aggregation and ?-sheet formation are 
mainly low solubility, structural polymorphism, and strong environmental dependencies 
i.e. pH, temperature and salt conditions of the aggregation and conformational folding 
process. Additionally, synthesis of insoluble peptides, such as A? variants, is extremely 
difficult
120
. Impurities arising from the synthesis have significant effect on the aggregation 
thermodynamics and kinetics
30
.  
A designed model system for peptide aggregation in a membrane environment, should 
resemble the natural amyloid forming proteins and peptides in the their common 
characteristics: (a) strong electrostatic binding of the protein or peptide to negatively 
charged lipid membranes, (b) random coil-to-?-sheet transition upon binding to the lipid 
membrane followed by (c) association and formation of oligomers and larger aggregates. 
The peptide with the sequence of (KIGAKI)3 complies with these basic requirements
121
. 
Moreover, due to its net positive charge of its lysine residues the peptide is well soluble 
(>2 mM) and self-aggregation in aqueous solution at a pH lower than 9 could not be 
observed. Although, the (KIGAKI)3 peptide sequence has been designed, its sequence 
pattern of polar and unpolar amino acids is also found in natural derived amyloid peptides, 
like within the polyglutamine repeats of the exon-1 peptide, which is related to the 
Huntington’s disease
17
. 
In contrast to the A? peptides, which forms helix and ?-sheet structures, the (KIGAKI)3 
peptide can only form ?-sheet structures at the membrane surface, which simplifies the 
investigation of conformational changes (see figure 3). In addition, the chemical synthesis 
of (KIGAKI)3 is much simpler than that of A?, due to the shorter chain length and higher 
polarity. 
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Figure 3. Helical wheel (left) and ?-sheet diagram (right) showing the distribution of amino acids (red = 
positively charged lysine, grey = hydrophobic amino acids, white = glycine). The hydrophobic moment (μH) 
is calculated by using the consensus hydrophobicity scale and is denoted for both conformations
122
. The 
picture is taken from reference
121
. 
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2. Aims of research 
 
The formation of aggregates with similar structures by proteins of unrelated primary 
sequence suggests a generic mechanism governing the process. A full understanding of the 
protein aggregation mechanism requires the knowledge of the thermodynamic and 
conformational changes occurring during the protein transition from a native to an 
aggregated state. The study of the thermodynamic driving forces and structural changes of 
an aggregation process is the main goal of this thesis. 
The most abundant structural element in protein aggregates is the ?-sheet. It has been 
proposed that intermolecular ?-sheet formation is the initial molecular event in the protein 
aggregation pathway, especially in the case of amyloid formation. For this purpose we 
attempted to develop a well-defined model system for a random coil ? ?-sheet transition, 
which allows drawing general conclusions about the structural and thermodynamic 
properties of protein aggregation. 
A promising model peptide to study the random coil ? ?-sheet transition is the 
(KIGAKI)3 peptide. The benefit of the KIGAKI3 peptide is that the structural transition of 
interest can be induced upon binding to anionic lipid vesicles. To understand membrane 
induced ?-sheet folding for the (KIGAKI)3 peptide, we first have to understand peptide 
binding to the membrane surface. Therefore, the first part of this thesis (Chapter 3) derives 
and evaluates a general binding model for charged molecules to lipid membranes. The 
binding model is in particular suitable for data evaluation of isothermal titration 
calorimetry (ITC) experiments. ITC is the most direct technique to measure 
thermodynamic parameters and thus it will serve to identify the driving forces of the 
random coil ? ?-sheet folding reaction in a membrane environment (Chapter 4). 
A further aim is to investigate the difference between the ?-sheet folding reaction in a 
native and aggregated protein (Chapter 5). Current models of extended ?-sheets, like in 
amyloid fibrils, indicate that ?-sheet folds in aggregates tend to be distinctively longer 
(about 10 residues) than in native proteins (2 to 6 residues). Therefore the length 
dependence of the random coil ? ?-sheet folding reaction is studied for a set of peptides 
with the repeating sequence of KIGAKI to reveal differences in the folding reaction. 
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In order to obtain information about the structure and dynamics of the (KIGAKI)3 peptides 
at the membrane surface, we employ circular dichroism (CD) and nuclear magnetic 
resonance spectroscopy (NMR) (Chapter 4 and 5). An experimental strategy was 
developed to gradually disrupt the extended ?-sheet structure of (KIGAKI)3 at the 
membrane surface. Spectroscopic results were correlated with the thermodynamic 
observations of the ?-sheet folding reaction. In addition, we focused on gaining 
information about the size and mobility of extended ?-sheet structure at the membrane 
surface. With respect to medical implications we are also interested to investigate the 
integrity of the lipid membrane upon binding and formation of ?-sheet aggregates. 
In chapter 6 we provide a new approach to determine high-resolution structures of peptide 
aggregates at lipid membrane surfaces. For this purpose we encapsulate the (KIGAKI)3 
peptide in reverse micelles. The surfactant interface of the reverse micelles is thought to 
mimic the biological membrane environment while fast correlation of reverse micelles in a 
low viscosity solvent enhances spectroscopic resolution. 
In a further part of the thesis we study partitioning of xenon atoms into lipid bilayers by 
129
Xe- and 
2
H-NMR (Chapter 7). Xenon membrane partitioning is of special interest due 
to the ability of xenon to induce general anesthesia. The participation of lipid molecules in 
mediating the anesthetic effect has been a long lasting question. We have probed lipid 
molecule and xenon atoms upon partitioning by NMR in order to shed light on this 
question. Because of profound differences of xenon compared to other common anesthetic 
components we expect to obtain new information on the mechanism of the anesthetic 
effect. 
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3.1 – Summary: Interaction of Verapamil with Lipid Membranes and P-
glycoprotein: Connecting Thermodynamics and Membrane Structure 
with Functional Activity 
 
The first part of the thesis is a general thermodynamic binding study of a model drug 
component to the membrane protein P-glycoprotein (Pgp), an ABC transporter that binds 
its substrates generally from the inner leaflet of the lipid membrane. This work is directly 
linked to the overall topic of peptide aggregation at membrane surfaces due to the fact that 
binding of charged molecules, like drug components or peptides, to lipid membranes obey 
the same thermodynamic rules. We therefore derived a binding model with the Gouy-
Chapman theory, which takes electrostatic attraction and repulsion between charged 
molecules and lipid membranes to consideration. The binding theory does not differentiate 
between incorporation and adsorption of charged molecule to the lipid membrane. In order 
to evaluate and test the binding model, we studied binding of a well behaving drug 
component, verapamil, to lipid membranes under different electrostatic conditions by 
isothermal titration calorimetry. Within the presented work we evidence that the derived 
Gouy-Chapman binding model is valid for binding of charged molecules to positively, 
neutral and negatively charged lipid membranes under a variety of conditions. It is thus 
the framework for the following peptide binding studies. 
Concomitantly, we correlated the determined lipid binding parameters of verapamil with 
functional activity measurements of Pgp, to answer biologically relevant questions of drug 
membrane and protein interactions. Accordingly, verapamil is a substrate of P-
glycoprotein. Pgp binds drugs form the cytosolic leaflet of the cell membrane and exports 
them to the extracellular environment. As a consequence, Pgp may cause multidrug 
resistance if overexpressed upon a prolonged exposure of biological cells to such drugs. In 
this view, it is a long-lasting question, how Pgp recognize its various substrates. Most 
theoretical predictions of substrate binding to Pgp failed simply due to unknown or 
inconsistent experimental binding data. The major drawback in studying substrate binding 
to Pgp is that the drug first has to partition into the membrane. Binding data of substrates 
to Pgp hitherto published are binding constants, which include the membrane partition 
coefficients of the drugs. Here, strong binding constants reflect mostly the hydrophobicity 
of the drug ("membrane partitioning") and not the intrinsic binding to Pgp. Conclusions 
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from such binding constants about the molecular interactions between drugs and to Pgp 
are thus misleading. 
We therefore revealed for the first time direct drug-Pgp binding constants within the lipid 
bilayer by dissecting the binding process into two steps, namely into a partitioning step of 
the drug from the aqueous phase into the lipid membrane, and a binding step of the drug to 
the Pgp active site in the membrane. The resulting binding constant of verapamil to Pgp 
revealed that the effective free energy of binding is only about -4.7 kcal/mol, which 
explains the low specificity of Pgp for its substrates. For two other drugs of the same 
family (Calcium antagonists) we found comparable values for the free energy of binding. 
Using a novel hypothesis for substrate recognition of Pgp via well-defined hydrogen bond 
acceptor groups, we calculated an average free energy of hydrogen bond formation of -
0.95 kcal/mol between Pgp and verapamil. Finally, alteration of lipid conformation upon 
membrane-insertion of verapamil and thus possible changes of the activity on Pgp could 
be excluded by deuterium nuclear magnetic resonance spectroscopy. 
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3.2 – Published Article 
 
Interaction of Verapamil with Lipid Membranes and P-Glycoprotein:
Connecting Thermodynamics and Membrane Structure with
Functional Activity
M. Meier, X. Li Blatter, A. Seelig, and J. Seelig
Department of Biophysical Chemistry, Biozentrum, University of Basel, Basel, Switzerland
ABSTRACT Verapamil and amlodipine are calcium ion influx inhibitors of wide clinical use. They are partially charged at neutral
pHandexhibit amphiphilic properties. Thenonchargedspecies caneasily cross the lipidmembrane.Wehavemeasuredwith solid-
state NMR the structural changes induced by verapamil upon incorporation into phospholipid bilayers and have compared them
with earlier data on amlodipine and nimodipine. Verapamil and amlodipine produce a rotation of the phosphocholine headgroup
away from themembrane surface and a disordering of the fatty acid chains.We have determined the thermodynamics of verapamil
partitioning into neutral andnegatively chargedmembraneswith isothermal titration calorimetry. Verapamil undergoesapK-shift of
DpKa¼ 1.2 units in neutral lipid membranes and the percentage of the noncharged species increases from 5% to 45%. Verapamil
partitioning is increased for negatively charged membranes and the binding isotherms are strongly affected by the salt
concentration. The electrostatic screening can be explained with the Gouy-Chapman theory. Using a functional phosphate assay
we havemeasured the affinity of verapamil, amlodipine, and nimodipine for P-glycoprotein, and have calculated the free energy of
drugbinding from theaqueousphase to theactive center ofP-glycoprotein in the lipid phase.By combining the latter resultswith the
lipid partitioning data it was possible, for the first time, to determine the true affinity of the three drugs for the P-glycoprotein active
center if the reaction takes place exclusively in the lipid matrix.
INTRODUCTION
Broad-spectrum resistance to chemotherapeutic agents has
been termed multidrug resistance (MDR). Although several
mechanisms may contribute to MDR in mammalian cells, the
best characterized is the efflux or flippase activity of the 170
kDa plasma membrane protein P-glycoprotein (Pgp, MDR1,
or ABCB1). Pgp binds its substrates in the cytosolic leaflet of
the lipid membrane and flips them to the extracellular leaflet
or exports them to the extracellular environment (for review
see (2)). Substrate binding to Pgp is best described by a two-
step mechanism consisting of 1), a lipid-water partitioning
step followed by 2), a binding to the transporter in the lipid
phase (l) (3,4). The overall binding constant Ktw for the
binding from the aqueous phase (w) to the transporter (t) can
thus be expressed as product of the lipid-water partition co-
efficient,Klw, and the transporter binding constant in the lipid
phase, Ktl (5). We measured the transporter-water binding
constant, Ktw, and the lipid-water partition coefficient, Klw,
for several structurally different drugs and derived the corre-
sponding free energies of binding DG0tw and DG
0
lw. The free
energy of substrate binding to Pgp in the lipid membrane,
DG0tl, cannot be measured directly but was determined as the
difference DG0tl ¼ DG0tw  DG0lw (6). The value DG0tl can be
rationalized with a modular binding concept based on
hydrogen-bond formation (6–8).
The quantitative understanding of the two-step Pgp binding
mechanism is of importance for efficient pharmacotherapy as
well as for drug design. We therefore have selected three
calcium channel blockers (verapamil, amlodipine, and
nimodipine) of chemically different structure but similar num-
bers of hydrogen-bond modules (Fig. 1) for a detailed ther-
modynamic and functional study. Verapamil (pKa 8.9 (9))
and amlodipine (pKa 8.6 (10)) are positively charged at pH
7.4 whereas nimodipine is electrically neutral. Using ther-
modynamic and spectroscopic techniques we examine the
partitioning of verapamil into phospholipid membranes and
compare it to previous studies on amlodipine and nimodipine
(11). The structure of the lipid membrane at different con-
centrations of verapamil was elucidated with solid-state NMR
methods using selectively deuterated lipids. The influence of
verapamil on the order of the lipid membrane is of special in-
terest since it was claimed that a decrease in membrane order
would reduce the activity of Pgp (for review, see (12,13)).
The thermodynamic results are correlated with a functional
assay for the binding of the three calcium-channel antago-
nists to Pgp in inside-out vesicles of MDR1-transfected
mouse embryo fibroblasts (NIH-MDR1-G185) (14,15) and
compared to extracellular acidification rate measurements
performed with living cells (6,16,17).
MATERIALS AND METHODS
Materials
Verapamil hydrochloride was purchased from Fluka Biochemika (Buchs,
Switzerland), amlodipine maleate from Sequoia Research Products
(Pangbourne, United Kingdom), and nimodipine from Sigma-Aldrich
(Sternheim, Germany). 1-palmitoyl-2-oleoyl-sn-glycero-3-phosphocholine
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(POPC), 1,2-dioleoyl-trimethylammonium-propane (DOTAP), and 1-palmitoyl-
2-oleoyl-sn-glycero-3-phosphoglycerol (POPG) were from Avanti Polar
Lipids (Alabaster, AL). All other chemicals were purchased at highest purity
from commercial sources.
Preparation of lipid vesicles
Small unilamellar vesicles (SUVs) of ;30 nm diameter were prepared as
follows. Defined amounts of lipid were dissolved in chloroform and were
dried first with a stream of N2 and then overnight under high vacuum. For
binary lipid mixtures the second lipid was added in chloroform solution to
the dried film of the first lipid and treated as before. Subsequently, buffer
solution (typically 50 mM HEPES, pH 7.4, plus various NaCl concentra-
tions) was added to the lipid film and the mixture was vortexed extensively.
Next, the lipid dispersion was sonicated under a nitrogen atmosphere for
10–25 min (at 10C) until a clear solution was obtained. Metal debris from
the titanium tip was removed by centrifugation at 14,000 g for 10 min.
Cell lines and cell culture
The mouse embryo fibroblast cell lines NIH3T3 and NIH3T3 transfected
with the human MDR1 gene, NIH-MDR-G185, were generously provided
by Dr. M. M. Gottesman, National Institutes of Health, Bethesda, MD. Cells
were maintained as described earlier (16,17). From these cells crude mem-
branes were prepared as described elsewhere (17,18).
NMR measurements
POPC was deuterated either at the a- or b-position of the choline headgroup
or at the cis-double bond of the oleic acyl chain (carbon atoms C-99, C-109)
(19,20),
POCH2 CH2N
a b
A defined amount of deuterated lipid was transferred into a NMR sample
tube (typically 10–20 mg lipid) and drug/buffer solution was added to
achieve a predefined drug/lipid ratio. For all NMR samples we used 25 mM
MES, pH 5.5, and 100 mM NaCl as buffer. The concentration of verapamil
was determined before mixing by UV spectroscopy at l ¼ 277 nm (e ¼
5818.8 M1 cm1). To achieve a homogeneous suspension, the sample was
extensively vortexed at room temperature with several freeze-thaw cycles in-
between. Centrifugation at 30,000 g for 60 min at room temperature led to a
clear supernatant. To calculate the molar amount of verapamil bound per
mol of POPC, Xb (mol/mol), the verapamil concentration in the supernatant
was determined again. A flat baseline above 380 nm was used as a criterion
FIGURE 1 Chemical structures and
conformational models of three calcium
channel antagonists: verapamil, nimo-
dipine, and amlodipine. The three-
dimensional structures were obtained
by searching the most amphiphilic,
energy-minimized conformation with
the minimal cross-sectional area, AD.
Oxygen and nitrogen molecules are
shown in red and blue, respectively.
Hydrogen-bond acceptors, constituting
the binding modules for P-glycopro-
tein, are connected with dotted yellow
lines. Pgp does not accept secondary
amino groups (NHR) or NO2
groups (for details, see (7)).
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for complete lipid removal. All 2H-NMR experiments were performed on a
Bruker Avance 400 MHz spectrometer (Bruker AXS, Berlin, Germany).
2H-NMR spectra were recorded at 64 MHz with the quadrupole echo tech-
nique. The lipid pellets were used without further manipulations. 2H-NMR
spectra simulation was done with the NMR WebLab V.4.0 program (21).
31P-NMR spectra were recorded at 161 MHz using a Hahn echo sequence
with broadband proton decoupling (WALTZ-16) and a recycle delay of 6 s.
The chemical shielding anisotropy, Ds, was measured as full width at 10%
maximum intensity.
Isothermal titration calorimetry
Isothermal titration calorimetry was performed with a VP ITC instrument
(Microcal, Northampton, MA). Unless noted otherwise, measurements were
made at 37C. Appropriate buffer solutions were freshly prepared and the
pH was properly adjusted when the temperature was changed. The sample
cell contained the verapamil solution at a concentration of typically 100 mM.
Lipid vesicles suspended in the same buffer as verapamil (lipid concentra-
tion of ;25–30 mM) were placed in a 300 mL syringe. Five microliter in-
jections were made every 5 min. As a control, lipid vesicles were injected
into the calorimeter cell containing buffer without verapamil.
Analysis of the ITC data
The classical way to describe drug partitioning into the lipid phase is to use
the bulk concentration, CD,eq. Here CD,eq is the equilibrium drug concentra-
tion far from the membrane surface. The amount of bound drug, Xb ¼
nD=n
0
L, is then given by
Xb ¼ KCD;eq: (1)
Here nD is the molar amount of bound drug and n
0
L is the total lipid available
for binding (for charged drugs that cannot permeate the lipid membrane, n0L
is the lipid on the outer vesicle surface). This simple partitioning law is valid
for neutral drug molecules such as nimodipine. A more complex situation is
encountered for charged drugs as the adsorption of the cationic amphiphiles
leads to a positive surface potential c, repelling ions of like charge. Al-
ternatively, the membrane may contain negatively charged lipids, producing
a negative surface potential. Under these conditions, drug binding is in-
creased because of electrostatic attraction. In both cases, the drug concen-
tration at the plane of binding,CD,M, is not identical to the bulk concentration,
CD,eq, but is given by
CD;M ¼ CD;eqezDcF0=RT; (2)
where zDF0 is the molar electric charge, and RT is the thermal energy. The
partition equilibrium Eq. 1 can then be modified as
Xb ¼ KpCD;M: (3)
Electrostatic attraction/repulsion effects are thus explicitly taken into ac-
count. Equation 3 predicts a linear relationship between the extent ofmembrane-
bound drug and the drug surface concentration. Comparison with Eq. 1
demonstrates that K is not constant for charged drugs but depends on the
surface potential and the effective charge according to K ¼ KpezF0c=RT.
Consequently, K varies with the drug and salt concentration. For a mono-
valent drug such as verapamil and anionic POPC/POPG (75:25 mol/mol)
membranes in 0.1 M NaCl, K is typically 5–10 times larger than Kp
(verapamil concentration is in the mM-range). The surface potential, c, can
be evaluated with the Gouy-Chapman theory (22,23) and the details of this
analysis have been described previously (11,24). The analysis includes the
binding of Na1 ions to phosphatidylglycerol using the Langmuir adsorption
isotherm with a Na1 binding constant of 0.6 M1. In this evaluation the
HEPES buffer was counted as a 1:1 salt. The sulfonic acid has a pKa ; 3.6
(25) and is fully charged; the counterion is Na1. The piperazin ring is 50%
charged. This latter effect was not included.
Surface activity measurements
Surface activity measurements were performed at ambient temperature and
pH 7.4 (50 mMTris buffer, 114 mMNaCl) (26,27). Due to the low solubility
of amlodipine and nimodipine in water, stock solutions were prepared in
methanol. The total concentration of methanol in the Langmuir trough was,
however, ,5% v/v. The surface activity was corrected for the effect of
methanol. Despite this correction, the surface activity of charged drugs dis-
solved in methanol tends to be slightly higher than that of drugs dissolved in
water due to a small pKa shift. To obtain comparable experimental conditions,
verapamil was also injected as methanolic stock solution, despite its better
water solubility.
Pgp-ATPase activation assay
The P-glycoprotein associated ATPase activity was measured according to
Litman et al. (15) in a 96-well microtiter plate. The ATPase assay buffer
contained 25 mM Tris-HCl, 50 mM KCl, 3 mM ATP, 2.5 mM MgSO4,
3 mM DTT, 0.5 mM EGTA, 2 mM ouabain, and 3 mM sodium azide, where
the latter three compounds were used to inhibit the Ca-, the Na/K-, and the
mitochondrial ATPase, respectively. The assay buffer was adjusted to pH
7.4 at 37C. Membrane vesicles were diluted to a protein concentration of
0.1 mg/ml in ice-cold ATPase assay buffer. Each series of experiments
contained 5 mg protein in a total assay volume of 60 ml. Incubation with the
various drugs was started by transferring the plate from ice to a water bath,
where it was kept 1 h at 37C. The reaction was terminated by rapidly cool-
ing the plate on ice. The released inorganic phosphate was determined by
adding to each well an ice-cold stopping medium (200 ml) containing the
color reagent (sulfuric acid 1.43% v/v; and SDS, 0.9% w/v), ammonium
molybdate (0.2% (w/v)), and freshly prepared ascorbic acid (1% (w/v))).
After incubation at room temperature for 30 min, the released phosphate was
quantified calorimetrically at 820 nm using a microplate reader Spectramax
M2 (Molecular Devices, Sunnyvale, CA). To determine the vanadate-sensitive
PgpATPase activity, control samples were incubated in parallel with 500mM
vanadate and the values were subtracted from the values of the Pgp ATPase
activationmeasurements. For stock solutions,drugsweredissolved inDMSO.
The DMSO content of the sample was 1.67% (v/v). The data were analyzed
according to the model proposed by Litman et al. (15),
Vsw ¼ K1K2Vbas1K2V1Csw1V2C
2
sw
K1K21K2Csw1C
2
sw
; (4)
where Vsw is the rate of Pi release as a function of Csw, the substrate con-
centration in aqueous solution; Vbas is the basal activity of Pgp in the absence
of drug; V1 is the maximum transporter activity (if only activation occurred);
and V2 is the minimum activity at infinite substrate concentration. At a
substrate concentration, Csw ¼ K1, half-maximum binding of the activating
binding region is reached and at a substrate concentration, Csw ¼ K2, half-
maximum binding of the inhibitory binding region is reached.
RESULTS
Verapamil-induced structural changes of
the lipid bilayer
Fig. 2 shows 2H-NMR spectra obtained with coarse lipo-
somes composed of POPC, deuterated at the a-segment of
the choline moiety (POCD2CH2N) and measured in
buffer at pH 5.5. Under these conditions, verapamil carries a
charge of z ¼ 11 (pKa 8.9, at 25C (9)).
All spectra are characteristic of liquid crystalline bilayers
with a single quadrupole splitting seen at all drug concen-
trations. A single, time-averaged quadrupole splitting is also
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found for the b-segment of the choline headgroup and the
cis-double bond of the oleic acyl chain (carbon atoms C-99,
C-109). Apparently, themobility of verapamil in the lipidmem-
brane is fast enough so that the presence of the drug is sensed
by all lipids in the bilayer within 105 s even at low drug con-
centration. The quadrupole splitting, DnQ, which is defined
as the separation of the two most intense peaks in the deu-
terium NMR spectrum, is gradually changed as the molar
verapamil/POPC ratio increases. The quadrupole splittings
of the labeled carbon atoms are plotted in Fig. 3 as a function
of bound drug, Xb (mol drug bound per mol lipid), revealing
a linear relationship between the two parameters. For the two
headgroup segments, linear regression analysis yields
DnQðaÞ ¼ 6:45 46:14XbðkHzÞ (5)
and
DnQðbÞ ¼ 5:51 15:3XbðkHzÞ: (6)
Fig. 2 also demonstrates that the quadrupole splitting of the
a-segment collapses to a single line at a mole fraction of;Xb
; 0.14. The bilayer structure remains, however, unchanged
as evidenced by the phosphorus-31 NMR spectra shown next
to the corresponding deuterium NMR spectra. The phos-
phorus-31 NMR spectra with and without verapamil are very
similar and exhibit the typical signature of the bilayer phase
(28). The chemical shielding anisotropy is Ds ¼ 47.9 ppm
and remains approximately constant in the concentration
range investigated. From the shape of the phosphorus-31NMR
spectra it can be concluded that the long-range structure of
the bilayer remains unaltered. The deuterium NMR spectra,
on the other hand, provide evidence for a change in the orient-
ation of the choline dipole.
The verapamil-induced orientational change of the phos-
phocholine headgroup can be specified in more detail. Bind-
ing of the cationic verapamil to neutral POPC membranes
imparts a positive electric charge onto the membrane surface.
The orientation of choline headgroup P-N1 vectorwith respect
to the membrane surface is, however, dependent on the mem-
brane surface charge density (29). In particular, a positive
surface charge moves the N1 end of the P-N1 dipole toward
the water phase. This change in orientation entails a counter-
directional response of the quadrupole splittings of the
a- and b-segment such that DnQ(a) decreases and DnQ(b)
increases. Indeed, this counterdirectional change of the quad-
rupole splitting of the two choline segments is also observed
for verapamil (Fig. 3). The extent of the out-of-plane rotation
cannot yet be quantitated but exceeds that induced by
amlodipine (11) or other monovalent hydrophobic drugs
when applied at a similar membrane concentration (30).
The influence of verapamil on the hydrophobic part of the
bilayer membrane was also examined with deuterium NMR.
The deuterium labels were attached to the cis-double bond
(C-99 andC-109 segment) of the sn-2 oleic acyl chain of POPC.
FIGURE 2 Deuteriumandphosphorus-31NMRspectra ofPOPC liposomes
deuterated at the a-position of the choline headgroup (POCD2CH2N1).
Approximately twenty-five milligrams of POPC was suspended in 50 mL
buffer (25 mM, MES 0.1 M NaCl, pH 5.5, deuterium-depleted water) con-
taining different concentrations of verapamil. The two top spectra correspond
to pure POPC membranes without verapamil. The spectra below are char-
acterized by increasing drug concentrations. The verapamil/POPCmolar ratio
from top to bottom is: 0, 0.02, 0.04, 0.07, 0.11, and 0.14. Virtually all
verapamil is incorporated into the membrane. (Number of FIDs: 2H NMR
spectra 8 K, 31P NMR 2 K.)
FIGURE 3 Variation of the deuterium NMR quadrupole splittings of
POPC membranes with the verapamil/lipid molar ratio. (A) Phosphocholine
headgroup segments: (n) a-CD2 POPC (POCD2CH2N); (d) b-CD2-
POPC (POCH2CD2N1). (B) POPC deuterated at the cis-double bond of
the oleic acyl chain: (n) C-99 deuteron, (d) C-109 deuteron. Measurements
at 22C in buffer (MES 25 mM 1 0.1 M NaCl, pH 5.5).
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The two deuterons give rise to two separate quadrupole
splittings with separations of 13.5 (C-99) and 2.3 kHz
(C-109), even though they are connected to the same rigid
structure (see Fig. 4). The molecular origin of this effect is a
tilting of the cis-double bond with respect to the bilayer
normal (20).
The variation of these quadrupole splittings with the mole
fraction of bound verapamil is included in Fig. 3. The quad-
rupole splittings of both deuterons are moderately decreased
upon increasing the verapamil concentration, according to
DnQðC-99Þ ¼ 11:5Xb1 13:65 ðkHzÞ (7)
and
DnQðC-109Þ ¼ 21:9Xb1 2:3 ðkHzÞ: (8)
The fact that both quadrupole splittings decrease simulta-
neously suggests a disordering of the hydrophobic core upon
verapamil intercalation, that is, a more random motion of the
cis-double bond. This is quite different from amlodipine and
nimodipine, which induce a small increase in the C-99 and
C-109 quadrupole splittings (11).
Fig. 4 illustrates a second effect induced by the incorpo-
ration of verapamil into the lipid bilayer but limited to the
hydrophobic region. All spectra in Fig. 4 were measured
under identical conditions, in particular, the same number of
free induction decays. Inspection of Fig. 4 nevertheless reveals
a loss in signal intensity with increasing amount of verapamil
in the membrane, which can be quantified by spectral sim-
ulation (smooth lines in Fig. 4). The spectrum with the lowest
verapamil concentration serves as a reference spectrum and
the areas under the two quadrupole splittings of this spectrum
are identical (1:1 intensity ratio, Fig. 4, lower panel). At the
highest verapamil concentration (Xb ¼ 0.43) the intensity of
the C-109 deuteron is still 83% of the initial intensity; that of
the C-99 deuteron, however, is reduced to 33%. The most
likely explanation of this effect is a reduction in the rate of
motion of the cis-double bond caused by a weak complex
formation with the aromatic ring system of verapamil. The
reduced rate of motion makes the refocusing of the quad-
rupole echo more difficult, particularly for large quadrupole
splittings. Similar effects have been observed for amlodipine
in POPC membranes (11) and for reconstituted lipid-protein
systems such as sarcoplasmic reticulum membranes, cyto-
chrome c-oxidase, and rhodopsin (31–33). No intensity losses
are observed for the a- and b-segments of the choline head-
group, indicating that the dynamics of the headgroup is not
affected by the presence of verapamil.
Verapamil binding to lipid bilayers: variation of
salt concentration and membrane charge
The adsorption of charged, amphipathic molecules to mem-
branes involves electrostatic and hydrophobic interactions,
protonation reactions, and dehydration effects. They contrib-
ute, to differing extent, to the heat measured in an isothermal
titration calorimetry (ITC) experiment. As an example, Fig. 5
shows the titration of a 100 mM verapamil solution in buffer
(50 mM HEPES, 50 mM NaCl, pH 7.4) with sonicated lipid
FIGURE 4 2H-NMR spectra of POPC membranes deuterated at the cis-
double bond of the sn-2-oleic acyl chain and suspended in buffer with
various verapamil concentrations. Approximately twenty-five milligrams of
lipid suspended in 50 mL buffer (MES 25 mM1 0.1 M NaCl, pH 5.5) were
used. The verapamil/lipid molar ratios from bottom-to-top are 0.003, 0.021,
0.037, and 0.048. The smooth lines are the simulated deuterium NMR
spectra. The lower panel shows the loss in signal intensity of the C-99 and
C-109 deuteron as a function of the verapamil/lipid molar ratio referenced to
the pure POPC spectrum. The C-99 deuteron with a 13 kHz splitting shows a
much steeper intensity loss than the C-109 deuteron with a 2 kHz splitting.
(4 K free induction decays for all spectra.)
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vesicles composed of POPC/POPG (75/25 mol/mol). Ve-
rapamil is contained in the calorimeter cell (Vcell ¼ 1.4037
mL) while the lipid suspension is injected at 5 mL aliquots.
The total lipid concentration is 25 mM. Each lipid injection
causes an exothermic binding reaction as revealed by the
heat flow in Fig. 5 A. The size of the titration peak becomes
smaller with increasing number of injections as less and less
verapamil is available for binding. The integration of the heat
flow peaks yield the heats of reaction, hi, and Fig. 5 B dis-
plays the cumulative heat of reaction, Shi, as a function of
the injection number i.
Fig. 5 further demonstrates that the reaction comes to com-
pletion after n ; 30 injections. The molar binding enthalpy,
DH0D, can then be calculated according to
DH
0
D ¼ +
n
i¼1
hi=n
0
D; (9)
where n0D is the total molar amount of verapamil in the
calorimeter cell. Fig. 6 and Table 1 summarize the binding
enthalpies,DH0D, of verapamil binding to POPC/POPG, POPC,
and POPC/DOTAP membranes, as a function of total salt
concentration (at 37C). HEPES buffer was treated as a mono-
valent salt.
For negatively charged POPC/POPG vesicles the binding
enthalpy is almost independent of the salt concentration and
averages to DH0D ¼ 2:860:5 kcal=mol. Neutral POPC and
cationic POPC/DOTAP vesicles have DH0D values in the
range of 0.4 to 1.1 kcal/mol, which decrease with in-
creasing salt concentration. At salt concentrations ,50 mM
for POPC and ,75 mM for POPC/DOTAP (95:5 mol/mol),
no heat of reaction could be observed. Also, no drug binding
could be measured when the DOTAP molar percentage was
raised above 10 mol %.
It is possible to deduce the amount of bound drug directly
from the calorimetric titration according to
n
ðiÞ
D;bound ¼ +
i
k¼1
hk=ðDH0DVcellC0DÞ; (10)
where n
ðiÞ
D;bound is the molar amount of bound drug after i injec-
tions, +i
k¼1 hkis the cumulative heat of the first i injections,
Vcell is the volume of drug solution in the calorimeter cell,
and C0D is the total drug concentration. The amount of free
drug is then given from mass conservation as
nðiÞD;free ¼ n0D  nðiÞD;bound: (11)
The degree of binding was defined above as
X
ðiÞ
b ¼ nðiÞD;bound=gn0L; (12)
where n0L is the total molar amount of lipid and gn
0
L is the
fraction of lipid accessible to the drug. It is hence possible
to deduce the complete binding isotherm Xb ¼ f (ceq) from
the calorimetric titration without invoking a specific binding
model.
For POPC/POPG vesicles at pH 5.5, n0L is only 60% of the
total lipid (g ¼ 0.6), since the drug is fully charged and cannot
translocate across the membrane. For all other measurements
FIGURE 5 Titration of a 100 mM verapamil solution in 50 mM HEPES,
pH 7.4 with 30 nm unilamellar lipid vesicles in the same buffer. Lipid
composition is POPC/POPG (75:25 mol/mol). The injection of the lipid
vesicles was in 5 mL steps. Measuring temperature 37C. (A) Heat flow and
(B) cumulative heat of reaction as a function of injection number.
FIGURE 6 Reaction enthalpies of verapamil binding to phospholipid
vesicles (30 nm) of different lipid composition. Variation of the binding
enthalpy, DH0D, with the salt concentration. (n) POPC/POPG 75:25 mol/mol,
(d) pure POPC, and (n) POPC/DOTAP 95:5 mol/mol.
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described in this study, a rapid translocation of verapamil
across the membrane was assumed (g ¼ 1). For example,
POPC/POPG vesicles at 150 mM salt and pH 7.4 exhibit a
surface potential of ;30 mV, which reduces the pH near
the membrane surface to pH 6.8. At this pH, the neutral form
of verapamil accounts for only 1% of the total drug con-
centration. However, upon entering the membrane, verapa-
mil experiences a pKa shift by 1.2 units (see below). Both
effects together are sufficient to establish a rapid trans-
membrane equilibrium.
Fig. 7 then displays ITC-derived binding isotherms for
POPC/POPG bilayers at various salt concentrations. The
strongest binding is observed for the lowest salt concentra-
tion where the electrostatic attraction between the anionic
membrane and the cationic drug is maximal. All binding iso-
therms have a curved appearance and the binding constant
defined according to Eq. 1 varies with the verapamil and salt
concentration. At a verapamil concentration of CD,eq ¼ 10
mM, apparent binding constants are K ; 4 3 103 M1. In
contrast, the solid lines in Fig. 7 were calculated with the
Gouy-Chapman theory and a common binding constant
Kp¼ 4106 30M1 describes all three binding isotherms over
thewhole concentration range. The valueKp refers to the bind-
ing of the charged form of verapamil. Table 1 summarizes
the Kp values for the different systems investigated. The
value Kp is distinctly smaller than the apparent binding
constant K, since the electrostatic attraction is not included.
For neutral POPC and cationic POPC/DOTAP vesicles at
pH 7.4, the pH increases near the membrane surface and the
fraction of the neutral form also increases. Membrane trans-
location of the drug is thus easily possible. Fig. 8 shows
binding isotherms for POPC SUVs (three different salt con-
centrations) and for POPC/DOTAP SUVs. The extent of
drug binding to POPC and POPC/DOTAP SUVs is clearly
smaller than that observed for POPC/POPG SUVs at the same
salt concentration. Electrostatic attraction/repulsion is the
dominant factor for verapamil binding to charged membranes.
For anionic POPC/POPG membranes the electrostatic
FIGURE 7 Verapamil binding isotherms for POPC/POPG membranes
(75:25 mol/mol) at three different salt concentrations. All measurements
made at pH 7.4 and 37C. 50 mM HEPES1 50 mM NaCl; 50 mM HEPES;
and 25 mM HEPES. The solid lines were calculated with the partition
constants, Kp, given in Table 1 and the Gouy-Chapman theory. A rapid
translocation of the neutral form of verapamil across the membrane was
assumed.
TABLE 1 Thermodynamics of verapamil binding to phospholipids bilayer vesicles of different charge and size
SUV
30 nm
POPC
mol %
POPG
mol %
HEPES
mM
NaCl Drug electric charge near
membrane surface Æzæ DH0D kcal=mol Kp M
1 DG0D kcal=mol
75 25 50 100 0.84–0.89 3.2 520 3.84
75 25 50 50 0.87–0.93 2.1 400 3.75
75 25 50 25 0.88–0.94 2.8 450 3.75
75 25 50 0 0.91–0.96 3.3 300 3.50
80 20 25 0 0.91–0.97 2.5 380 3.65
80 20 5 0 0.96–0.99 2.9 330 3.56
100 50 100 0.57–0.63 1.1 900 4.18
100 50 50 0.57–0.62 0.9 800 4.1
100 50 25 0.53–0.61 0.4 1200 4.35
TRIS
100 50 100 0.59–0.64 3.1 900 4.18
PO4
100 50 100 0.59–0.64 11.4 750 4.06
DOTAP HEPES
94.2 5.8 50 100 0.49–0.51 1.1 500 3.81
LUV
100 nm 100 50 100 0.61–0.64 1.0 470 3.78
100 50 50 0.61–0.63 1.1 400 3.68
100 50 25 0.59–0.63 0.6 500 3.81
Note that all measurements are at 37C, pH 7.4.
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interaction is favorable, for cationic POPC/DOTAP mem-
branes it is repulsive. However, even for neutral membranes,
electrostatics is important since the membrane surface
becomes positively charged as soon as the first cationic
drug molecule is incorporated into the membrane. Further
binding of drug molecules thus becomes increasingly more
difficult. The solid lines in Fig. 8 were again calculated with
the Gouy-Chapman theory.
The results described above were obtained with vesicles
prepared by sonication, having an average diameter of ;30
nm (SUV). Verapamil binding to POPC membranes was also
studied with unilamellar vesicles of 100 nm diameter (LUVs)
prepared by extrusion through polycarbonate filters. LUVs
exhibit a tighter lipid packing than SUVs and resemble more
closely planar lipid bilayers. The ITC data were analyzed
with the same model as described for SUVs. Again fast
translocation of the drug (in its uncharged form) across the
membrane was assumed. The experimental results are in-
cluded in Table 1. The reaction enthalpy at 37C is DH0D ¼
1:1 kcal=mol for SUVs and DH0D  1:0 kcal=mol for
LUVs. The binding constants, again deduced with the Gouy-
Chapman theory, are somewhat smaller than those of SUVs
(see Table 1).
Membrane-induced pKa shift of verapamil
The ionization constant of verapamil in aqueous solution at
25C is pKa 8.9 (9). It is temperature-dependent and decreases
with increasing temperature (see below). A decrease in pKa
can also be expected for verapamil entering the lipid mem-
brane, because the neutral form is favored in the nonpolar
environment. The pKa shift was quantified by measuring the
binding reaction in buffers of different dissociation en-
thalpies, since the reaction enthalpy is the sum of the ve-
rapamil deprotonation and the buffer protonation. Verapamil
binding to POPC vesicles yields DH0D ¼ 3:0 kcal=mol in
50mMTris buffer,DH0D ¼ 1:1 kcal=mol in 50mMHEPES
buffer, and DH0D ¼ 11:4 kcal=mol in phosphate buffer (all
measurements at 100 mM NaCl, pH 7.4). This provides
evidence for a deprotonation reaction (34–36) of verapamil
as it enters the membrane. Fig. 9 shows a plot of the binding
enthalpy, DH0D, versus the buffer dissociation enthalpy,
DHbuffer, yielding
DH
0
D ¼ 0:41DHbuffer1 1:5: (13)
From the slope it can be deduced that 0.41 H1 dissociate
upon verapamil insertion into the neutral POPC membrane.
While the average charge of verapamil in solution at pH 7.4
is ÆzDæ ¼ 0.97 e.u., the membrane-bound drug carries an
average charge of ÆzDæ  0.56 e.u. The reduction by dz ¼
0.41 e.u. can be traced back to two sources. Upon binding to
the membrane, verapamil repels H1 ions from the membrane
surface. At 150 mM salt and 0.1 mM verapamil, the pH at the
membrane surface increases to ;pH 7.6 and the electric
charge of verapamil decreases concomitantly to z¼ 0.95 e.u.
(dz ¼ 0.02 e.u.). However, from the buffer dependence one
deduces a much larger change of dz¼ 0.41 e.u., attesting to a
FIGURE 8 Binding of verapamil to POPC SUVs and mixed POPC/
DOTAP (94.2:15.8 mol/mol) SUVs at various salt concentrations. (s) Pure
POPC SUVs; (h) POPC/DOTAP SUVs. All measurements in 50 mM Tris
or HEPES buffer 1 various concentrations of NaCl at 37C: The solid lines
are theoretical binding isotherms calculated with the partition coefficients
listed in Table 1.
FIGURE 9 Variation of the verapamil binding enthalpies with the buffer
dissociation enthalpies. POPC vesicles with 30 nm diameter. Measurements
made in Tris (DHDiss ¼ 11.51 kcal/mol), HEPES (DHDiss ¼ 4.9 kcal/mol),
and phosphate (DHDiss ¼ 1.22 kcal/mol) at 37C (36).
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 pKa shift as the drug enters the hydrophobic environment. At
pH 7.6, a pKa shift from pKa; 8.9 to pKa; 7.7 reduces the
charge from Æzæ ¼ 0.95 to z ¼ 0.56 (dz ¼ 0.39). The two
effects together (pH change plus pKa shift) then explain the
experimental data. Based on chemical equilibria consider-
ations it can be calculated that the uncharged drug has a
10DpKa;16-times higher partition-coefficient for the lipid
membrane than the protonated species. The binding constant
of uncharged verapamil is thus Kp ¼ 6.5 3 103 M1 for
POPC/POPG membranes and Kp ; 1.6 3 10
4 M1 for
POPC vesicles (at pH 7.4 and 37C).
For membranes composed of diphytanoyl PC, a dissoci-
ation constant for uncharged verapamil was estimated as
Kd ¼ 0.061 6 0.01 mM at pH 10.5 based on electrophoretic
and membrane potential measurements (37). This translates
into a binding constant of Kp ¼ 1.6 3 104 M1.
We also measured the molar reaction enthalpy of verap-
amil binding to POPC vesicles at pH 5.5. At this pH,
verapamil is fully charged and no deprotonation takes place
upon binding to the membrane. The binding enthalpy was
found to be DH0DðpH 5:5Þ ¼ 2:7 kcal=mol. On the other
hand, the (extrapolated) binding enthalpy at pH 7.4 in the
absence of a buffer dissociation reaction is DHD (pH 7.4) ¼
1.5 kcal/mol (see Fig. 9 for DHDiss¼ 0). The value DHD (pH
7.4) is thus composed of the binding enthalpy of the fully
charged drug, DHD (pH 5.5), plus the dissociation enthalpy
for 0.41 H1,
DHDðpH 7:4Þ ¼ DHDðpH 5:5Þ1 0:41DHNHDiss; (14)
where DHNHDiss is the dissociation enthalpy of the verapamil
amino group. The latter is then calculated as DHNHDiss ¼
10:2 kcal=mol. This result is consistent with data obtained
for N-terminal amino group of peptides where the dissoci-
ation energy is ;11 6 2 kcal/mol (38).
Heat capacity change DCP
0
We have measured the temperature-dependence of the
verapamil-membrane partition equilibrium. For PC/PG
(75:25 mol/mol) membranes in 50 mM HEPES at pH 7.4,
DH0D shows only a small temperature-dependencewith amolar
heat capacity of DC0P ¼ 14 cal=molK. For pure PC SUVs in
buffer (100 mM NaCl, 50 mM HEPES, pH 7.4), the heat cap-
acity change is DC0P ¼ 12 cal=molK.
Molecular cross-sectional area and air-water
partition coefficient
Amphiphilic molecules such as verapamil, amlodipine, and
nimodipine partition into the air-water and lipid-water inter-
face such that the polar groups remain in either the aqueous
phase (e  80) or the polar headgroup region of the lipid
membrane (e  30). The hydrophobic group is then exposed
to air (dielectric constant, e  1) or inserts into the lipid core
region (e  2). The approximate conformation of the three
Ca21 blockers, calculated by optimizing polar and nonpolar
interactions, are shown in Fig. 1 (39). The cross-sectional
areas of the three molecules, relevant for membrane inser-
tion, were calculated as AD ¼ 82 A˚2 for verapamil, 66.2 A˚2
for amlodipine, and 69.4 A˚2 for nimodipine.
The surface activities of the three Ca21 blockers were mea-
sured with the Wilhelmy plate method (data not shown) and
were described by the Szyszkowski isotherm. The measured
cross-sectional area of verapamil in aqueous solution is AD¼
82 6 2 A˚2 and in good agreement with the calculated value.
The cross-sectional areas of amlodipine (AD ¼ 122 A˚2) and
nimodipine (AD ¼ 87 A˚2) are, however, larger than the cal-
culated data, which is caused by association effects at higher
concentrations. For the following calculations, we use the
calculated cross-sectional areas.
The air-water partition coefficients are KA/W ¼ 1.7 3 105
M1 for verapamil, KA/W ¼1.9 3 106 M1 for amlodipine,
and KA/W ¼ 7.1 3 105 M1 for nimodipine. Insertion into
the lipid bilayer expands the surface area and requires ad-
ditional expansion work pAD (40) where p is the monolayer-
bilayer equivalence pressure (41). The lipid-water partition
coefficient can then be calculated from the air-water partition
coefficient as KLip/W ¼ KA/W exp (p AD/kT) (26). For
POPC LUVs (100 nm) and planar membranes with an
equivalence pressure of p ; 30 mN/m, the lipid-water par-
tition coefficient of charged verapamil is predicted to be
Klip/W  540 M1 in excellent agreement with the ITC
measurements. For amlodipine Klip/W¼ 1.83 104 M1, again
in good agreement with previous ITC measurements (Kp ¼
1.6 3 104 M1 at pH 7.2, (11)). For nimodipine, the lipid
water partition coefficient was calculated as Klip/W ¼ 5.4 3
103 M1. This value must be considered as a lower limit as
nimodipine has a strong tendency to adsorb to the vessel walls.
The data are summarized in Table 2.
P-glycoprotein transporter activity measurements
with verapamil, amlodipine, and nimodipine
The P-glycoprotein transporter (Pgp) accepts its substrates
from the cytosolic membrane leaflet. The Pgp transport eff-
iciency is determined by 1), the lipid solubility of the sub-
strate; and 2), the affinity of the substrate for the transporter
in the lipid phase. The latter can be estimated on the basis of
characteristic hydrogen-bonding patterns (6,7). Pgp shows
basal activity in the absence of substrates. In the presence of
substrates it follows a bell-shaped curve with an initial in-
crease in activation (characterized by the concentration of half-
maximum activation, K1) followed by a decrease in activa-
tion at higher drug concentrations (characterized by the
concentration of half-maximum inhibition, K2). The model is
detailed in references (6,15). Experimental results obtained
with inside-out vesicles using a phosphate assay are shown
in Fig. 10 for both verapamil and amlodipine. The quanti-
tative analysis in terms of the model described by Litman
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et al. (15) yields the parameters K1, K2 and also the cor-
responding reaction velocities V1 and V2. The data are
summarized in Table 2. As outlined previously, the param-
eters K1 and K2 can be interpreted as dissociation constants.
Table 2 reveals that amlodipine has a higher affinity to Pgp
than verapamil during the activation phase. Whereas the in-
hibition phase can be well measured for verapamil it cannot
be measured to high concentrations for amlodipine and
nimodipine due to drug association in solution. Partitioning
into the lipid membrane requires the monomeric form of
drugs and is not possible at concentrations which are higher
than the critical micelles concentration.
DISCUSSION
Structural aspects of verapamil binding
Verapamil HCl is a calcium-ion influx inhibitor of wide
clinical use. It is administered as a racemic mixture of R- and
S-enantiomers. At low drug concentration and pH 7.4, a neu-
tral (3%) and a charged species (97%) are in equilibrium in
aqueous solution. The molecule exhibits amphiphilic prop-
erties and is well soluble in water, organic solvents, and lipid
membranes. The pKa-value of verapamil decreases distinctly
with increasing temperature as the present ITC data show
that the dissociation enthalpy is endothermic with DHNHDiss;
10 kcal=mol.
Fig. 1 displays the conformations of verapamil, amlodip-
ine, and nimodipine in the lipid membrane obtained by an
energy minimization calculation (39). Verapamil adopts a
folded conformation such that both aromatic ring systems
can be inserted into the hydrophobic core of the membrane
whereas the charged amino group remains at the lipid-water
interface. Partitioning of verapamil into the lipid membrane
modulates the lipid bilayer structure, as evidenced by deu-
terium NMR. The predominant effect in the hydrocarbon
region is a disordering of the hydrocarbon chains and a weak
complex formation of the cis-double bond with the aromatic
rings of verapamil. Hydrocarbon chain disordering is a
common phenomenon when proteins or other nonlipid com-
ponents are inserted into the lipid bilayer (11,32). Particu-
larly effective are detergent molecules (42,43), whereas
cholesterol has the opposite effect; that is, the rodlike mol-
ecule induces a stiffening of the hydrocarbon chain (44–47).
Membrane disordering has been implied in Pgp inactivation
TABLE 2 Comparison of verapamil, amlodipine, and
nimodipine; bilayer structure, binding thermodynamics,
and P-glycoprotein activity
Nimodipine Amlodipine Verapamil
Deuterium NMR
Headgroup segments
ma (kHz/mol) no effect* 30.50* 46.14
mb (kHz/mol) no effect* 15.25* 15.30
cis-double bond
mC-99 (kHz/mol) 11.50
mC-109 (kHz/mol) 21.90
Surface activity
measurements
Cross-sectional area
AD (A˚
2) 69.4 66.2 82
KA/W (M
1)y 7.1 3 105z 1.9 3 106 1.7 3 105
Klip/w (M
1)
at 30 mN/m
5.4 3 103z 1.8 3 104 540
ITC measurements
Kp (M
1) LUVS nd 7.6 3 103§ 470{
DG0lwðkcal=molÞ 5.275 5.484 3.776
DH0 (kcal/mol) nd 8.90§ 1.0{
Max. electric charge 0 1 1
pK — 8.6 8.9
Pgp activity
K1 (M) 7.9 3 10
7 1.1 3 107 9.5 3 107
DG0twðkcal=molÞ 8.624 9.834 8.511
K2 (M) — 3.9 3 10
5 3.7 3 105
V1 (%) 2.06 2.13 2.6
Drug affinity in
lipid bilayer
DG0tlðkcal=molÞ 3.35 4.350 4.735
Ktl (M
1) 234 1200 2240
No. of H-bond
acceptors
4 4 5
DG0HiðJ=molÞ 0.84 1.088 0.947
*Data taken from Ba¨uerle et al. (11).
yData obtained with methanolic stock solutions (see Materials and
Methods).
zLower limit due to adsorption to the Teflon trough.
§Multilamellar POPC liposomes, 0.1 M NaCl, 10 mM Tris, pH 7.25.
Ba¨uerle et al. (11) gives Kp ¼ 1.553 104 M1 and DH0 ¼ 8.9 kcal/mol at
23C. Using van9 t Hoff’s law and assuming a temperature-independent
DH0, Kp was recalculated for 37C.
{100 nm POPC LUVs, 0.1 M NaCl, 50 mM HEPES, pH 7.4, 37C.
FIGURE 10 Pgp activation profiles obtained by a phosphate release assay
with inside-out vesicles prepared from NIH-MDR-G185 cells. (n) Verap-
amil; (s) amlodipine.
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but cannot play an important role for verapamil as this mol-
ecule is considered as the substrate per-excellence for spe-
cific drug-Pgp interactions. At the headgroup level, verapamil
moves the 1N end of the choline dipole toward the water
phase. Verapamil is more efficient than amlodipine in turning
the P-N1 dipole since the change of the DnQ(a) quadru-
pole-splitting-per-mole-incorporated drug is ma ¼ 46.1
kHz/mol for verapamil and onlyma¼30.5 for amlodipine.
Nimodipine as a noncharged molecule has no effect (11).
The consequence of this change in dipole orientation is a
change in the electric field across the bilayer membrane. The
P-N1 dipole has a large dipole moment of;25 Debye (48).
If the P-N1 dipole is approximately parallel to the mem-
brane surface, as in a pure POPC bilayer (49), the electric
dipole field cannot penetrate deeply into the membrane. An
orientation 20 away from themembrane surface can, however,
creates a field of ;100 mV in the adjacent hydrophobic part
of the membrane with its low dielectric constant of e ¼ 2.
Dipole fields are not efficiently screened by salt and are thus
long-range. The electric effect of a single verapamil molecule
will therefore extend over several layers of surrounding phos-
pholipids. Electric fields of 100 mV across a distance of 2 nm
thickness correspond to a field strength of 5 3 107 V/m and
can induce conformational changes in proteins.
Thermodynamic binding parameters
and Pgp activation
The extent of partitioning of verapamil into a lipid bilayer
membrane is influenced by the electric charge of the mem-
brane surface and the screening of Coulombic interactions
through inert electrolytes. This is illustrated with the binding
isotherms obtained for negatively charged (Fig. 7) and neutral
(Fig. 8) membranes. In both cases, increasing NaCl concen-
trations decrease the amount of bound verapamil. Negatively
charged POPC/POPG (75/25 mol/mol) membranes exhibit a
surface potential of 40 mV in 150 mM NaCl, decreasing to
115 mV in 5 mM NaCl. The verapamil binding-affinity
increases in parallel with the electrostatic attraction (Fig. 7).
By using surface concentrations, CD,M, instead of bulk con-
centrations, the variation of electrostatic attraction can be ac-
counted for, leading to constant intrinsic binding constant.
The solid lines in Fig. 7 were simulated with similar binding
constants (Kp ¼ 410 6 30 M1; see Table 1). The average
electric charge of verapamil is Æzæ ; 0.85–0.99.
A different situation is encountered for pure POPC bi-
layers. They are noncharged in the absence of verapamil and
becomepositively charged upondrug binding.Under the pres-
ent experimental conditions the surface potentials are small
(c ; 5–15 mV) and the binding constants determined with
and without electrostatic correction differ by ;0–20% only.
The insertion into the hydrophobic membrane entails a dis-
tinct pKa-shift and the electric charge of verapamil in themem-
brane is only Æzæ ; 0.5. The binding constant of the charged
species is Kp ; 400–500 M
1 for LUVs but Kp; 900–1200
for SUVs. Verapamil binding to phosphatidylcholine bila-
yers was determined previously by a centrifugation assay at
22C (1). For multilamellar liposomes composed of egg lec-
ithin (which typically contains 40% POPC), a verapamil par-
tition coefficient of PLipid ; 267 was determined (see also
Fig. 4).
Verapamil binding to POPC LUVs can be compared to
related data obtained for amlodipine and nimodipine leading
to the following order of partition coefficients Kp, for POPC
LUVs (at 37C): verapamil 470 M1, nimodipine; 5.43
103 M1 , amlodipine 7.6 3 103 M1 (see Table 2).
Lipid solubility is a prerequisite for a drug to be
recognized by Pgp, since the active center of this enzyme is
located in the inner part of the lipid membrane. The Pgp ac-
tivity can be measured with a phosphate release assay or,
alternatively, a Cytosensor assay (6). Both assays refer to the
overall process, that is, the binding of the drug from the aque-
ous phase to the active center of the transporter in the lipid
phase. The corresponding free energy, DG0tw, is given by
DG0tw ¼ RT lnðK1Þ, where K1 has been defined above as the
dissociation constant derived from the activation part of the
bell-shaped curve given by Eq. 4. The value DG0tw can be
divided into two physically distinct processes, namely 1), the
partitioning of the drug from water into the lipid membrane,
DG0lw, followed by 2), the binding of the drug to the
transporter in the lipid matrix, DG0tl (6):
DG
0
tw ¼ DG0lw1DG0tl: (15)
DG0lw is related to the lipid-water partition coefficient
according to DG0lw ¼ RT lnKp. In this and previous studies
we have measured Kp by ITC and by surface activity mea-
surements. We thus know DG0lw for all three drugs from
physical-chemical experiments. On the other hand, Pgp acti-
vation has been measured in the present study for verapamil,
amlodipine, and nimodipine with the phosphate release assay
leading to the overall free energyDG0tw (Table 2). Knowledge
of DG0tw and DG
0
lw then allows the evaluation of DG
0
tl, i.e., the
affinity of the drug for the transporter in the lipid phase. The
corresponding results for verapamil, amlodipine, and nimo-
dipine are DG0tl ¼ 4.7, 4.4, and 3.4 kcal/mol, respec-
tively.
DG0tl can be further converted to lipid binding constants and
it is thus possible, for the first time, to derive the binding
constants of verapamil and amlodipine to Pgp in the lipid
phase. The corresponding numbers are Ktl ¼ 2.24 3 103 for
verapamil, 1.23 103 for amlodipine, and 230 for nimodipine.
We have previously proposed a model which explains the
substrate versatility of Pgp on the basis of a modular binding
concept, that is, Pgp recognizes well-defined hydrogen-bond
acceptor groups (7). Not all hydrogen-bond acceptor groups
form hydrogen bonds with same free energy. We distinguish
among strong (oxygen atoms), intermediate (nitrogen and
sulfur atoms, phenyl groups), and weak (fluorine atoms)
hydrogen-bond acceptors, weighted with hydrogen-bond
energy units of EUH ¼ 1, 0.5, and 0.25, respectively. This
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model leads to EUH ¼ 5 for verapamil and EUH ¼ 4 for
amlodipine and nimodipine, respectively. Based on the above
free energy of binding in the lipid phase, DG0tl, the average
bonding free energy per hydrogen bond is thus DG0Hi ¼
0:95 kcal=molð1:1 kcal=mol; 0:85 kcal=molÞ for ve-
rapamil (amlodipine, nimodipine). This is in good agreement
with a larger set of 15 drug molecules where the free energy
of binding from water to the transporter was derived from
Cytosensor measurements monitoring the extracellular acid-
ification rate (see (6), Table 1). The average free energy per
hydrogen bond was found to be DG0Hi  0:79 kcal=mol.
Transport of calcium channel antagonists by Pgp
As Pgp accepts its substrates from the cytosolic leaflet, lipid
solubility is an important prerequisite for a substrate to be
recognized by Pgp. The second factor is the binding affinity
of the drug to Pgp determined by the respective hydrogen-
bonding patterns. The above analysis shows that verapamil
exhibits the lowest lipid solubility but has the highest bind-
ing affinity to the transporter. If dissolved at equal concentra-
tions in the lipid phase, verapamil is binding more efficiently
than amlodipine or nimodipine. However, if dissolved at equal
concentrations in the aqueous phase, amlodipine and nimo-
dipine are more efficient in saturating Pgp because of their
better lipid solubility. On the other hand, amlodipine and
nimodipine diffuse more rapidly across the lipid membrane
than verapamil due to the smaller cross-sectional area of the
former two. Thus they can escape transport by Pgp more
easily. Nimodipine, moreover, lacks the cationic charge and
is thus not retained at the inner negatively charged membrane
leaflet from which Pgp takes its substrates. Nimodipine can
therefore be expected to cross the blood-brain barrier more
easily. Indeed, in animal experiments, nimodipine had a
strong effect on dilating the cerebral arteries, whereas the
other two agonists act mainly on peripheral and cardiac
vessels.
In conclusion, we have provided a complete binding anal-
ysis of verapamil and amlodipine to P-glycoprotein. We
have dissected drug binding into a partitioning step into the
lipid membrane, followed by the actual binding to the Pgp ac-
tive site in the hydrophobic membrane. We could thus deduce
the intrinsic binding constants of verapamil and amlodipine to
Pgp in the lipid phase. All three drugs produce some
disordering of the hydrocarbon chains. However, Pgp is not
deactivated by membrane disordering as proposed previously.
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3.3 – Appendix 
 
Gouy-Chapman binding model 
Binding isotherms of charged drugs or peptides to lipid membranes are obtained by 
standard isothermal titration calorimetry protocols (see previous paper). Such a binding 
isotherm (see figure 7 in the article) describes the binding ratio, Xb, as function of the free 
drug concentration in bulk, CD, free  according to 
 (A1) 
where Xb is defined as the ratio of bound drug or peptide, nD, bound , to the fraction of lipids, 
accessible for binding, ? ?nL . Whereas such a binding isotherm is directly obtained from 
the experimental ITC data, a specific binding model has to be applied to evaluate the 
binding parameters. The term "drug" will be used in the following representative for the 
ligand. Differences in the binding theory between drugs and peptides are quoted in the 
text. 
The binding model applied to the experimental data assumes that membrane binding of 
charged drugs will be described as surface partition equilibrium
1, 2
 
 
(A2) 
where K is the equilibrium constant and CD,M  the concentration of the drug immediately 
above the membrane surface. The fraction of lipid accessible for binding depends on the 
ligand. For charged drugs, that have only access to the outer leaflet of the lipid bilayer, ? is 
about 0.6 in small unilamellar vesicles, whereas for drugs that can cross the bilayer both 
leaflets of the membrane have to be accounted for, and therefore ? is 1. Note, that (A2) 
Xb =
nD,bound
? ?nL = K ?CD,M
Xb = f (CD, free )
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uses the surface concentration of the drug, CD,M , whereas a partition equilibrium is 
commonly defined via the bulk concentration such as in A1. Here, the surface 
concentration is connected to the bulk concentration, CD,eq , and the surface potential 0? , 
via a Boltzmann distribution 
 
(A3) 
where zD is the signed valency of the ligand, e0 the elementary charge, T the temperature 
and k the Boltzmann constant. The corresponding surface potential can be determined by 
solving the Gouy-Chapman equation
3, 4
 (for review see
5, 6
) 
 
(A4) 
where ?  is the two-dimensional density of charge on the surface, ?0 is the permittivity of 
the free space, ?r the dielectric constant of the solution, R the universal gas constant, F the 
Faraday constant, ci  the concentration of the i
th
 electrolyte in the bulk aqueous phase and 
zi is the signed valency of the i
th
 species. The summation in A4 is done over all ions in 
solution. Since, the charge density and the effective charge of the ligand are not known ab 
intio for the calculation of the membrane potential, a second independent model must be 
applied to find a self-consistent solution. The derivation of the surface charge density 
model for a lipid bilayer is given under (A8) to (A17). At his point by definition, the 
surface charge density can be written as 
 
(A5) 
? = e0
AL
?
??
?
??
?zLXL+ /? 1? XIon( ) + zDXb
1+
AD
AL
?
??
?
?? Xb
? 2 = 2000?0?rRT ci
i
? exp ? zi? 0F
RT
?
??
?
?? ?1
???
???
CD,M = CD,eqexp ? zDe0? 0kT
?
??
?
??
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where AL is the surface area of lipid (AL = 68 Å
2
 for POPC and POPG
7, 8
), AD is the surface 
area requirement of the inserting component, zL the effective charge of the ligand, and 
XL
+ /?  the mol fraction of charged lipid in the membrane. The ligand's surface area, AD, is 
not known for most drugs and peptides but can be estimated
2
. Accordingly, AD is in the 
range between 50 to 150 Å
2 
for most drugs and peptides, and therefore the contribution 
from the corrected term of peptide insertion, (AD / AL )Xb , is small compared to unity. The 
approximation of AD is thus not critical and the correction term can be even neglected for 
substances that only adsorb to the membrane surface. The reduction of the surface charge 
density due to counterion binding is accounted for by XIon, which denotes the mole 
fraction of charged lipids associated with Na
+ 
or Cl
-
. XIon is calculated by assuming a 
Langmuir adsorption isotherm for the monovalent ions to the membrane surface 
XIon =
KIon ?CIon,M
1+ KIon ?CIon,M
 
(A6) 
Here, KIon  is the binding constant for monovalent ions. For sodium ion binding to POPG, 
the KIon is 0.6 M
-1 9, 10
 and the binding constant of chloride ions to DOTAP is set equal to 
K
Na+
. Finally, C
Ion,M
is the concentration of the ion in close proximity to the membrane 
surface and is connected to the bulk equilibrium concentration, C
Ion,eq
via a Boltzmann 
distribution 
C
Ion,M
= CIon,eq exp ? F? 0RT
?
??
?
??  (A7) 
This binding model can now be linked to the experimental isothermal titration calorimetry 
data. Unfortunately, two parameters are unknown, the effective charge of the drug and the 
surface potential. The equation (A3) to (A7) can be solved for each experimentally 
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obtained pair of Xb and CD, free , when a zD value is given. This procedure has to be repeated 
for a range of zD values, in search of the drug binding constant and valency of the drug 
that corresponds to the best fit to the experimental data according to equation (A1). 
 
Model for the derivation of the surface charge density in lipid bilayers 
The surface charge density, ?, at a lipid surface is defined as 
? = Q
AT
 
(A8) 
where Q is the electric charge of the lipid surface and AT is the surface area of the lipid 
bilayer. The surface area of the lipid bilayer is given by the moles of the lipid molecules 
within the lipid bilayer and their surface area, AL, 
AT = AL nL0 + nL+ /?
free
+ n
L+ /?
bound( )  (A9) 
Furthermore equation (A9) distinguishes between the moles of uncharged lipids, n
L0
, 
charged lipids free of counter ions, n
L+ /?
free
, and charged lipids bound to counter ions, 
bound
L
n ?+/ . 
The electric charge of the surface can be expressed by 
Q = e0 (?zL ?nL+ /?free )  (A10) 
where zL is the signed valency of the charged lipid and ?0 is the permittivity of the free 
space. Substitution of (A10) and (A9) into (A8) leads to 
? = e0
AL
?zL ?nL+ /?free
n
L0
+ n
L+ /?
free
+ n
L+ /?
bound
?
??
?
??  (A11) 
The molar amount of free charged lipids can be written due to mass conservation 
n
L+ /?
free
= n
L+ /?
total ? n
L+ /?
bound
= n
L+ /?
total ? XIon ?nL+ /?total = nL+ /?total 1? XIon( )  (A12) 
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where n
L+ /?
total  is the total amount of charged lipids. n
L+ /?
bound  can be deviated from n
L+ /?
total  by 
knowing the mol fraction of charged lipids associated with counterions, XIon. XIon is 
described by (A6) and (A7). Substitution of (A12) into (A10) leads than to  
? = e0
AL
?zL ?nL+ /?total 1? XIon( )
n
L0
+ n
L+ /?
free
+ n
L+ /?
bound
?
??
?
??  (A13) 
Equation (A14) can be simplified to 
? = e0
AL
?zL ? XL+ /? 1? XIon( )( )  
(A14) 
where XL
+ /?  denotes for the mol fraction of charged lipids. To this point, the surface 
charge density of the lipid bilayer was derived in dependence of the molar fraction of 
charged lipids by taking only the effect of counterions at the membrane surface into 
consideration. However, upon binding of charged drugs to the membrane the surface 
charge density is altered. Therefore, incorporation of drugs into the lipid bilayer changes 
the surface area of the lipid bilayer according to 
AT = AL nL0 + nL+ /?
free
+ n
L+ /?
bound( ) + nPep.APep.  (A15) 
The electric surface charge also changes upon incorporation and/or adsorption of drugs 
according to 
Q = e0 (zL ?nL+ /?free + zDnD )  (A16) 
Following the derivation from (A11) to (A14) with the additional terms of peptide or drug 
binding we find in analogy to A14 
? = e0
AL
?
??
?
??
?zLXL+ /? 1? XIon( ) + zDXb
1+
AD
AL
?
??
?
?? Xb
 
(A17) 
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4.1 – Summary: Thermodynamics of the Coil 
 
?  ?-Sheet Transition in a 
Membrane Environment 
 
As discussed in the introduction, there are good reasons to believe that peptide adsorption 
to lipid membranes is the starting point of a various human diseases, e.g. the Alzheimer’s 
disease. In the case of amyloid peptides adsorption or binding is generally accompanied by 
a structural transition from the native to an aggregating state rich in ?-sheet structure. 
Hydrogen bonds within ?-sheets can be formed intra- and intermolecular, while formation 
of the latter can also be regarded as an aggregation process. To investigate the membrane-
induced random coil 
 
?  ?-sheet transition a model system was developed utilizing of a 
designed peptide, namely (KIGAKI)3 (see Chapter 1.6). Briefly, upon binding to anionic 
lipid membranes the (KIGAKI)3 peptide forms a highly amphipathic ?-sheet, whereas in 
aqueous solution it adopts a random coil conformation.   
Within the studies the (KIGAKI)3 sequence was systematically modified to vary the extent 
of the ?-sheet formation on the membrane surface. To achieve this we have taken 
advantage of synthetic analogs of the KIGAKI repeat in which two adjacent amino acids 
were replaced by their D-enantiomers. For a set of (KIGAKI)3 peptides in which D-
enatiomers of Ala-Lys were introduced we found that the membrane inducible extent of 
the ?-sheet formation is dependent on the number and position of the double D amino acid 
substitution. In conclusion, substitution of double D amino acids results in a local 
disturbance of the ?-sheet structure. Aggregation size was investigated with deuterium 
magnetic resonance using (KIGAKI)3 peptides in which a single Ala residue carried a 
deuterated methyl group (-CD3). The NMR analysis revealed that the (KIGAKI)3 peptide 
without double D amino acids substitution forms a rigid extended ?-sheet, whereas a 
KIGAKI peptide, in which several D-enatiomers were introduced, freely diffuses at the 
lipid membrane surface. Additionally, the extent of ?-sheet formation on the surface of 
negatively charged vesicles could be monitored and quantified with circular dichroism 
(CD) spectroscopy. For example the (KIGAKI)3 peptide without D-amino acids forms ?-
sheets of 13.4 residues on average, whereas the stereo-analog (KIGakI)3 (small letters 
denote for D amino acids) formed a ?-sheet of 3.4 residues.  
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The thermodynamic parameters of the overall peptide binding process to anionic lipid 
vesicles, which combines the folding and intrinsic binding process, were determined for 
all peptides with high-sensitivity isothermal titration calorimetry (ITC). By correlating the 
overall thermodynamic parameters of the binding process with the structural change of ?-
sheet formation (gained form CD spectroscopy), it was possible to separate the intrinsic 
peptide binding to the lipid membrane from the process of ?-sheet formation. The results 
showed that the ?-sheet folding reaction in the case of the (KIGAKI)3 peptide is driven by 
enthalpy (?H? = -0.2 kcal/mol per residue) and disfavored by entropy (T?S? = -0.08 
kcal/mol per residue), where the free energy of ?-sheet folding reaction is -0.15 kcal/mol 
per residue. These are the first thermodynamic ?-sheet folding and concomitant peptide 
aggregation parameters in a membrane environment. 
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4.2 – Published Article 
 
 
Thermodynamics of the Coil ⇆ β-Sheet Transition in a
Membrane Environment
Matthias Meier and Joachim Seelig⁎
Department of Biophysical
Chemistry, Biozentrum,
University of Basel,
Klingelbergstrasse 50/70,
CH-4056 Basel, Switzerland
Biologically important peptides such as the Alzheimer peptide Aβ(1–40)
display a reversible random coil ⇆ β-structure transition at anionic
membrane surfaces. In contrast to the well-studied random coil ⇆ α-helix
transition of amphipathic peptides, there is a dearth on information on the
thermodynamic and kinetic parameters of the random coil ⇆ β-structure
transition. Here, we present a new method to quantitatively analyze the
thermodynamic parameters of the membrane-induced β-structure forma-
tion. We have used the model peptide (KIGAKI)3 and eight analogues in
which two adjacent amino acids were substituted by their D-enantiomers.
The positions of the d,d pairs were shifted systematically along the three
identical segments of the peptide chain. The β-structure content of the
peptides was measured in solution and when bound to anionic lipid
membranes with circular dichroism spectroscopy. The thermodynamic
binding parameters were determined with isothermal titration calorimetry
and the binding isotherms were analysed by combining a surface partition
equilibrium with the Gouy–Chapman theory. The thermodynamic para-
meters were found to be linearly correlated with the extent of β-structure
formation. β-Structure formation at the membrane surface is characterized
by an enthalpy change of ΔHβ=−0.23 kcal/mol per residue, an entropy
change of ΔSβ=−0.24 cal/mol K residue and a free energy change of ΔGβ=
−0.15 kcal/mol residue. An increase in temperature induces an unfolding of
β-structure. The residual free energy of membrane-induced β-structure
formation is close to that of membrane-induced α-helix formation.
© 2007 Elsevier Ltd. All rights reserved.
*Corresponding author
Keywords: random coil-β-sheet transition; peptide-membrane interaction;
peptide-aggregation; (KIGAKI)3 peptide
Introduction
The thermodynamics and kinetics of the coil ⇆
helix transition of peptides and proteins have been
studied intensively for several decades. In contrast,
little is known about the thermodynamic and kinetic
factors that influence the stability of β-sheet folds.1
β-Sheets form a significant proportion of protein
structure and are found to be associated with
protein misfolding; in particular, in the formation
of amyloid fibrils and other non-native protein
aggregates that have been implicated in a variety
of human diseases. The origin of the stability of
β-sheets in proteins has been attributed to con-
formational preferences of residues in the strands,2–4
to the hydrophobic effect,5 inter-strand hydrogen
bonds,6,7 and solvent properties.8
A closer insight into the thermodynamics of
β-sheet formation might be obtained from small
model peptides forming β-sheets and β-hairpins;
that is, two-stranded antiparallel β-sheet structures,
rather than from whole proteins. Homooligopep-
tides such as poly-lysine, poly-tyrosine, and poly-
cysteine,9–11 have been the first model peptides for
β-sheet formation and aggregation. Examples of
naturally occurring β-sheets were derived, for ex-
ample, from protein G and ubiquitin.12,13 More re-
cently designed peptides like the Gellman peptides14
Abbreviations used: ITC, isothermal titration
calorimetry; SUV, small unilamellar vesicles; POPC,
1-palmitoyl-2-oleoyl-sn-glycero-3-phosphocholine; POPE,
1-palmitoyl-2-oleoyl-sn-glycero-3-phosphoethanolamine;
POPG, 1-palmitoyl-2-oleoyl-sn-glycero-3-phosphoglycerol;
mPEG 2000 PE, 1,2-dioleoyl-sn-glycero-3-
phosphoethanolamine-N[methoxy(polyethylene
glycol)-2000.
E-mail address of the corresponding author:
joachim.seelig@unibas.ch
doi:10.1016/j.jmb.2007.02.082 J. Mol. Biol. (2007) xx, xxx–xxx
0022-2836/$ - see front matter © 2007 Elsevier Ltd. All rights reserved.
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and the WW domain15 have contributed to the ther-
modynamic understanding of β-sheet stability.
The free energy of β-sheet formation varies in the
range of −1.6 kcal/mol ≤ ΔGβ ≤ 1.2 kcal/mol per
residue depending on the model system under
investigation.4,16–18 Both enthalpy-driven and
entropy-driven β-sheet stabilization is documented
in the literature.9,19–21 The thermodynamic analysis
is hampered by the relatively low tendency of model
peptides to form β-sheets in aqueous solution, as
intramolecular hydrogen bond formation is in
competition with binding to water molecules.
Even less is known about β-sheet formation in a
membrane environment. Experimental studies on
the energetics of peptide folding in a lipidmembrane
are still limited to a few examples. The best investi-
gated systems for the coil ⇆ α-helix equilibrium are
amphipathic peptides such as melittin, magainin, or
signal peptides that form α-helices at the lipid–water
interface.22–27 The membrane-induced β-sheet for-
mation, on the other hand, has been investigated
with the model peptide AcWL5,
28–30 with the Alz-
heimer peptides βAP(25–35) and βAP(1–40),31–33
and with a designed 18 residue peptide, (KIGAKI)3-
NH2.
34 The latter has no amphipathic character as an
α-helix but can form a highly amphipathic β-sheet
when bound to lipid membranes.
In the present study we have systematically mod-
ified the (KIGAKI)3 sequence to vary the extent of β-
sheet formation on the membrane surface. In
analogy to previous work on linear amphipathic
peptides35 and Alzheimer βAP(1–40) peptides,36 we
have taken advantage of synthetic analogues of the
KIGAKI repeat in which two adjacent amino acids
were replaced by their D-enantiomers. Substitution
of double D amino acids results in a local dis-
turbance of β-sheet structure without modifying
other characteristics such as hydrophobicity and
side-chain functionality.37 Figure 1 shows the
envisaged perturbation of the β-structure if an L-
Ala-L-Lys pair in a β-sheet is replaced by its d,d-
enantiomers. A Lys side-chain that is above or below
the β-sheet in the L-enantiomer is rotated into the
plane of the β-sheet causing a steric repulsion
between neighbouring strands. We have synthe-
sized eight different (KIGAKI)3 peptides in which D-
enantiomers of Ala-Lys were introduced in each of
the three repeats, either as a single substitution in
one repeat or as multiple substitutions in two or
three repeats (D-enantiomers are denoted with lower
case letters ak). The extent of β-sheet formation on
the surface of negatively charged vesicles was
monitored and quantified with circular dichroism
(CD) spectroscopy. Aggregate size was investigated
with deuterium magnetic resonance (2H-NMR)
using a (KIGAKI)3 peptide in which a single alanine
carried a deuterated methyl group (-C2H3). The
thermodynamic parameters of the binding process
were determined with high-sensitivity isothermal
titration calorimetry (ITC). By correlating the ther-
modynamic parameters with the percentage of β-
sheet formation, it was possible to separate binding
to the lipid membrane from β-sheet formation.
Results
The peptide–membrane binding equilibrium
measured with isothermal titration calorimetry
Table 1 shows the set of synthesized peptides with
their corresponding short-hand notation. For accurate
Figure 1. β-Sheet conformation of one KIGAKI unit with and without double D amino acid substitution. The broad
arrow indicates the direction of the peptide backbone involved in β-sheet building. The L-Lys and L-Ala side-chains are
above the β-sheet. Changing the stereochemistry at the Cα atom to D-Lys and D-Ala rotates the side-chain of the Lys from
an orientation perpendicular to the plane of the backbone-backbone hydrogen bonds into a parallel alignment. Lys was
chosen for D-substitution as its side-chain is particularly large.
2 Coil-β-sheet Transition in a Membrane Environment
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determination of the peptide concentration, Ile2 was
replaced by Trp and peptide concentrations were
calculated using the Trp molar extinction coefficient
(5500 M−1 cm−1). The C-terminal carboxyl groups of
all peptides were amidated.
In the following, the term binding is used in a
general sense to describe the adsorption of the cat-
ionic peptide from bulk solution to the anionic mem-
brane surface. Binding isotherms were determined
by injecting lipid vesicles into a peptide solution.38 A
typical example is shown in Figure 2. The calorimeter
cell contained a 25 μMsolution of peptide 8, and 10 μl
aliquots of a 12 mM 1-palmitoyl-2-oleoyl-sn-glycero-
3-phosphoethanolamine (POPE)/1-palmitoyl-2-
oleoyl-sn-glycero-3-phosphoglycerol (POPG)/1,2-
dioleoyl-sn-glycero-3-phosphoethanolamine-N
[methoxy(polyethylene glycol)-2000 (mPEG 2000
PE) (70:25:5 mol%) SUV suspension were injected
(measuring temperature 25 °C). The Figure demon-
strates that the heat of reaction, hi, is endothermic
and thus unfavourable for binding (Figure 2(a)). hi
decreases with increasing injections as less and less
peptide is available for binding. Control experiments
of 10 μl injections of lipid suspension into pure buffer
revealed a constant heat of dilution of −1.8 μcal,
which was subtracted from the actual measurement.
The heat of reaction approaches zero after ∼20
injections, indicating that essentially all peptide is
bound to the lipid vesicles. The molar binding
enthalpy, ΔH0, can then be calculated according to:
DH0 ¼
Xn
i¼1
hi=n0 ð1Þ
where n0 is the total molar amount of peptide in the
calorimeter cell and is the cumulative heat of reaction
(Figure 2(b)). The measured binding enthalpies for
all eight peptides are summarized in Table 2. They
vary between 6.5 kcal/mol and 8.7 kcal/mol,
depending on the position and extent of the d,d
substitution of the peptide. ΔH0 is a consequence of
peptide binding and of β-sheet formation. The
variation in ΔH0 can be correlated with the extent
of β-structure formation (see below).
Binding can be observed only for membranes that
are negatively charged. If the anionic POPG in our
vesicles is replaced by an equal amount of zwitterionic
1-palmitoyl-2-oleoyl-sn-glycero-3-phosphocholine
Table 1. Amino acid sequences of the synthesized
peptides
Peptide Abbreviation used in the text
KWGAKI- KIGAKI- KIGAKI-NH2 1
a
KWGakI- KIGAKI- KIGAKI-NH2 2
KWGAKI- KIGakI- KIGAKI-NH2 3
KWGAKI- KIGAKI- KIGakI-NH2 4
KWGakI- KIGakI- KIGAKI-NH2 5
KWGAKI- KIGakI- KIGakI-NH2 6
KWGakI- KIGAKI- KIGakI-NH2 7
KWGakI- KIGakI- KIGakI-NH2 8
KWGakI- KIGAkI- KIGakI-NH2 9
Amino acids with small letters denote a D stereochemistry at the
Cα atom. Underscored Ala residues are deuterium-labelled at the
Cβ methyl group and are in the L configuration. All peptides are
amidated at the C terminus.
a Peptide 1was synthesizedwith andwithout a deuterium label.
Figure 2. Titration calorimetry of a (KIGakI)3 (peptide
8)solution (18.8 μM) with small unilamellar vesicles
(POPE/POPG/mPEG 2000 POPE (70:25:5 mol%)) with a
total lipid concentration of CL
0 =12 mM. (a) Each peak
corresponds to the injection of 10 μl of lipid suspension
into the reaction cell (V=1.4053 ml) containing the peptide
solution. The reference cell contained 25 mM Tris–HCl
(pH 7.4), 50 mMNaCl, T=25 °C. (b) Heat of reaction hi as a
function of the injection number Ni. The continuous line
was calculated by combining a surface partition equili-
brium with electrostatic attraction (ΔH0=9.0 kcal/mol,
K0=40 M
−1, z=4.9). Binding was assumed to occur only
outside the vesicle (60% of total lipid).
Table 2. Thermodynamic parameters for the binding of
peptides 1–8 to small unilamellar vesicles composed of
POPG/POPE/POPE-PEG 2000 (25:70:5 mol%) at 25 °C
Peptide
ΔH0
(kcal/mol) K0 (M
−1) zp
ΔG0
(kcal/mol)
TΔS0
(kcal/mol)
1 6.3±0.3 890±150 4.0 −6.38 12.7
2 7.2±0.3 420±140 4.2 −5.93 13.1
3 8.3±0.25 230±100 4.5 −5.58 13.8
4 7.1±0.3 400±120 4.1 −5.91 13.0
5 8.4±0.3 80±5 4.6 −4.95 13.3
6 8.6±0.15 85±10 4.9 −5.0 13.6
7 7.9±0.1 200±10 4.7 −5.50 13.4
8 8.8±0.4 50±20 4.9 −4.72 13.6
Measurements were performed in triplicate or duplicate.
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(POPC), no heat of reaction can bemeasured in an ITC
experiment.
The binding isotherm can be derived from the
lipid-into-peptide titration,24,38 and is shown in Fig-
ure 3 for the ITC data of the previous Figure. The
binding isotherm, Xb= f(cf), describes the amount of
bound peptide per lipid, Xb, a function of the
equilibrium concentration of free peptide cf. Xb is
defined as Xb=np,bound/nL
0 where nL0 is the molar
amount of lipid available for binding. In the present
case, the charged peptides cannot penetrate the lipid
membrane and only the outermembrane leaflet (60%
of the total lipid) is available for peptide binding.
np,bound is the molar amount of lipid-bound peptide.
In the case of i injections, Xb can be determined
from the measured heats of reaction as follows.
np,bound
(i) is given by
nðiÞp;bound ¼
Xi
k¼1
hk=ðDH0Vcell c0pÞ ð2Þ
nL
(i) is calculated from the concentration of lipid in the
injection syringe and the number of injections i.
Knowledge of the amount of bound peptide allows
calculation of the concentration of peptide free in
solution from mass conservation. The binding iso-
therm can thus be determined in a model-indepen-
dent fashion. Small dilution effects due to the increase
in reaction volume must be taken into account.
The further analysis of the binding isotherm re-
quires models for the binding mechanism. One
possibility would be a complex formation such that
the peptide interacts with a defined number of lipids.
Such amodel is unlikely, however, since no change in
the orientation or motion of the phospholipid head-
groups is observed by 31P-NMR (see below). The
model employed in the following is a surface
partition model in which the peptide adsorption is
related to the concentration of peptide cM found
immediately above the plane of binding:24,39
Xb ¼ K0cM ð3Þ
The model is based on the observation that the
negatively charged membrane surface will attract
cationic species in its vicinity. The concentration of
peptidewill thus increase from its equilibrium value,
cf, far away from the membrane surface to the much
higher value cM in the lipid–water interface, an
equilibrium governed by the Boltzmann relation:
cM ¼ cfezpF0w=RT ð4Þ
zp is the effective peptide charge (usually smaller
than the nominal charge), ψ is the membrane surface
potential, F0 is the Faraday constant, and RT is the
thermal energy. Using the Gouy–Chapman the-
ory,40,41 it is possible to calculate the surface potential
ψ and the surface concentration cM for each datum
point of the ITC curve (and the binding isotherm)
leading to the surface partition constant K0. A
detailed description of this bindingmodel as applied
to the binding of an α-helix-forming amphipathic
peptide has been given.24,38,39 As an additional
feature of this model, the well-known binding of
sodium ions to phosphatidylglycerol was taken into
account with a Langmuir adsorption isotherm and a
Na+ binding constant of 0.6 M−1. Tris–HCl buffer
was counted as a 1–1 salt. The continuous line in
Figure 3 is the theoretical fit to the experimental data.
The effective peptide charge is zp=4.2 and the
surface potential varies between ψ=−45 mV in the
absence of peptide to ψ=−9 mV at the highest Xb
value. The binding constant according to equation
(2) is K0=300 M
−1. An excellent agreement between
the model and the experimental data is obtained for
all peptides. The corresponding binding constantsK0
are listed in Table 2.
The free energy of binding, ΔG0, follows from:
DG0 ¼ RT ln 55:5K0 ð5Þ
where the factor 55.5 is the molar concentration of
water. It corrects for the fact that the concentration of
free peptide in the aqueous phase is given in mol/l
and not as mole fraction, whereas the concentration
of the bound peptide is given as mole fraction. ΔG0
corresponds to the transfer of peptide from the
lipid–water interface (peptide concentration cM) into
the lipid bilayer surface. The reaction entropy can
then be calculated from ΔG0 =ΔH0–TΔS0. The
thermodynamic parameters for all eight peptides
are given in Table 2.
Peptide secondary structure determination of
(KIGAKI)3 peptides in aqueous solution
The thermodynamic results can be correlated
with the changes in peptide conformation. For this
Figure 3. Binding isotherm of (KIGakI)3 (peptide 8) for
small unilamellar vesicles (d ∼30 nm) as derived from
titration calorimetry. The degree of binding Xb (i.e. mmol
peptide bound per mol lipid) is plotted against cfree, the
equilibrium concentration of peptide in bulk solution. The
experimental points are derived from the ITC data shown
in Figure 2 without assuming a specific binding model. In
contrast, the continuous line is the theoretical binding
isotherm calculated by combining the Gouy–Chapman
theory with a surface partition equilibrium with a
partition constant K0=40 M
−1 and an electric charge
z=4.9.
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purpose, CD spectra of all (KIGAKI)3 analogues
were measured in buffer and in the presence of lipid
vesicles (POPE/POPG/mPEG 2000 PE; 45:50:5 mol
%). Figure 4(a) shows the CD spectra of the eight
peptides measured in buffer. The analysis of the CD
spectrum of peptide 1, which has only L-amino
acids, yields 23% β-sheet and 77% random coil
conformation, but no contribution from α-helix or
β-turn. Peptides 2–4 have one d,d substitution,
peptides 5–7 have two d,d substitutions and
peptide 8 has three such substitutions. Peptides
with the same number of d,d pairs have rather
similar CD spectra in buffer. However, the substitu-
tion with D-amino acids reduces the spectral
intensity distinctly. Peptides 2–4 have a single d,d
pair (11% of total amino acids). An almost perfect
simulation of the CD spectra in buffer is achieved if
the CD spectrum of peptide 1 is superimposed with
its mirror image at a ratio of 89:11. The shape of the
resulting CD spectrum is identical with that of
peptide 1 but its ellipticity is reduced to 78% (89%–
11%). (A detailed justification of this approach is
given in the Material and Method section.) The
same model may be applied to peptides 5–7 with
two d,d pairs (22% of all amino acids) and predicts
a reduced ellipticity of 56% (78%–22%) compared to
peptide 1. Indeed, the shape of all three CD spectra
is still very similar to that of the all-L amino acid
peptide 1. For peptide 7, the reduction is 56%, in
agreement with the theory; for peptides 5 and 6, the
reduction is larger, with 36% and 40% of the peptide
1 ellipticity, respectively. This can be explained by a
small increase in β-structure (see Material and
Method section). Peptide 8 has three d,d substitu-
tions (33% D-amino acids). Its CD spectrum has
reduced intensity, since L and D-amino acids almost
compensate each other but its shape also differs
from the random coil spectrum of peptide 1 as the
result of an increased β-content.
The spectral shape and the molar ellipticity of all
peptides are independent of the concentration of
peptide in the range 25 μM to 1 mM. The solutions
remain optically clear, arguing against the formation
of large peptide aggregates. Using the method
described in the Material and Method section, we
have analysed the CD spectra of all eight peptides in
terms of their random coil and β-structure content.
The results are summarized in Table 3.
Structure of (KIGAKI)3 peptides interacting with
lipid membranes
Addition of POPE/POPG/mPEG 2000 PE vesicles
(45:50:5 mol%) to (KIGAKI)3 solutions induces a
distinct conformational change for peptide 1 (as first
reported using POPG vesicles34), and for the d,d
substituted peptides 2–8. The corresponding spectra
are displayed in Figures 4(b) and 5. Figure 4(b)
compares the CD spectra of peptides 1–8 recorded at
a lipid-to-protein molar ratio of ∼20 to ensure
complete peptide binding. Peptide 1, composed of
L-amino acids only, has the CD spectrum with the
largest ellipticity and corresponds to an almost
perfect β-sheet spectrum (Table 3). The CD spectra
of peptides 2 and 4 have shapes similar to that of
peptide 1 but the ellipticity is reduced to 80% and
65%, respectively. For peptide 2, this is consistent
with a prediction of 78% if the spectrum of lipid-
bound, all-L peptide 1 (89%) is superimposedwith its
all-D mirror image (11%). The remaining peptides
have smaller β-contents. The spectra were analysed
as described inMaterial andMethod section, and the
structural elements are quantified in Table 3.
It is obvious from the above that the extent of
β-structure formation is dependent on the number
and position of double D amino acid substitution in
the peptide sequence. The largest effect is observed
when the d,d pair is placed in the middle of the
KIGAKI sequence. Table 3 displays the percentage
change of β-structure,Δβ, and the number of amino
acids, Δβaa, involved in this change.
The lipid-induced random coil to β-structure
transition is a two-state equilibrium, as illustrated
for peptide 1 in Figure 5,which displays the variation
of the CD spectra of 50 μM peptide 1 upon addition
of anionic phospholipid SUVs composed of POPE/
POPG/mPEG 2000 PE (45:50:5 mol%) added in
small portions of a 25 mM SUV stock solution. The
random coil spectrum is gradually replaced by a
Figure 4. (a) CD spectra of peptides 1–8 in aqueous
solution. The spectra were recorded at a peptide concen-
tration of 50 μM in 5 mM cacodylate buffer (pH 7.4). The
numerals indicate the number of d,d substitutions.
Peptides with the same number of d,d pairs have similar
CD spectra. (b) CD spectra of peptides 1–8 recorded in
excess of POPE/POPG/mPEG-2000-POPE (70:25:5 mol%)
SUVs (lipid to peptide mol ratio of 15). The peptide
concentration was 50 μM in 5 mM cacodylate buffer (pH
7.4). The largest intensity is observed for peptide 1 with no
d,d substitution. The smallest intensity is recorded for
peptide 8 with three d,d pairs.
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spectrum characteristic of β-structure. The transition
shows an isosbestic point at 210 nm, indicating that
only two types of structures are involved, one
predominantly random coil, the other almost 100%
β-sheet.
Mobility of KIGAKI peptides on the membrane
surface: NMR measurements
We wished to determine whether β-structure for-
mation is an intra-or intermolecular process. We
labelled two peptides with deuterated alanine
(C2H3-Ala) and measured the deuterium NMR
spectra of the pure peptide in the solid state and
when bound to the liquid-like lipid membrane.
Figure 6(a) and (c) show the 2H-NMR spectra of
the Ala-d3 label attached to peptide 1 (all-L amino
acids) and peptide 9 (two d,d pairs) in lyophilized
powder. The characteristic parameter of a deuter-
ium spectrum is the quadrupole splitting, ΔνQ,
which is defined as the separation of the two most
intense peaks. The quadrupole splitting of the
methyl group deuterons provides a direct measure
of the order parameter (Sc–c=0.5 〈3 cos
2 Θ-1〉) of the
methyl rotor axis. The quadrupole splitting of the
alanine deuterons of peptides 1 and 9 are 39.5 kHz
and 39 kHz, respectively, at 298 K. The rigid limit of
the quadrupole splitting of methyl group deuterons
in Ala-d3 is about 126 kHz. Rapid (∼109 s−1) rota-
tion around the methyl Cα–Cβ bond axis reduces the
static quadrupole splitting of 126 kHz by a factor of
1/3 to ∼42 kHz. Thus, the observed quadrupole
splitting of about 39 kHz for the lyophilized peptide
powder is close to this limit. For rigid molecules
undergoing only rapid axial symmetric reorienta-
tion about a single axis, the quadrupole splitting is
independent of the temperature, which was found
for both peptides in the powder state in the
temperature range between 248 K and 298 K.
Next, 2H-NMR spectra were recorded for pep-
tides 1 and 9 in the presence of multilamellar lipid
bilayer dispersions composed of POPC/POPG (3:1
mol%) at a lipid-to-peptide ratio of 40 (Figure 6(b)
and (d)). Obviously, the deuterium spectra differ
distinctly. Deuterons attached to peptide 1 have a
motionally averaged quadrupole splitting of
38.2 kHz, a value close to that of the lipid-free solid
powder (Figure 6(b)). The only motion is the rotation
around the Cα–Cβ threefold symmetry axis. Peptide
1 thus exhibits a rigid structure when bound to
negatively charged liposomes. This result can be
explained by the formation of extended intermole-
cular β-sheet aggregates of peptide 1 at the mem-
brane surface. In contrast, the deuterons attached to
peptide 9 produce an isotropic deuterium signal
(single sharp line) when lipid-bound, suggesting a
high level of mobility (Figure 6(d)). The rotational
motion of peptide 9 at the membrane surface is fast
on the time-scale of the deuterium NMR experiment
(>105 s−1), which leads to the isotropic averaging of
the quadrupole splitting. The D amino acids in
peptide 9 prevent the formation of an extended
intermolecular β-sheet at the negatively charged
membrane surface, and peptide 9 appears to be
bound as a monomer. The membrane spectra of
peptide 9 show a temperature-dependent quadru-
pole splitting. At 248 K, a quadrupole splitting of
38 kHz is observed, and the molecular motion is
completely frozen in. Only the rotation of the methyl
group is observed at this temperature.
The bilayer structure of the multilamellar vesicles
remains unchanged upon addition of peptides 1 and
9, as evidenced by the 31phosphorus NMR spectra,
shown in Figure 6(e). The 31phosphorus NMR
Figure 5. Random coil-to-β-sheet transition of peptide
1 (50 μM) upon titration with POPE/POPG/mPEG 2000
POPE (70:25:5 mol%) SUVs (5 mM cacodylate buffer, pH
7.4). CD spectra were recorded at lipid/peptide ratios of 0,
1, 2, 4, 8, 12, 15, and 20, respectively, reading from bottom
to top at 198 nm. The structural transition comes to
completion at a lipid to peptide mol ratio of 15.
Table 3. CD spectral analysis of peptides 1–8 in buffer and when bound to lipid vesicles
Peptide
Peptide in buffer Peptide with excess lipid Change in
Random coil (%) β-Structure (%) Random coil (%) β-Structure (%) Δβ-Structure (%) Δβ-Structurea (residues)
1 77 23 2 98 75 13.5
2 77 23 17 83 60 10.8
3 75 25 28 72 47 8.5
4 77 23 8 92 69 12.4
5 67 33 31 69 36 6.5
6 68 32 43 57 25 4.5
7 73 28 18 82 54 9.7
8 55 46 36 64 19 3.4
The percentages of random coil and β-structure are listed for peptide in buffer and bound to lipid.
a The column lists the number of amino acid residues (aa) that change from random coil to β-structure (Δβ(aa)=18Δβ(%)/100).
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spectra of the POPC/POPG bilayer with and with-
out peptides are very similar and exhibit the typical
signature of the bilayer phase. The chemical shield-
ing anisotropy is Δσ=−49.2 ppm and remains
constant at a lipid-to-peptide mol ratio above 40.
From the shape of the 31phosphorus NMR spectra, it
can be concluded that the long-range structure of the
bilayer remains unaltered. At higher peptide con-
tents (i.e. lower lipid-to-peptide mol ratios) the
(KIGAGI)3 peptide will perturb the bilayer struc-
ture. An isotropic component was observed, con-
tributing 30%–70% to the total spectra intensity
when the lipid to protein mol ratio was reduced to
25 or 12.5.42
This was further supported by deuterium NMR
experiments with and without peptide 8 (three d,d
substitutions) using deuterated POPC membranes
(spectra not shown). In these experiments, it was the
lipid membrane that was deuterated. To be more
specific, POPC was deuterated selectively at the β-
position of the choline moiety (-NC2H2CH2OP-) and
mixed with non-deuterated POPG (3:1 mol%).43 The
quadrupole splitting was ΔνQ=5.9 kHz in the
absence of peptide 8 and did not change up to the
highest peptide/lipid mol ratio measured (50). The
only noticeable effect was a broadening of the line
shape. This is in distinct contrast to observations
made with, for example, amphiphilic peptides such
as melittin or magainin, where the binding to the
lipid membrane induces a large change in the
quadrupole splitting of the headgroup as the head-
group moves more into the aqueous phase.44–46 The
present results exclude a conformational change or a
spatial reorientation of the −P-N+ dipole.
Peptide β-structure formation and correlation
with thermodynamic parameters
The binding of peptides 1–8 to lipid membranes
entails two different processes: (i) the association
with the membrane surface; and (ii) the conforma-
tional change of the peptide. As all peptides adopt
virtually identical structures in solution (∼70%
random coil, ∼30% β-sheet) we assume rather
similar association energies. The differences in the
experimentally measured thermodynamic para-
meters are then caused by the change in secondary
structure following binding to the membrane sur-
face. Table 3 shows the increase in β-structure upon
lipid binding for peptide 1 to peptide 8, both in
percentage of β-structure and with the number of
amino acid residues involved.
A correlation between the thermodynamic para-
meters ΔH0, ΔG0, and ΔS0 of the peptide binding
reaction and the change in β-structure can now be
established, and is displayed in Figure 7, which
reveals a linear dependence of the thermodynamic
binding parameters on the change in β-structure and
regression analysis yields the following expressions:
DH0 ¼ 0:23Dnh þ 9:8ðkcal=molÞ R ¼ 0:90 ð6Þ
DG0 ¼ 0:15Dnh  4:2ðkcal=molÞ R ¼ 0:93 ð7Þ
DS0 ¼ 0:24Dnh þ 46:5ðkcal=molÞ R ¼ 0:82 ð8Þ
where Δnβ denotes the number of random coil
segments that change to β-structure. The contribu-
Figure 6. (a) and (c) Deuterium NMR powder spectra
of ∼3 mg of freeze-dried peptide 1 and peptide 9,
respectively. Both peptides are labelled with Ala-d3 at
position 9. Peptide 1 consists of L-amino acids only; in
peptide 9 the L-amino acid residues at position 4, 5, 10, 15,
and 16 are substituted by their D-enantiomers. (b) and (d)
Deuterium NMR spectra of peptides 1 and 9 bound to
POPC/POPG (3:1 mol%) liposomes, at a lipid to peptide
mol ratio of 50. (e) 31Phosphorus NMR spectra of the
POPC/POPG bilayer without peptide (continuous line)
and in the presence of peptide 1 (broken line). The
31phosphorus spectrum was recorded with the same
sample of peptide 1 used to obtain the deuterium NMR
spectrum in (b).
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tion of β-structure formation to the binding process
is thus given by the slopes of the regression lines:
ΔHβ=−0.23 kcal/mol per residue
ΔGβ=−0.15 kcal/mol per residue
ΔSβ=−0.24 cal/mol K per residue
From the intercepts with the ordinate, the ther-
modynamic binding parameters of a hypothetical
(KIGAKI)3 peptide with no conformational change
can be estimated as:
ΔH0 =9.8 kcal/mol,
ΔG0 =−4.2 kcal/mol
ΔS0=46.5 cal/mol K
We have also measured the temperature depen-
dence of ΔH0 for the (KIGAKI)3 peptide as ΔCp
0≈
−100 cal/mol K.
Discussion
Structural aspects of membrane-peptide
interactions
We have used the (KIGAKI)3 peptide and its d,d
analogues to obtain information on the thermody-
namics of the random coil ⇆ β-structure transition
at the membrane surface. Formation of β-structure
requires either a folding of the peptide chain onto
itself or a lateral association of two or more peptides.
Thermodynamics allows no distinction between
these two processes. On the basis of the deuterium
NMR spectra of deuterated (KIGAKI)3 peptides,
both possibilities appear to be realized in the present
set of peptides. When bound to the membrane the
all-L peptide 1 molecule exhibits a deuterium NMR
spectrum characteristic of a solid powder, suggest-
ing extensive lateral aggregation. On the other hand,
peptide 9 with two d,d pairs gives rise to a sharp
deuterium NMR resonance when bound to the lipid
membrane. This result argues against the formation
of solid-like aggregates. Small aggregates with
internal mobility, however, cannot be excluded.
The deuterium and phosphorus NMR measure-
ments provide no evidence that the (KIGAKI)3
peptide changes the bilayer structure, or the confor-
mation and orientation of the −P-N+ choline dipoles.
The chemical shift anisotropy of the phosphate
segment and the deuterium quadrupole splitting of
the choline β-segment (POCH2CD2N) remain
unchanged up to a lipid to peptide mol ratio of 40.
The quadrupole splitting of the β-segment in
mixed POPC/POPG bilayers (3:1) is Δν(β) =
3.6 kHz. This is smaller than that observed in the
absence of POPG, which is νQ ∼5.9 kHz and can be
explained by the influence of the negative POPG
charge on the −P-N+ dipole.47 As only a single
quadrupole splitting is observed, this requires a
homogeneous distribution of anionic POPG mole-
cules in the electrically neutral POPC matrix.
The quadrupole splitting in the presence of
(KIGAKI)3 peptide is almost identical with that in
the absence of peptide with Δν(β)=3.3 kHz. Again,
a single quadrupole splitting is observed. This is
possible only if the −P-N+ dipoles sense a similar
surface charge as before. The POPGmolecules hence
remain distributed randomly in the lipid bilayer. A
phase separation of the anionic lipids induced by the
binding of cationic peptides can be excluded.
Thermodynamics of β-sheet formation
The peptides employed have the same sequence
with respect to side-chain functionality and, in turn,
similar intrinsic hydrophobicities. In water, they
adopt a conformation that is mainly random coil,
with about 30% β-structure. The percentage of β-
structure is independent of the concentration of
peptide up to 1 mM, arguing against an aggregation
of the peptides in buffer solution. Binding of pep-
tides 1–8 to negatively chargedmembranes increases
the fraction of β-conformation and induces the
formation of aggregates at the membrane surface.
The binding process is an endothermic reaction
and makes an energetically unfavourable contribu-
tion to the binding process. This is in distinct contrast
to the membrane binding of helix-forming peptides
such as magainin23,24,34,48 and the mitochondrial
signal sequence RDH,25 which exhibit exothermic
reactions of considerable magnitude. Binding of
melittin and melittin analogues (E. Gonçalves and
Figure 7. Variation of the thermodynamic parameters
of peptide–lipid interaction with the extent of β-sheet
formation of peptides 1–8. (a) Enthalpy ΔH0 (■) and free
energy ΔG0 (●). (b) Entropy ΔS0. All data were recorded
at 25 °C.
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J.S., unpublished results) to lipid bilayers entails
reaction enthalpies between +4 kcal/mol and −4
kcal/mol, depending on temperature.30
The free energy of binding, however, is negative
for β-structure as well as for α-helix formation, and
contains two contributions: (i) the electrostatic at-
traction to themembrane surface; and (ii) the binding
step proper driven by hydrophobic and hydrogen
bonding interactions and aggregation. As the mem-
brane is negatively charged, the concentration of the
cationic peptide is larger at the membrane surface
(cM) than in bulk solution (cf) and the electrostatic
contribution to the free energy, ΔGel, is given by:
DGel ¼ RT lnðcM=cfÞ ð9Þ
The hydrophobic/hydrogen bonding part of the free
energy is more important in the present context, as it
includes the energy change of the conformational
transition from random coil to β-sheet. It is given by:
DG0 ¼ RT ln 55:5 K0 ð10Þ
where the factor 55.5 corrects for the cratic contribu-
tion. K0 can be determined from the ITC binding
isotherms, using the Gouy–Chapman theory to
eliminate electrostatic effects.24,39 K0 is independent
of salt concentration, peptide concentration, and
membrane surface charge, provided the structure of
the membrane remains unchanged.
Table 2 summarizes the binding constants K0, the
effective charge zp, and the free energy ΔG
0,
calculated from K0. The charge zp was determined
to yield an optimum fit to the individual ITC curves
and varies between 4.0 and 4.9. However, it is
equally possible to analyse all ITC curves with a
common average electric charge of zp=4.5 for all
eight peptides. The numerical results are not
essentially different from those presented in Table
2. The binding constants shown in Table 2 fall in the
range of 50–890 M−1 and are thus relatively weak.
The change in free energy, ΔG0, is of the order of
−4.7 to −6.4 kcal/mol.
The electrostatic energy must be added to the
chemical adsorption process. ΔGel varies continu-
ously during an ITC titration requiring a point-by-
point correction of the ITC curve. The surface po-
tential of a POPC/POPG (3:1 mol%) membrane in
50 mM NaCl plus 25 mM Tris and in the absence of
peptide is ψ0=−45 mV. If the peptide concentration
is 10 μM in bulk solution, the surface concentration is
cM ∼68 μM for peptide 1. The corresponding elec-
trostatic energy thus amounts to ΔGel=−1.16 kcal/
mol. At the same time, the surface potential is
reduced to ψ0=−13 mV due to neutralization of the
membrane charge by peptide adsorption. For less
concentrated peptide solutions, the electric energy,
ΔGel, is higher.
Membrane-induced β-structure versus α-helix
formation
We may now compare the β-structure formation
of (KIGAKI)3 with the corresponding membrane-
induced α-helix formation of magainin and related
amphipathic peptides.23 From the slope of the ΔG0
line in Figure 7, we deduce that the incremental
change in the free energy for β-structure formation
of (KIGAKI)3 is ΔGβ=−0.15 kcal/mol per amino
acid residue. Almost the same value, ΔGhelix=−0.14
kcal/mol per residue, has been reported for the helix
formation of magainin 2 amide on the membrane
surface.23 The numerical agreement is probably
accidental, as other amphipathic peptides such as
the mitochondrial signal peptide RDH and melittin
display ΔGhelix values in the range of −0.2 to −0.4
kcal/mol per residue.22,25 Nevertheless, the com-
parison illustrates two different aspects. First,
induction of β-structure and helix formation appear
to involve very similar free energies. This is not
surprising, as both processes entail the formation of
H bonds, be it intra-or intermolecular. Secondly,
though energetically favourable, the change in free
energy, ΔGβ, from random coil to β-structure is
small and can be reversed easily. On the other hand,
if a longer stretch of peptide is involved and the
segmental contributions accumulate cooperatively,
the interaction with the membrane can produce a
more stable conformational change.
A similar comparison can be made for the reaction
enthalpy ΔH0. From the slope of the ΔH0 line in
Figure 7 one findsΔHβ=−0.23 kcal/mol per residue,
which is smaller by a factor of 3 than ΔHhelix=−0.78
kcal/mol per residue for magainin 2 amide. As an
immediate consequence, it follows that both second-
ary structures are destabilized at higher tempera-
tures but that this effect is less pronounced for the β-
sheet conformation than for the α-helix.
An even larger difference is found for the
segmental entropy which is ΔShelix ≈ −1.9 cal/mol
K per residue for α-helix formation but only ΔSβ=
−0.25 cal/mol K for β-sheet structure. It can be
speculated that α-helix formation imposes more
drastic steric constraints on distances and bond
angles than a loosely packed β-sheet.
The intercepts of the straight lines in Figure 7
provide the binding thermodynamics of a hypothe-
tical (KIGAGKI)3 peptide that binds to the mem-
brane surface without a conformational change. As
the binding enthalpy is endothermic, with ΔH0=9.8
kcal/mol, the driving force for the association with
the membrane is the entropic contribution with
ΔS0=47 cal/mol K. This result is quite different
from data reported for a (hypothetical) random coil
magainin 2 amide, where the enthalpy is favourable
with ΔH0=−4.7 kcal/mol and is counteracted by a
negative entropy term. The thermodynamic differ-
ence between the two types of peptides probably
arises from the fact that (KIGAKI)3 aggregates at the
membrane surface, while magainin 2 amide binds as
a monomer. Lateral association itself will reduce the
entropy due to motional restrictions. The large posi-
tive entropy term must then arise from the release of
hydration water.
Membrane-induced β-sheet formation has been
investigatedwith a hydrophobic hexapeptide acetyl-
Trp-Leu5.
29 The mechanism of β-sheet formation is,
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however, different from that observed for the
charged (KIGAKI)3 peptide. As AcWL5 is hydro-
phobic, it partitions as a monomer from the aqueous
phase into the hydrophobic part of the bilayer, where
it assembles cooperatively into β-sheet aggregates
containing 10–20 monomers. At about 60 °C the
aggregates undergo a relatively sharp and reversible
unfolding to random coil monomers. Using equili-
brium dialysis and spectroscopic methods, β-sheet
formation could be analyzed quantitatively and
described by a cooperative model. The free energy
change per residue was calculated for two different
membranes to be in the range of −0.46 kcal/mol to
−0.61 kcal/mol per residue.29 These values are larger
than those observed here for the (KIGAKI)3 peptides.
However, AcWL5 penetrates deeply into the mem-
brane, while (KIGAKI)3 remains adsorbed in the
lipid–water interface.
Using ITC and differential scanning calorimetry,
the partitioning of AcWL5 monomers into the lipid
membrane as well as the thermal unfolding of the β-
sheet aggregates in the membrane were investi-
gated.30 Membrane partitioning is associated with
an enthalpy close to zero, while the enthalpy of
unfolding is estimated as 1.3 kcal/mol per residue.
The corresponding process of peptide folding thus
has ΔHβ=−1.3 kcal/mol and is again distinctly
larger than the value of −0.23 kcal/mol observed for
the (KIGAKI)3 peptide. The differences demonstrate
the influence of the solvent on the physical pa-
rameters of the random coil⇆ β-structure transition.
A related example without the involvement of a
lipid membrane is the β-hairpin formation of the G-
peptide, a short linear peptide consisting of only 16
amino acid residues. It folds into a β-hairpin
structure in water and the unfolding process was
investigated with NMR and differential scanning
calorimetry.49 A heat of unfolding of ΔH=12.2
kcal/mol was derived from the differential scan-
ning calorimetry experiments. If all amino acids are
involved in β-hairpin formation, this leads to
ΔHβ=−0.76 kcal/mol per residue for the folding
process. The above examples demonstrate that a
large variability exists for the enthalpy of β-sheet
formation. This is in contrast to α-helix formation,
which is always associated with ΔHhelix∼−0.7 to
−1.1 kcal/mol.
The (KIGAKI)3 model peptide was developed
primarily as a new antimicrobial peptide.34 How-
ever, the formation of β-structure when bound to
membranes makes it a model compound for other
amyloid-forming peptides such as the Alzheimer
peptides. The Alzheimer peptide Aβ(1–40) under-
goes a two-state random coil ⇆ β-structure transi-
tion when titrated with anionic lipid vesicles.31–33
Like (KIGAKI)3 the Aβ(1–40) molecule does not
penetrate into the lipid membrane, at least when
added from the aqueous phase. ITC experiments at
ambient temperature reveal an exothermic binding
reaction. However, the quantitative analysis of this
process is difficult because: (i) Aβ(1–40) aggregates
in solution even without lipid; and (ii) because the
random coil ⇆ β-structure transition in the mem-
brane is followed by a β-structure ⇆ α-helix tran-
sition at high lipid-to- protein ratios. Knowledge of
the thermodynamics of the (KIGAKI)3 reaction is
helpful in unravelling the more complex Aβ
membrane interaction.
A number of conclusions can be drawn from the
present studies that may be of interest in other areas.
First, the enthalpy for β-structure formation, ΔHβ,
shows a greater variability than that of α-helix
formation. The influence of the environment (mem-
brane surface, membrane interior, or aqueous solu-
tion) appears to have an important role. Secondly,
comparing ΔSβ of (KIGAKI)3 and ΔShelix of magai-
nin 2 amide, the reduction in entropy is much less for
β-structure formation. Finally, the method of multi-
ple d,d substitutions appears to be a general
approach to study the conformational and thermo-
dynamic properties of other amyloid-forming pep-
tides. A corresponding study on Alzheimer peptide
Aβ(1–40) is in progress.
Material and Methods
1-Palmitoyl-2-oleoyl-sn-glycero-3-phosphocholine
(POPC), 1-palmitoyl-2-oleoyl-sn-glycero-3-phosphoetha-
nolamine (POPE), 1-palmitoyl-2-oleoyl-sn-glycero-3-
phosphoglycerol (POPG), and 1,2-dioleoyl-sn-glycero-3-
phosphoethanolamine-N[methoxy(polyethylene glycol)-
2000] (mPEG 2000 PE) were purchased from Avanti
Polar Lipids (Alabaster, AL). All other chemicals were
purchased from commercial sources at the highest purity
available.
All peptides were synthesized using Fmoc (N-(9-fluo-
renyl)methoxycarbonyl) chemistry on an Applied Biosys-
tems model 433A peptide synthesizer. The crude peptides
were purified by reverse phase HPLC. Purity was assessed
by HPLC and mass spectrometry. The concentration of
peptide in all experiments was determined by measuring
the absorbance at 280 nm (ε=5500 M−1 cm−1) as the N-
terminal repeat contained Trp2 instead of Ile2.
Preparation of lipid vesicles
Small unilamellar vesicles (SUVs) of ∼30 nm diameter
were prepared as follows. Defined amounts of lipid were
dissolved in chloroform and were dried first with a stream
of N2 and then over night in vacuo. For ternary lipid
mixtures, the second and third lipid in chloroform were
added to the dried film and the mixed solution was treated
as before. Subsequently, buffer solution was added to the
lipid film and the mixture was vortex mixed extensively.
Next, the lipid dispersion was sonicated with a G112SP1
Special Ultrasonic Cleaner (Laboratory Supplies CO., Inc.)
until an opalescent solution was obtained.
For CD spectroscopy and ITC, we used SUVswith 5 mol
% mPEG 2000 PE. Incorporation of mPEG 2000 PE into
SUVs was crucial, because binding of the polycationic
(KIGAKI)3 peptide to negatively charged lipids leads to
charge neutralization with concomitant formation of large
aggregates. Aggregation produces a noisy ITC baseline
and causes extensive light-scattering in CD spectroscopy.
The inclusion of grafted hydrophilic polymers, such as
PEG chains, into phospholipid vesicles prevented vesicle
aggregation without influencing peptide–lipid binding.
The vesicle composition was POPE/POPG/mPEG 2000
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PE at molar ratios 70:25:5 for ITC and 45:50:5 for CD
spectroscopy. mPEG 2000 PE is negatively charged as the
amino group is no longer protonated.
NMR measurements
All NMR experiments were performed on a Bruker
Avance 400 MHz spectrometer. Deuterium NMR spectra
(2H-NMR) were recorded at 64 MHz with the quadrupole
echo technique with full-phase cycling. 31P-NMR spectra
were recorded at 161 MHz using a Hahn echo sequence
with broadband proton decoupling (WALTZ-16). The
chemical shielding anisotropy, Δσ, was measured as full
width at 10% maximum intensity.
Peptides observed by deuterium NMR were labelled
with Ala-d3 (HCα-Cβ
2H3) at amino acid position 9. About
3 mg of the lyophilized peptides was used for the 2H-
NMR powder spectra. To obtain 2H-NMR spectra of
peptides bound to non-oriented multilamellar vesicles, a
defined amount of lipid was transferred into an NMR
sample tube (typically 50 mg of lipid), and buffer solution
was added to achieve a predefined water/lipid ratio of 2:1
(v/w). For all NMR samples, we used a POPC/POPG
molar ratio of 75:25 and 25 mM Tris-HCl (pH 7.4), 50 mM
NaCl as buffer. In order to achieve a homogenous
suspension, the sample was vortex mixed extensively at
room temperature, followed by several freeze–thaw cycles
and further vortex mixing. The lyophilized peptide was
added in 0.2 mg steps in small volumes of buffer. After
peptide addition, the sample was again vortex mixed
extensively between at least five freeze–thaw cycles. The
procedure was repeated until the final lipid/peptide ratio
was achieved.
Isothermal titration calorimetry (ITC)
ITC was performed on a VP ITC instrument (Microcal,
Northampton, MA). Unless noted otherwise, all measure-
ments were made at 25 °C in 25 mM Tris–HCl (pH 7.4),
50 mM NaCl. Buffer solutions were freshly prepared. The
sample cell contained the peptide solution at a concentra-
tion of, typically, 25 μM. Lipid vesicles were suspended in
the same buffer as the peptide (∼12–15 mM lipid) and
10 μl was injected into the peptide solution every 5 min via
a 300 μl syringe. As a control, lipid vesicles were injected
into pure buffer containing no peptide.
Circular dichroism spectroscopy (CD)
CD measurements were performed on a Jasco J-720
spectropolarimeter. Spectra were recorded from 250 nm to
197 nm at room temperature, with resolution of 0.5 nm, a
response time of 2 s, a bandwidth of 1 nm, a scan speed of
20 nm/min and six accumulations. CD samples were
prepared by adjusting the peptide concentration to 50 μM
in 2.5 mM cacodylate buffer at pH 7.4, and by subse-
quently adding aliquots of POPE/POPG/mPEG 2000 PE
(45/50/5) SUVs suspended in the same buffer, to the
peptide solution. A blank of pure buffer solution was
subtracted from all samples.
Evaluation of CD spectra of peptides containing
D-amino acids
Figure 5 shows the titration of peptide 1 with anionic
lipid vesicles. An isosbestic point is observed at 209 nm,
providing evidence for a two-state equilibrium. The
analysis yields the following composition of ellipticity:
epep1buffer ¼ 0:77erc þ 0:23ehuCbuffer lipid=peptide ¼ 0 ð11Þ
epep1buffer ¼ 0:22erc þ 0:98ehuCbuffer lipid=peptide ¼ 10 ð12Þ
where εrc(εβ) is the ellipticity of the pure random coil
(β-sheet) spectrum at a given wavelength. Peptide 1 in
buffer has a spectrum that is 77% random coil and 23%
β-structure.
All intermediate spectra can be simulated by a super-
position of these two spectra. The observed conformation
Ci can be described as:
Ci¼ fi;bufferCbufferþ fi;lipidClipid ¼ fi;bufferCbufferþð1 fi;bufferÞClipid
Ci ¼ fi;bufferðCbuffer  ClipidÞ þ Cbuffer ð13Þ
Here, fbuffer is the fraction of the initial spectrum at
lipid/peptide=0 and flipid=1–fbuffer is the spectral contribu-
tion of the peptide bound to lipid (lipid/peptide=10).
By combining equations (11)–(13) it is possible to
evaluate the random coil and β-content of all intermediate
spectra shown in Figure 5.
Figure 8(a) displays the CD spectra of peptide 2 in buffer
and in excess lipids. The continuous lines represent the
corresponding spectra of peptide 1 but at a reduced ellip-
ticity of 78% and an almost perfect agreement is obtained.
Figure 8. Comparison of experimental and calculated
CD spectra of peptides containing D-amino acids. (a)
Peptide 2 with one d,d pair: (□) peptide in buffer solution;
(○) peptide bound to lipid. The continuous lines are the
corresponding spectra of the all-L peptide 1 but with a
reduced intensity of 78% (theory 78%). (b) Peptide 7 with
two d,d pairs: (□) peptide in buffer solution; (○) peptide
with excess lipid. The continuous lines correspond to the
spectra of peptide 1 with 50% intensity (theory 56%).
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A quantitative explanation of this result can be given as
follows. If peptide 1 is synthesized from all-D amino acids,
the corresponding CD spectra without and with lipid
would be mirror images of those shown in Figure 5
(mirrored at the x-axis), that is:
eDðkÞ ¼ eLðkÞ
Considering the peptide in buffer, the conformation is
essentially unstructured (random coil). The observed
ellipticity can be predicted as:
eobs ¼ XD eDðkÞ þ XLeLðkÞ
¼ ð1 XLÞðeLðkÞÞ þ XLeLðkÞ
¼ 2XLeL þ eL ¼ eLð2XL  1Þ
ð14Þ
XD and XL are the mole fractions of the D and L-amino
acids. Peptide 2 with a total length of 18 residues contains
two D-amino acids (11%) and this simple model predicts
εobs=0.78 εL, in agreement with the experiment. For an
essentially random coil conformation, this result can
perhaps be anticipated, as each amino acid contributes its
CD increment (L or D) to the non-structured peptide.
However, it is surprising that the same model leads to the
correct prediction ofpeptide 2 bound to the lipidmembrane.
This means that the D-amino acids in the β-conformation of
peptide 2 make the same contribution to the spectrum as if
they were incorporated into an all-D peptide 1 molecule.
A further reduction of intensity occurs if two d,d pairs
(peptides 5–7) or three d,d pairs (peptide 8) are incorpo-
rated. Equation (14) then predicts only 56% and 33%
intensity compared to peptide 1. For the peptide spectra in
buffer, this prediction is only approximately fulfilled
(Figure 4(a)). The deviations of the experimental results
from the theoretical spectra are significant, however, and
cannot be ignored. They must be traced back to changes in
the conformation. An optimal fit is obtained by first
reducing the intensity of the basic spectra of peptide 1
(Figure 1)) according to the D-amino acid fraction and,
secondly, by mixing the reduced basic spectra. Figure 8(b)
shows the optimal fit for peptide 7 with and without lipid.
The continuous lines correspond to 50% intensity (theore-
tical value 56%) of the CD spectra of the all-L peptide 1. It
is possible to calculate the random coil and β-structure
content for all spectra by this method. The results are
summarized in Table 3 and discussed above.
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5.1 – Summary: Length dependence of the Coil ?  ?-Sheet Transition in 
a Membrane Environment 
  
In the previous chapter we determined the thermodynamic parameters for the ?-sheet 
folding reaction of the (KIGAKI)3 peptide in a membrane environment. In the following 
we investigate the difference between the ?-sheet folding reaction in a native and 
aggregated protein.  
To this purpose we increase the length of the ?-sheet forming (KIGAKI)3 peptide by one 
and two KIGAKI repeats or we shorten it to a total length of 12, 10, 8, or 7 amino acids 
residues. The thermodynamic overall binding parameters, which combines the folding and 
binding process, were determined by ITC for all peptides. Structural changes upon binding 
to lipid vesicles were monitored by CD spectroscopy. For peptides with one KIGAKI 
repeat longer and shorter than (KIGAKI)3 we applied the double D amino acid substitution 
strategy to divide the overall binding reaction contributions from ?-sheet folding and the 
binding process proper. A length-dependence of the ?-sheet folding and binding reaction 
can be deduced from the thermodynamic parameters measured for (KIGAKI)2, 
(KIGAKI)3, and (KIGAKI)4. Upon extending the length of the ?-sheet the thermodynamic 
driving forces changed dramatically. For ?-sheets shorter than 10 residues the folding 
reaction is driven by entropy, whereas for longer ?-sheets the folding reaction is driven by 
enthalpy. Considering that ?-strands in proteins are statistically 2 to 6 residues in length 
and current models of ?-sheet in protein aggregates, i.e. amyloid fibrils, predict a length of 
at least 10 residues, our results may explain a fundamental thermodynamic difference in 
the folding reaction of the two ?-sheet folds. We further demonstrate that the stability of 
the ?-sheet folds increases only slightly upon lengthening the ?-sheet and that 
cooperativity effects are rather small compared to the random coil to ?-helices transition. 
The present findings provide evidence that small changes of pH or temperature can have a 
profound effect on the ?-sheet aggregation reaction. 
In addition to the length-dependence of the ?-sheet folding reaction we also studied the 
binding of the polycationic peptides to anionic membrane surfaces. Binding of the 
peptides is mainly driven by electrostatic interactions, although hydrophobic and 
dehydration effects also play a role. Finally, we show thermodynamic parameters derived 
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for the three peptides discussed above to shorter or longer chain length explains the 
experimental data observed for KIGAKI peptides with chain length of 8, 10 and 30 
residues. 
 
 
5.2 – Manuscript: Length dependence of the Coil ?  ? -Sheet Transition 
in a Membrane Environment 
 
Introduction 
?-sheet folds in proteins are typically 2 to 6 residues in length, with few longer than 12 
residues
1, 2
. In comparison to ?-helices which on the average have 7-20 residues3, 4, ?-
sheet structures tend to be distinctively shorter. Interestingly, current models of ?-sheets in 
non-native protein structures, i.e. amyloid fibrils, are about 10 residues in length
5-7
. Length 
stabilization is well known for the ?-helix8, 9, but is still controversial for the ?-sheet 
structure. Isolated helices become more stable as the length of the ?-helix increases. 
However, a more complex situation is encountered in the case of ?-sheets since two 
orthogonal dimensions must be considered for ?-sheet stabilization10, namely along and 
perpendicular to the strands. A closer insight into stabilization forces of ?-sheets is 
obtained from small model peptides forming ?-hairpins, that is a two-stranded antiparallel 
?-sheet, 7, 10. In such model peptides the length dependence of the ?-sheet stability has 
been examined in both dimensions. Extension of the ?-sheet structure perpendicular to the 
strand has been shown to gradually stabilize the ?-sheet 11-13, whereas a discontinuous 
effect was found upon strand lengthening along the peptide axis. It has been suggested that 
?-sheet stability may not increase beyond seven to nine residues14. 
  Chapter 5 
 
64 
The thermodynamic analysis of ?-sheet formation in aqueous solution is hampered by the 
low solubility of the specific peptides in water. Chain extension usually reduces the 
solubility even further. Both ?-sheet formation and peptide solubility are, however, 
increased in hydrophobic environments such as organic solvents and lipid membranes
15
. 
Few experimental studies on the stabilization of a ?-sheet fold in a membrane 
environment are available to date. We have recently determined the thermodynamic 
parameters of the membrane-induced random coil ? ?-sheet folding reaction of the 
(KIGAKI)3 peptide using isothermal titration calorimetry (ITC) 
16
. ITC data were obtained 
for the binding of the (KIGAKI)3 peptide to anionic lipid vesicles. The thermodynamic 
data are the result of two processes, namely the transfer of the peptide from the aqueous 
phase to the lipid surface, ?GBinding, and the conformational change of the peptide from a 
random coil conformation to a ?-sheet structure, ?GFolding. The contribution of the folding 
reaction to the overall process was determined with analogs of the KIGAKI repeat, in 
which two adjacent amino acids were replaced by their D-enatiomers. Substitution of L 
amino acids by their D enatiomers led to a local disturbance of the ?-sheet structure 17, 18, 
the extent of which was dependent on the number and position of the D amino acid 
substitutions. The extent of ?-sheet formation on the surface of negatively charged 
membranes was measured with circular dichroism (CD) spectroscopy. By correlating the 
thermodynamic parameters with the percentage of ?-sheet formation of peptides with and 
without D-amino acids it was possible to separate the binding thermodynamics from the 
process of ?-sheet formation. 
In the present study we were interested in the influence of the peptide chain length on the 
thermodynamic parameters of ?-sheet formation. To this purpose we increased the length 
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of the (KIGAKI)3 peptide by one and two KIGAKI repeats or shortened the peptide to 12, 
10, 8, or 7 amino acid residues. The thermodynamic binding parameters and structural 
changes of all peptides were determined with ITC and circular dichroism spectroscopy, 
respectively. By comparing the different peptides distinct differences were observed 
between short (n ? 12) and long peptides (12 < n  ? 30). 
 
Materials and Methods  
1-Palmitoyl-2-oleoyl-sn-glycero-3-phosphoethanolamine (POPE), 1-palmitoyl-2-oleoyl-
sn-glycero-3-phosphoglycerol (POPG), and 1,2-dioleoyl-sn-glycero-3-
phosphoethanolamine-N-[methoxy (polyethylene glycol)-2000] (mPEG 2000 POPE) were 
purchased from Avanti Polar Lipids (Alabaster, AL). All other chemicals were purchased 
at highest purity from various sources. 
All peptides were synthesized using the Fmoc (N-(9-fluorenyl)methoxycarbonyl) 
chemistry on an Applied Biosystems model 433A peptide synthesizer. The crude peptides 
were purified by reverse phase high performance liquid chromatography (HPLC). Purity 
was proven by HPLC and mass spectrometry. Peptide concentration in all experiments 
was determined by absorbance at 280 nm using an extinction coefficient of ? = 5500 M-1 
cm
-1
 for Trp. 
 
Preparation of Lipid Vesicles  
Small unilamellar vesicles (SUV) of ~30 nm diameter were prepared as follows. Defined 
amounts of lipid were dissolved in chloroform and were dried first with a stream of N2 and 
then over night under high vacuum. The second and third lipid for the ternary lipid 
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mixtures was added to the dried film in chloroform solution and treated as before. 
Subsequently, buffer solution was added to the lipid film and the mixture was vortexed 
extensively. The lipid dispersion was sonicated with a G112SP1 Special Ultrasonic 
Cleaner (Laboratory Supplies CO., Inc.) until a clear solution was obtained. To prevent 
vesicle aggregation all small unilamellar vesicles (SUVs) contained 5 mol% of 1,2-
dioleoyl-sn-glycero-3-phosphoethanolamine-N-[methoxy (polyethylene glycol)-2000] 
(mPEG 2000 POPE).  
 
Circular Dichroism Spectroscopy 
Circular dichroism (CD) measurements were performed with a Jasco J-720 
spectropolarimeter. Spectra were recorded at room temperature from 250 to 198 nm, with 
resolution of 0.5 nm, response time of 2 s, bandwidth of 1 nm, scan speed of 20 nm/min 
and 6 accumulations. CD samples were prepared by adjusting the peptide concentration to 
50 ?M or 75 ?M in 2.5 mM cacodylate buffer at pH 7.4. Aliquots of a 25 mM 45/50/5 
POPE/POPG/mPEG 2000 POPE SUV dispersion in the same buffer were added to the 
peptide solution. A blank of pure buffer solution was subtracted from all samples. 
 
Isothermal Titration Calorimetry  
Isothermal titration calorimetry (ITC) was performed with a VP ITC instrument (Microcal, 
Northampton, MA). All measurements were made at 25 °C in buffer (25 mM Tris/HCl, 50 
mM NaCl, pH 7.4). Buffer solutions were freshly prepared. The sample cell contained the 
peptide solution at a concentration of 25-50 μM. Lipid vesicles were prepared in the same 
buffer (lipid concentration varied from 5 to 25 mM) and injected into the peptide solution 
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in 10 μL aliquots. As a control, lipid vesicles were injected into pure buffer containing no 
peptide. 
 
Results 
The peptide-membrane binding equilibrium of the KIGAKI repeats measured with 
isothermal titration calorimetry 
Table 1 shows the set of synthesized peptides with their corresponding short-hand 
notation. For accurate determination of the peptide concentration, Ile-2 was replaced by 
Trp, and peptide concentrations were calculated using the Trp molar extinction 
coefficients (5500 M-1 cm-1). The C-terminal carboxyl groups of all peptides were 
amidated. 
 
Table 1 
 
In the following the term “binding” is used in a general sense to describe the adsorption of 
the cationic peptide from the bulk solution to the anionic membrane surface. Binding of 
the KIGAKI peptides with length of 7 to 30 residues to negatively charged lipid vesicles 
was studied by ITC. Following the standard protocol for lipid-into-peptide titration19 a 
diluted peptide solution was filled into the calorimeter cell and 10 μL aliquots of a lipid 
suspension were injected at constant time intervals. Figure 1A shows a representative 
calorimetric trace obtained at 25 °C by titration of 50 μM pep-8 with 25 mM SUVs 
composed of POPE/POPG/mPEG 2000 POPE (70:25:5 molar ratio).  
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Figure 1 
 
Each lipid injection causes an endothermic reaction as illustrated by the calorimetric trace. 
The size of the titration peak becomes smaller with increasing number of injections as less 
peptide is available for binding. After about 20 injections all peptide is bound and further 
lipid injections entail no additional heat of reaction (except of dilution effects). The molar 
binding enthalpy, ?H 0 , can then be calculated according to 
 
?
=
=?
n
i
nhH
1
0
pepi
0 /  (1) 
where 
0
pepn
 
is the total molar amount of peptide in the calorimeter cell and ?
=
n
i
h
1
i  is the 
cumulative heat of reaction. The measured binding enthalpies for all peptides except for 
pep-7 are summarized in table 2. For pep-7 we observed only small heat peaks upon 
titration with anionic lipid vesicles. 
 
Table 2 
 
The ITC data can be translated into binding isotherms as described elsewhere
20
. Figure 1 
B shows the binding isotherm corresponding to the ITC measurement of figure 1A. The 
binding isotherm, Xb = f (cf ) , describes the extent of binding, Xb, as a function of the 
equilibrium concentration of the free peptide cf. Xb is defined as 
(i)
L
(i)
boundpep,
(i)
b / nnX = , 
where 
(i)
bound pep,n is the molar amount of bound peptide after i injections, and 
(i)
Ln  is the 
molar amount of injected lipid available for binding. (i)Ln  is known from the lipid 
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concentration in the injection syringe and the number of injections i. In the present case 
the charged peptides are not able to translocate across the membrane and only the outer 
membrane leaflet of the SUVs (60% of the total lipid) is available for peptide binding. 
(i)
bound pep,n  can be calculated from the experimental heats of reaction, hi, according to  
 
np, bound
(i)
= hk / ?H 0VCell c0,pep( )
k=1
i?  (2) 
c0,pep is the total peptide concentration in the calorimeter cell. Knowledge of the amount of 
bound peptide allows the calculation of the peptide concentration free in solution from 
mass conservation. The binding isotherm can thus be determined in a model-independent 
fashion. 
The further analysis of the binding isotherm is based on a surface partitioning model, in 
which the peptide adsorption is related to the peptide concentration cM found immediately 
above the plane of binding
18, 21
 
 
M0b cKX =  (3) 
The model is based on the observation that the negatively charged membrane surface will 
attract cationic species in its vicinity. The peptide concentration will thus increase from its 
equilibrium value, cf, far away from the membrane surface to the much higher value cM in 
the lipid water interface. The electrostatic equilibrium governed by the Boltzmann relation 
 
cM = cf exp ?zpepF0? / RT( )  (4) 
zpep is the effective peptide charge (usually smaller than the nominal charge), ? is the 
membrane surface charge potential, F0 is the Faraday constant, and RT the thermal energy. 
Using the Gouy-Chapman theory it is possible to calculate the surface potential ? and the 
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surface concentration cM for each data point of the ITC curve and for the binding isotherm 
leading to a surface partition constant K0 
22, 23
. A detailed description of this binding model 
has been given elsewhere 
20
. As an additional feature the binding of Na
+
 ions to 
phosphatidylglycerol was taken into account with a Langmuir adsorption isotherm and a 
Na
+
 binding constant of 0.6 M
-1
 
24
. Tris/HCl buffer was counted as a 1-1 salt. The 
continuous line in figure 1B is the best theoretical fit to the experimental data. The 
effective peptide charge is zpep = 3.1-3.3 and the surface potential varies between ? = -45 
mV at low Xb to ? = -17 mV at the highest Xb  value. The binding constant according to 
eq. (4) is K0 =  170 M
-1
. An excellent agreement between the model and the experimental 
data is obtained for all peptides. The corresponding binding constants K0 are listed in table 
2. The free energy of binding, ?G0, follows from 
 
)5.55ln( 0
0
KRTG ?=?  (5) 
where the factor 55.5 is the molar concentration of water and corrects for the cratic 
contribution. The binding entropy can then be calculated from ?G0 = ?H 0 ? T?S0 . 
 
Circular dichroism spectroscopy of KIGAKI peptides with and without lipid 
The CD spectra of KIGAKI peptides of chain length n = 8 to 30 in buffer are displayed in 
figure 2A. All spectra are characteristic of a predominantly random coil conformation. 
 
Figure 2 
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The ellipticity decreases with decreasing peptide length. The spectra can be simulated with 
conventional CD simulation programs and the random coil content is in the range of 71 to 
85%. The detailed analysis is given in table 3.  
Upon addition of anionic lipid vesicles the cationic peptides bind to the membrane surface 
and undergo a conformational change to a ?-structured conformation. Figure 2B displays 
the 
 
Table 3 
 
corresponding CD spectra recorded in excess of anionic lipid vesicles. The ?-sheet content 
increases from 38% for n=8 to 90-100% for n=18, 24 and 30. The detailed analysis is 
again listed in table 3. We have also synthesized peptides with a chain length of 6 and 7 
residues. They bind only weakly and the changes in the CD spectra are small.  
The last two columns in table 3 quantitate the observed spectral change in terms of the 
fraction of ?-structure, ?f?, and the total numer of amino acids, ??(aa) involved in the 
random coil-to-?-structure transition. ??(aa) is obtained by multiplying ?f? with the 
peptide chain length ntotal. A plot of ??(aa) vs the total peptide length ntotal is shown in 
figure 3 and 
  
Figure 3 
 
yields a straight line with 
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??(aa) = 1.13ntotal - 7.86 (6) 
The figure predicts that for peptides with a chain length ntotal ? 7 no conformational 
change should be observed. This agrees with the experimental finding by ITC and CD that 
neither a heat signal nor a change in the CD signal can be observed if peptides with ntotal = 
6 are titrated with anionic lipid vesicles. The binding of short peptides appears to be too 
weak to be measured.  
As the KIGAKI peptides in solution have up to 20% ?-content it is physically more 
meaningful to plot the number of new ?-segments, ??(aa), on the membrane vs. the 
number of random coil segments of the same peptide in solution, nrc (plot not shown). 
Again a straight line is obtained with  
 
??(aa) = 1.23 nrc - 4.96 (7) 
The latter equation allows the following conclusion. Once a threshold of about 5 random 
coil segments is passed, each increase in the chain length by 1 rc-element will produce 
1.23 ?-segments upon binding to the lipid surface. This yields a first approximation of the 
free energy for the membrane induced random coil ? ?-structure transition of ?G? = -RT 
ln 1.23 = -0.12 kcal/mol. In a previous study using D,D substitution of pep-18 ?G? was 
found to be -0.15 kcal/mol.  
 
Thermodynamics of ?-structure formation 
The thermodynamic parameters measured in the ITC experiment are composed of the 
binding process and the conformational change induced by the interaction with the lipid 
matrix. Figure 3 shows a linear correlation between the total chain length, n, and the 
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number of amino acid residues, ??(aa), changing from random coil to ?-structure. A plot 
of the thermodynamic parameters ?H0, ?G0, and T?S0 against the chain length n or the 
increase in ?-structure, ??(aa), will lead to qualitatively similar diagrams. Figure 4 
displays the variation of the thermodynamic parameters as a function of the peptide chain 
length.  
 
Figure 4 
 
Two regions can be discerned. For small n (8 ? n ? 12; 1.5 ? ??(aa) ?  6) the 
thermodynamic parameters show a linear increase, whereas for large n (18 ? n ? 30; 13 ? 
??(aa) ? 25) the thermodynamic parameters decrease. In particular figure 4 reveals that 
for stretches of amino acids longer than n = 12 the formation of ?-structure is an 
exothermic process. A temperature-increase will decrease the ?-content of long 
aggregates. For shorter chains (n = 8-12) ?H0 is endothermic and the ?-structure will be 
stabilized upon increasing the temperature.  
However, it has to be taken into account that the peptide binding process to the membrane 
(without conformational change) varies with the peptide chain length. To exclude a strong 
contribution of the binding process to the ?-sheet folding and to quantify the ?-sheet 
folding reaction, we deduce the thermodynamic parameters of the ?-sheet foldig process 
by keeping the chain length constant but replacing pairs of L-amino acids by their D-
enantionmers.  
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?-structure formation of KIGAKI peptides with 12 and 24 residues containing D-amino 
acids  
It can be assumed that the basic binding properties of the all-L peptide and its D,D analogs 
are identical and that the differences in the thermodynamic parameters can be ascribed to 
different extents of ?-sheet formation. The systematic D,D substitutions at different chain 
positions have been successfully employed to quantitatively describe the membrane-
induced ?-helix formation of the antibacterial peptide magainin 25 and the ?-structure 
formation of pep-18 
16
. In the present study we have extended this method to a longer 
(KIGAKI)4 peptide (pep-24) with 2 or 3 D,D pairs and a shorter (KIGAKI)2 peptide (pep-
12) with 1 or 2 D,D pairs. 
Figure 5 summarizes the CD spectra of the three pep-24 analogs in buffer (fig 5A) and in 
the  
 
Figure 5 
 
presence of excess lipid (fig. 5B). The figure demonstrates a distinct change from a 
random coil spectrum in buffer to a ?-structured CD spectrum upon addition of lipids. The 
figure also reveals that the ellipticity is reduced as D-amino acids are incorporated into the 
sequence. An isosbestic point is observed at about ? = 210 nm suggesting a 2-state 
equilibrium. The evaluation of the CD spectra with D-amino acids has been described 
previously 
16
. In short, we start from the pep-24 or the pep-12 spectrum without D-amino 
acids, which can be analyzed by the conventional CD simulation programs. The results are 
given in table 3. Next, we reduce the ellipticities according to the fraction of D-amino 
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acids in the analog. If the fraction of D-amino acids in the sequence is XD, the ellipticitites 
of the all-L peptide in buffer and with lipid is multiplied by (1 - 2XD). In a third step we 
generate linear combinations of the buffer and lipid spectra with reduced ellipticities to 
reproduce the experimental spectra. The results of this conformational analysis are also 
listed in table 3.  
The structural changes can then be correlated with the changes in ?H0, T?S0, and ?G0 as 
shown for pep-24, pep-12, and pep-18 in figure 6. The slopes of the linear regression lines 
yield the parameters of ?-sheet folding per amino acid residue, whereas the intersections 
with the y-axis yields the binding parameters for a hypothetical peptide which binds 
without folding. The results are summarized in table 4. It is obvious that the regression 
analysis yields for all thermodynamic parameters a linear decrease of the binding enthalpy 
for pep-24, and pep-18 with increasing ?-structure.  
 
Figure 6 
 
 
A different behavior is observed for pep-12. The plot of ?H0, T?S0, and ?G0 vs. ??(aa) is 
only approximately linear with a positive slope. This result is consistent with the biphasic 
behaviour described above in figure 4, which shows a positive slope for short chains and a 
negative slope for long chains.  
In the following figure 7 we use ??(aa) as the physically more relevant parameter to 
quantify length dependence of the ?-sheet folding process per residue. Therefore the 
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thermodynamic parameters of the ?-sheet folding process of pep-12, pep-18, and pep-24, 
obtained from the DD amino acid substitution study, are correlated with ??(aa).  
 
Figure 7 
 
All thermodynamic parameters correlate linearly with a correlation coefficient higher than 
0.9. The change for the residual thermodynamics of ?-sheet formation with the ?-sheet 
length for the KIGAKI peptides are described by 
??H folding = ?0.04 ?n? + 0.31  (8) 
?T??Sfolding = 0.03 ?n? ? 0.36  (9) 
??Gfolding = ?0.02 ?n? + 0.19  (10) 
where n? is the length of the ?-sheet. Regression functions of the intrinsic binding reaction 
are given in the legend of table 4. 
 
Specific heat capacities 
Electrostatic as well as hydrophobic interactions contribute to membrane binding and 
peptide aggregation. In particular, the large entropic contribution to the binding reactions 
suggests a prominent contribution of the hydrophobic effect to the binding reaction. The 
hallmark of the hydrophobic effect is a large change in the specific heat capacity, which is 
associated with the adsorption or release of water from the hydrophobic surface. The last 
column in table 2 shows measured heat capacities for selected peptides. The heat 
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capacities are large (-150 to -400 cal mol
-1
 K
-1
) and negative confirming the role of the 
hydrophobic effect in the binding process.  
 
Discussion 
We have studied the influence of the peptide chain length on the ?-sheet ? random coil 
transition in a membrane environment using a set of peptides with the KIGAKI repeat. 
The chain length varied from 7 to 30 residues. As deduced from the CD spectra all 
peptides are predominantly random coil in water but adopt ?-sheet structures of different 
extent when bound to an anionic membrane surface.  
The overall binding process of the KIGAKI peptides to the membrane can be dissected 
into two steps. The first is an electrostatic attraction of the cationic peptides to the 
negatively charged membrane surface which leads to a higher peptide concentration near 
the membrane surface, cM, than the bulk concentration, ceq. This peptide concentration was 
calculated with the Gouy-Chapman theory. The ensuing binding equilibrium between 
peptide in the water-lipid interface and peptide bound to the membrane surface is 
governed by the interfacial concentration cM and follows a simple partition law (eq. 4). 
The bound peptide remains localized at the membrane surface as deduced from solid state 
NMR 
16
, and peptide partitioning into the hydrophobic core of the membrane can be 
excluded. The membrane binding step is coupled to a transition from a random coil to a ?-
sheet structure. The ?-sheet folding reaction entails additional enthalpic and entropic 
contributions, which are the theme of the present study. 
For three peptides with chain lengths of 24, 18 and 12 amino acids, we have synthesized 
stereo-analogs with double D amino acid substitution at different positions. The 
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replacement of L-amino acids by their D-enantiomers leads to a local disruption of 
hydrogen bonds and produces an enhanced flexibility in the regions around the D-amino 
acids 
17, 18
. On the other hand, other peptide properties such as the hydrophobicity and side 
chain functionality are maintained. We have recently shown that the overall binding 
enthalpy (as determined from ITC), the free energy (as determined from the analysis of the 
binding isotherm), and the entropy of pep-18 and its stereo-analogs varied linearly with 
the extent of ?-sheet formation at the membrane surface 16. In the present work, a linear 
correlation is also found for the KIKAGI derivatives pep-24 and pep-12 and their 
corresponding stereo-analogs. At the same time, our data demonstrate that the intrinsic 
thermodynamic parameters for ?-sheet formation are not constant but depend on the total 
chain length of the peptides investigated (see table 4). 
Which are the thermodynamic driving forces for the ?-sheet formation, and is ?-sheet 
folding a cooperative process? These topics have been partially addressed in the literature, 
but the results are controversial 
12, 26
. Stabilization energies of ?-sheets appear to depend 
on the particular model protein or peptide investigated, but it is generally believed that 
hydrophobic interactions are the dominant driving force for the ?-sheet folding reaction in 
aqueous solution 
27, 28
. In particular, interactions between non-polar side chains on 
adjacent strands were shown to stabilize ?-sheet structure 29-31. However, in a membrane 
environment or in the interior of globular proteins, polar interactions, in particular 
hydrogen bonds, are expected to drive ?-sheet formation 32, 33.  
Inspection of table 2 reveals endothermic reaction enthalpies for all peptides investigated. 
For the binding to the lipid membrane the enthalpic contribution to the free energy is 
therefore unfavorable and binding is exclusively driven by entropy. The measured ?H0 
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values vary considerably between the different peptides (??H0 ~9 kcal/mol between 
largest and smallest value). However, an entropy-enthalpy compensation mechanism 
smoothes out the enthalpy variations and leads to rather constant free energies (??G0 = 2.5 
kcal/mol). The peptides pep-24-1 D,D and pep-24-2 D,D have the most unfavorable ?H0 
parameters but, at the same time, possess the largest T?S0 values. The D-amino acids 
make these peptides more flexible than their parent compounds explaining the large 
positive entropy and this flexibility is retained upon binding to the lipid membrane.  
Although the detailed structure of the ?-sheet aggregates is not known, previous NMR 
results obtained with pep-18 suggest some general features. 
2
H-NMR studies on pep-18 
have shown that ?-sheet formation leads to large, immobile peptide aggregates at the 
membrane surface. In the present study, the percentage change of residues transferred 
from random coil to ?-sheet increases with the peptide chain length and is only 17% for 
pep-8 but 85% for pep-30. It can thus be expected that longer peptides form larger 
aggregates than shorter peptides.  
Table 2 provides no immediate insight into the thermodynamics of ?-structure formation 
as the experimental data are the sum of the consecutive binding steps. The characteristics 
of ?-structure growth can, however, be extracted by comparing peptides of identical chain 
length and different extents of D,D substitution. This comparisons is based on the 
assumption that the initial attachment of the peptides to the membrane surface has 
identical thermodynamic characteristics for all members of a given set. The 
experimentally observed differences between the individual peptides are then ascribed 
exclusively to the conformational change from random coil to ?-structure.  
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As mentioned above, enthalpy-entropy compensation leads to only small changes in the 
free energy. Figure 4 shows a small increase in ?G0 for short peptides (n ? 12) and a 
decrease in ?G0 for long peptides. Considering the pure folding thermodynamics, free of 
the peptide membrane binding contributions, the incremental change ??GFolding decreases 
linearly by -0.02 kcal/mol per residue. As a general conclusion it follows from these 
studies that the random coil ? ?-structure transition makes a small negative contribution 
to the free energy and favours the binding to the membrane for long peptides (n > 12).  
The analogous analysis can also be performed for enthalpic changes. Figure 4 shows that 
the variation of ?H0 with ?-structure formation is negative, whereas for long peptides and 
positive. The folding enthalpy HFolding varies from 0.13 kcal/mol per residue for shorter 
peptides (n ? 12) to -0.4 kcal/mol per residue for longer peptides (n > 12). The incremental 
change ??HFolding is -0.04 kcal/mol per residue. Other factors unchanged, an increase in 
temperature will reduce the ?-structure content for long peptides but increase it for short 
peptides. 
It is obvious from the above that the random coil conformation and the ?-structure have 
almost equal probabilities in a membrane environment with a small bias of ?GFolding = 0.08 
to - 0.2 kcal/mol per residue towards the ?-structure. For long peptides the free energies 
accumulate and a 10 amino acid stretch is 5-10 times more likely to adopt the ?-
conformation than random coil. 
The random coil ? ?-structure transition is, however, not the driving force for membrane 
binding as such. The dominant factor here are (i) the Coulombic attraction between the 
anionic membrane lipids and the cationic peptides and (ii) hydrophobic interactions with 
the membrane and between the peptides. Each KIGAKI repeat carries two positive 
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changes and the Coulombic interaction is established by the observation that no peptide 
binding occurs if the membrane is composed of electrically neutral phospholipids only.  
At high peptide concentrations saturation of the membrane surface is reached at about 5-
10 peptides per 100 lipids (depending on the chain length) for a membrane containing 
25% anionic phosphatidylglycerol. Each KIGAKI repeat carries 2 positive charges, but 
not all charges are sensed at the membrane surface. The effective peptide charge as 
deduced from the ITC experiments is zp ~ 3-4, on the average, but may reach zp~ 6.5 (cf. 
table 2). At saturation, the membrane charge is then almost neutralized by the polycation. 
Expressed in terms of amino acid residues, a saturation level of Xb = 70 mmol/mol for 
pep-24 corresponds to an amino acid residue-to-phospholipid ratio of 1.7. As the area of a 
lipid headgroup is ~60 Å
2
 and thus larger than the projected area of most amino acids, 
even at the saturation limit enough space is available that the KIGAGI peptides can be 
stretched out flat on the membrane surface. On the other hand, the adsorbed peptides must 
be packed rather tightly allowing sufficient hydrophobic interactions between neighboring 
molecules. Hydrophobic interactions are suggested by large negative heat capacities of the 
binding reaction (cf. table 2) and are consistent with the large positive binding entropies, 
T?S0. Both effects can be traced back to the release of hydration water as the hydrophobic 
peptidic side chains come into close contact.  
 
Concluding remarks 
We have modified the original (KIGAKI)3 peptide by lengthening or shortening the 
peptide chain and have investigated the membrane-binding characteristics of the new 
analogs. A minimum chain length of n = 7  amino acids is required to observe binding and 
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detect conformational changes with CD spectroscopy. For a chain length of 8 ? n ? 30 the 
thermodynamic parameters can be derived with ITC measurements. Membrane-binding 
requires an anionic surface and all bound peptides show an increased ?-structure content 
compared to their conformation in solution. The ?-content of the bound peptides ??(aa), 
i.e. the number of amino acids changed from random coil to ?-structure, is linearly 
dependent on the chain length. A more detailed analysis reveals actually two different 
thermodynamics for short and long peptides. For short peptides n ? 12, ?-structure 
formation has a positive free energy of ?GFolding = 0.08 kcal mol-1per residue and 
counteracts binding. For long chains with n ? 18 ?GFolding = -0.15 kcal mol-1 per residue is 
slightly favorable for membrane binding. These conclusions are supported by studies with 
peptides with D,D substitutions. The peptide binding to the membrane is an endothermic 
reaction and is hence driven exclusively by entropy. The large positive entropies and the 
large negative heat capacities suggest a prominent role of hydrophobic interactions in 
binding and peptide aggregation. As initially mentioned, ?-sheets in biological proteins 
are generally shorter than 10 residues
2
. In conclusion, this process is predominantly driven 
by the hydrophobic interaction, i.e. by the hydrophobic effect. On the other hand, it is 
thought that peptides in amyloid fibrils generally form ?-sheet than about 10 residues34. 
Interestingly, at a ?-sheet length of 10 residues the thermodynamic driving forces of the ?-
sheet folding processes changed. These results suggest for the first time fundamental 
differences in the folding thermodynamics of native and aggregated protein structures. 
Further the small stabilization effects of the ?-sheet structure serves as an explanation why 
only small changes of environmental parameters like pH or temperature can have a 
profound effect on aggregation reactions, for example in amyloid fibril formation. 
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Tables 
 
 
Table 1. Amino acid sequences of the synthesized peptides 
Short-Hand notation used 
in the text 
Peptide Sequence 
pep-7 KWGAKI-K-NH2 
pep-8 KWGAKI-KI-NH2 
pep-10 KWGAKI-KIGA-NH2 
pep-12 KWGAKI-KIGAKI-NH2 
pep-18
* 
KWGAKI-(KIGAKI)2-NH2 
pep-24 KWGAKI-(KIGAKI)3-NH2 
pep-30 KWGAKI-(KIGAKI)4-NH2 
pep-12-1DD KWGakI-KIGAKI-NH2 
pep-12-2DD KWGakI-KIGakI-NH2 
pep-24-2DD KWGAKI-KIGakI-KIGakI-KIGAKI-NH2 
pep-24-3DD KWGAKI-KIGakI-KIGakI-KIGakI-NH2 
The underlined small letters in the peptide sequences denote for D amino 
acids. The first number of the short hand notation represents the peptide 
length, the second the number of double D amino acid substitutions. 
*
Data of the length series of 18 residues were taken from reference
35
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Table 2. Thermodynamic binding parameters of the KIGAKI peptides to 
POPE/POPG/mPEG 2000 PE (70:25:5) SUVs at 25 °C 
Peptide 
K0 
a)
 
 
(M
-1
) 
?H0 b) 
(kcal/mol) 
T?S0 c) 
(kcal/mol) 
?G0 d) 
(kcal/mol) 
zeff 
?Cp 
cal/molK 
pep-7 No ITC data at 25 °C 
pep-8 170 ± 40 1.3 ± 0.1 6.7 -5.4 ± 0.12 3.2  
pep-10 80 ± 20 2.7 ± 0.1 7.6 -5.0 ± 0.1 3.2  
pep-12 55 ± 10 3.6 ± 0.3 8.3 -4.7 ± 0.1 3.7 -157 
pep-18
* 
890 ± 150 6.3 ± 0.3 12.7 -6.4 ± 0.1 3.4 -84 
pep-24 1200 ± 200 6.4 ± 0.3 12.6 -6.6 ± 0.1 3.7 -192 
pep-30 2000 ± 400 5.2 ± 0.3 12.1 -6.85 ± 0.1 3.5  
pep-12-1DD 100 ± 20 3.35 ± 0.1 8.4 -5.1 ± 0.1 2.7 -141 
pep-12-2DD 85 ± 10 3.0 ± 0.1 8.0 -5.0 ± 0.1 4.1 -134 
pep-24-2DD 160 ± 30 9.8 ± 0.5 15.2 -5.4 ± 0.1 5.8 -325 
pep-24-3DD 30 ± 40 10.7 ± 0.5 16.2 -4.35 ± 0.1 6.5 -411 
a) Gained from the theoretical calculation using a model, which combines a surface 
partition equilibrium with the Gouy Chapman theory. 
b) The enthalpy of the peptide binding reaction was determined directly from the 
ITC experiment see text. 
c) The entropy of the peptide binding reaction was calculated according to 
?G0 = ?H 0 ? T?S0  
d) The free energy of the peptide binding reaction was calculated according to  
?G0 = -RT ln(K0 * 55.5) using the given binding constant. 
        *
Data taken from reference
35
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Figure Captions 
 
Figure 1. (A) Calorimetric trace obtained at 25 °C by titration of 25 mM 
POPE/POPG/mPEG 2000 POPE (70/25/5 mol/mol/mol) SUVs into a 50 μM pep-8 
solution. Buffer conditions: 25 mM Tris, pH 7.4 and 50 mM NaCl. The injection volume 
of the lipid vesicles was 10 μL, injections occurred at 5 min intervals. (B) Corresponding 
binding isotherm of pep-8 derived from the ITC experiment shown in 1A. The extent of 
bound peptide per lipid (lipid of outer vesicle layer) is plotted vs. the equilibrium 
concentration of peptide in solution. The solid line is the theoretical binding isotherm 
derived by combining the Gouy Chapman theory with a surface partition equilibrium. 
 
Figure 2. Circular dichroism spectra of KIGAKI peptides with different chain lengths 
recorded in (A) aqueous solution and (B) excess of POPE/POPG/mPEG 2000 POPE 
(45/50/5) SUVs (L/P = 15). The CD spectra correspond to a chain length of n = 30, 24, 18, 
12, 8, and 10, respectively, reading from the bottom to the top at 198 nm in (A) or 217 nm 
in (B). The spectra were recorded at peptide concentrations of 50-75 μM in 5 mM 
cacodylate buffer (pH 7.4). 
 
Figure 3. Membrane-induced ?-structure. Binding of KIGAKI peptides to anionic lipid 
vesicles leads to an increase in ?-structure. The increase in ?-structure, ??(aa), is given as 
the number of amino acid residues which change from random coil to ?-structure. ??(aa) 
is plotted as a function of the total peptide chain length. A minimum chain length of n = 7 
is required to observe a conformational change.  
 
Figure 4. Thermodynamic parameters for the binding of KIGAKI peptides to anionic 
membranes. The membrane composition and the experimental conditions are the same as 
in figure 1. The reaction enthalpy ?H0 (?), the reaction free energy ?G0 (?) and the 
entropy term T?S0 (?) are plotted as a function of peptide chain length. The dotted line 
differentiates between the two thermodynamic regions of short and long peptides. 
 
Figure 5. Circular dichroism spectra of pep-24 and two D,D analogs in buffer (A) and in 
the presence of excess lipid (B).  
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Spectra from top to bottom at 198 nm in (A) and at 210 nm in (B): pep-24, pep-24-1DD, 
pep-24-2DD. The lipid vesicles (SUVs 30 nm) were composed of POPE/POPG/mPEG-
2000 POPE in a molar ratio of 45:50:5. The lipid-to-peptide ratio was ~ 15. Spectra were 
recorded at peptide concentrations of 50-75 μM in 5 mM cacodylate buffer (pH 7.4).  
 
Figure 6. The membrane binding enthalpy ?H0, free energy ?G0, and entropy T?S0 of 
pep-24 (?), pep-18 (?), pep-12 (?) and their stereo analogs. The structural change from 
random coil to ?-structure is largest for pep-24 and decreases with increasing D-
substitution. The figure shows the variation of all thermodynamic parameters with 
increasing conformational change. ??(amino acids) denotes the number of amino acid 
residues changing from random coil to ?-structure. 
 
Figure 7. The correlation of the structural changes ??(aa) of pep-12, pep-18, and pep-24 
with the thermodynamic folding parameters ?HFolding (?), -T?SFolding(?), and ?GFolding (?) 
shows a entropy-enthalpy compensation point at a ?-sheet length of about 10 residues. 
Slopes of the linear regression lines are given in the text.   
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6.1 – Summary: Structure analysis of encapsulated Peptide-Aggregates 
in reverse micelles  
 
Solid-state NMR spectroscopy is the method of choice to obtain structural insights of 
peptides forming an extended ?-sheet at the membrane surface. However, high-resolution 
structures and relative orientation of the peptides to the membrane surface are inaccessible 
with all known NMR techniques so far. A new approach to obtain structural information 
about ?-sheet aggregated peptides at lipid-surfaces is to use a reverse micelle system. 
Reverse micelles are nanometer-sized droplets of an aqueous solution stabilized in an 
apolar solvent by surfactant molecules located at the interface. Peptides can be 
incorporated into the aqueous core of such a microdroplet. The main advantage of using 
the reverse micelles dissolved in a low viscosity solvent is that the correlation time of the 
reverse micelles and thus of the hosted peptides are much faster in low viscosity solvents 
than in water. Due to this fact conventional solution NMR spectroscopy can be used for 
high-resolution structure analysis of the extended ?-sheets at surfactant-water interfaces.  
To mimic the biological negatively charged membrane surface we used anionic charged 
surfactant molecules for preparation of the reverse micelles. The work demonstrates that 
encapsulated (KIGAKI)3 and the Alzheimer peptide are adsorbed to the surfactant-water 
interface rather than dissolved in the water pool. It is shown by CD spectroscopy that all 
investigated peptides adopted a ?-sheet structure at the surfactant-water interface 
comparable to their ?-sheet structure found at negatively charged phospholipid 
membranes. NMR spectroscopy of encapsulated (KIGAKI)3 peptides evidence the 
suitability of the reverse micelles system for future applications with isotopic labeled 
peptides. 
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6.2 – Manuscript: Structure analysis of encapsulated Peptide-Aggregates 
in reverse micelles 
 
Introduction 
Despite some progress over the last years
1, 2
, high-resolution NMR structural information 
on membrane-associated peptides has remained sparse. Atom distances, dihedral angles 
and orientations relative to the lipid membrane are more difficult to obtain for peptides in 
?-sheet conformation at the membrane conformation than peptides in a helix 
conformation. For ?-helical membrane-associated peptides, the most common approach is 
to measure the 
15
N chemical shifts and 
15
N-
1
H dipolar couplings by solid state NMR, 
when the peptides are bound to macroscopically oriented lipid membranes
3
. These two 
15
N 
interaction tensors are approximately parallel to the helical axis and their frequencies 
reflect the orientation of the helical axis relative to the applied magnetic field, which is 
also the helix orientation relative to the bilayer normal. The fact that the N-H bonds in ?-
sheet peptides are perpendicular rather than parallel to the strand axis complicates the 
structural analysis
4, 5
. Additionally, ?-sheets have a strong tendency to twist6, 7, and 
therefore more orientations of the N-H bond than the perpendicular one to the membrane 
normal can be expected. Another obstacle in analyzing ?-sheet structures, formed by 
biological relevant peptides, i.e. amyloid peptides at membrane surfaces, is the fact that 
the ?-sheets are formed intermolecular rather than intramolecular8, 9. Therefore, in this 
case the structure of interest is a large aggregate and not a small peptide. In result, liquid-
state NMR techniques, as for example with sodium dodecyl sulfate (SDS) micelles
10
, 
suffer from low resolution. Further, the ?-sheet peptides avoid to adopt their ?-sheet 
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structure in organic solvents such as trifluorethanol or hexafluoroisopropanol, which are 
thought to mimic the membrane
11-13
. 
A new method to obtain structural information on ?-sheet aggregated peptides at lipid-
surfaces is to use a reverse micelle system
14
. Reverse micelles are nanometer-sized 
droplets of an aqueous solution stabilized in an unpolar solvent by surfactant molecules 
located at the interface
15
. Peptides can be incorporated into the aqueous core of such a 
microdroplet
16
. The benefit of the reverse micelles system is the low viscosity of the 
medium, in which the reverse micelles are formed. The correlation time, ?C, of a spherical 
particle dissolved in a solvent of viscosity ? can be described by the Stokes-Einstein 
relation 
?C = 4?r
3?
3kT
 (1) 
where k is the Boltzman constant, r is the hydrodynamic radius of the considered particle, 
and T is the absolute temperature. The NMR line width observed for the dissolved particle 
is determined by the transversal relaxation time, T2, which is governed by ?C17. Nonpolar 
solvents typically exhibit a lower viscosity than water
18
, which would result in decrease of 
?C, i.e. narrower lines for particles when dissolved in the low-viscosity solvent. It is 
important to note that the incorporation of a peptide into a reverse micelles results in an 
increased hydrodynamic radius, r, which means an increase of ?C. The advantage of low-
viscosity solvents is, therefore, abolished by the increase of r at least for smaller proteins. 
However, for larger peptide aggregates with a molecular weight exceeding circa 20 kDa, 
an improvement can be achieved
19
. It is also obvious that the size and the correlation time 
of reverse micelles are governed by the amount of water within the reverse micelles
20
. 
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Following the common convention, the water content of the micellar solution is expressed 
by the ratio between the water concentration, CH2O , and the surfactant concentration, CAOT  
w0 =
CH2O
CAOT
 (2) 
However, the correlation time advantage is only one aspect for using the reverse micelle 
system. Another benefit is the inverted lipid-water interface, which avoids unwanted 
aggregation of vesicles as it is often observed for SDS micelles and phospholipids vesicles 
after peptide binding. 
 
Figure 1 
 
Within this study we investigated the capability of the reverse micelles system for 
structural analysis of ?-sheet aggregated peptides at membrane surfaces by circular 
diochroism- (CD) and nuclear magnetic resonance (NMR) spectroscopy. For this we 
encapsulated two peptides: KWGAKI-KIGAKI-KIGAKI-NH2 (1) and KWGakI-KIGakI-
KIGakI-NH2 (2) (small italic letters denote for D-amino acids) into reverse micelles, 
composed of tetraethylenglycol dodecyl ether (C12E4) and/or bis(2-ethylhexyl)sodium 
sulfosuccinate (AOT), dissolved in isooctane. Peptide 1 and 2 have shown to exhibit a 
random coil to ?-sheet transition upon binding to negatively charged phospholipid 
surfaces. ?-sheet formation of peptide 1 results in large, rigid peptide aggregates. In 
contrast, peptide 2 forms distinctively smaller aggregates as peptide 1 indicated by a 
reduced ?-sheet content, and a high mobility at negatively charged phospholipid surfaces. 
Reduction of the aggregation size of peptide 2 at the membrane surface is explained by the 
substitution of two adjacent D-amino acids in all three KIGAKI segments. Double D 
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amino acid substitution leads to a local disturbance of the ?-sheet structure. Figure 1 
shows the envisaged encapsulation of peptides in a reverse micelle. Beside the (KIGAKI)3 
peptides we investigated the behavior of the amyloid peptide A?(1-40) within reverse 
miclles. 
 
Material and Methods 
Peptide 1 and 2 were synthesized using the Fmoc (N-(9-fluorenyl)methoxycarbonyl) 
chemistry on an Applied Biosystems model 433A peptide synthesizer. The crude peptides 
were purified by reverse phase high performance liquid chromatography (HPLC). TFA 
counterions of the KIGAKI peptides were exchanged by a lyophilization step with 10% 
acetic acid before use. Purity was proven by HPLC and mass spectrometry. The 
Alzheimer peptide (1-40) was purchased from rPeptide (Athens, USA).  
Isooctane, bis(2-ethylhexyl)sodium sulfosuccinate (AOT), and tetraethyleneglycol dodecyl 
ether (C4E12) were purchased from Sigma-Aldrich (Switzerland). AOT and C4E12 were 
used without further purification. Approximately 11 mg of AOT, 28.5 μL C4E12 and 1 mL 
of isooctane were added to a screw-cap to make a 100 mM surfactant solution. About 0.5 
to 1 mg of peptide was hydrated in 40 μL buffer solution. The buffer solution contained 20 
mM HEPES pH 7.4 and 25 mM NaCl. The peptide solution was added to the surfactant 
solution and gently stirred over night. Peptides, which were not incorporated into reverse 
micelles, were removed from solution by short centrifugation. The concentration of the 
KIGAKI peptides in the reverse micelle phase was determined by absorbance at 280 nm (? 
= 5500 M
-1
 cm
-1
 for Trp), whereas the A? concentration was estimated from the amount of 
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hydrated A? (see discussion). A control sample of reverse micelles was made without 
adding peptide.  
CD data obtained for peptides 1 and 2 in presence of 1-palmitoyl-2-oleoyl-sn-glycero-3-
phosphoethanolamine (POPE), 1-palmitoyl-2-oleoyl-sn-glycero-3-phosphoglycerol 
(POPG), and 1,2-dioleoyl-sn-glycero-3-phosphoethanolamine-N-[methoxy (polyethylene 
glycol)-2000] (mPEG 2000 POPE) small unilammelar vesicles (SUVs) are taken from 
reference
21
, whereas data for the A?(1-40) peptide in presence of or 1-palmitoyl-2-oleoyl-
sn-glycero-3-phosphocholine and POPG from reference
8
. 
1
H-and 
15
N-NMR experiments were performed on a Bruker 600 MHz spectrometer. 
Circular dichroism spectra measurements were performed on a Jasco J-720 
spectropolarimeter. Spectra were recorded from 250 to 197 nm at room temperature, with 
resolution of 0.5 nm, response time of 2 s, bandwidth of 1 nm, scan speed of 20 nm/min 
and 6 accumulations. As a blank we used the reverse micelles sample without peptides. 
Peptide concentrations within the CD samples were about 50 μM. CD and NMR 
measurements were performed at room temperature. 
 
Results 
Encapsulation of KIGAKI peptides in reverse micelles 
Although there are many different surfactants capable of forming reverse micelles and 
hosting proteins, bis(2-ethylhexyl)sodium sulfosuccinate (AOT) is most often used for this 
purpose
22, 23
. Furthermore, the negatively charged AOT provides a negative membrane 
surface potential at the water surfactant interface, which is important for binding and ?-
sheet formation of amyloid peptides, i.e. the KIGAKI- and Alzheimer peptides
8, 24, 25
. 
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However, starting experiments with reverse micelles composed of only AOT have shown 
to suffer from low peptide encapsulation efficiency (?20% of the applied peptide). 
Therefore a surfactant mixture of the noncharged E4C12 and AOT has been used in a molar 
ratio of 75 to 25, respectively. The peptide encapsulation efficiency for this system is 
about 40% and 75% for peptide 1 and 2, respectively. Encapsulation of peptide 1 and 2 in 
reverse micelles was evidenced by absorption at 280 nm. A control sample with 1 in pure 
isooctane showed that the KIGAKI peptides are insoluble in isooctane. Further, the A280 
value was used to determine the peptide concentration (?280 = 5500 M-1cm-1). For this 
purpose the reverse micelles sample without peptide was used as blank. A final maximum 
peptide concentration of 70 μM and 180 μM could be obtained for peptide 1 and 2 
respectively in an C4E12/AOT/water/isooctane reverse micelles system with a total 
surfactant concentration of 100 mM and a water content of w0=11. Formation of a reverse 
micelles phase in all investigated samples could be evidenced by a characteristic 
1
H-NMR 
spectrum
20
. The apparent water content within the reverse micelle system is slightly lower 
(w0?10) than the theoretically calculated value (w0=11). Apparent w0 values are 
determined from the ratio of the 
1
H-NMR integrals of H2O (?4.4 ppm in reverse micelles) 
to the CH groups of AOT (?3.20 ppm). For carbon nomenclature of AOT see reference19. 
 
 
CD spectroscopy of KIGAKI peptides in reverse micelles 
CD spectroscopy has revealed that peptide 1 and 2 exhibit a mainly random coil 
conformation in aqueous solution, whereas at the surface of negatively charged 
phospholipid vesicles both peptides adopt a ?-sheet conformation with different extent21. 
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Figure 2 shows the CD spectra of peptide 1 and 2 encapsulated into C4E12/AOT reverse 
micelles dissolved in isooctane (doted lines) or in presence of negatively charged 
phospholipid SUVs composed of POPE/POPG/mPEG 2000 PE in a molar ratio of 45/50/5 
(spectra are taken from reference
21
). 
Figure 2 
 
In both lipid environments the peptides show the characteristic CD spectrum of a ?-sheet 
conformation as indicated with the CD absorption bands at 217 and 198 nm. For a 
comparison of the peptide structure at the water-surfactant and water-phospholipid 
surface, the CD spectra were simulated with a conventional CD deconvolution program
26
. 
Table 1 summarizes the results of the simulation of all CD spectra shown in figure 2. It is 
obvious that the secondary structure of peptide 1 and 2 is in good agreement, when the 
peptides are encapsulated in C4E12/AOT reverse micelles, or bound to the surface of 
negatively charged phospholipid vesicles. The structural differences between 1 and 2 at 
both interfaces are caused by the structure breaking double D amino acid, substituted in 
peptide 2. For more details see reference
21
.  
 
NMR spectroscopy of KIGAKI peptides in reverse micelles 
To investigate the suitability of the reverse micelles system for aggregation studies by 
NMR we recorded 
1
H-NMR spectra of peptide 1 and 2, when encapsulated in AOT/C4E12 
reverse micelle dissolved in isooctane. Figure 3 shows the 
1
H-NMR spectrum of peptide 1 
and 2 in the region between 6.5 and 10.5 ppm. As a control we recorded a 
1
H-NMR 
spectrum of a reverse micelle phase without peptide under the same conditions. Despite 
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the large background signals from the solvent, surfactant, and buffer molecules amide 
proton resonances of the peptide backbone could be obtained in case of peptide 2. In 
difference, for peptide 1 we could not detected any 
1
H-NMR proton resonance. The absent 
of the proton resonances in case of peptides 1, when encapsulated in C4E12/AOT reverse 
micelles can be explained in two ways. Firstly, the concentration of peptide 1 is to low to 
observe natural abundance 
1
H-NMR resonances or secondly the correlation time (?C) of 
peptide 1 is to slow. From solid state NMR experiments it is known that peptide 1 in the 
aggregated state has no internal motion at the surface of negatively charged phospholipids 
membranes. Additionally, isothermal titration calorimetry has evidenced that the apparent 
lipid binding constant of peptide 1 for negatively charged phospholipid membranes is 
about two orders of magnitude larger as for peptide 2. The extremely rigid structure and 
strong lipid binding properties of peptide 1 leads to the conclusion that peptide 1 
aggregates might adopt the correlation time of the reverse micelle, whereas peptide 2 
exhibits a faster ?C due to a higher degree of rotational freedom within the reverse 
micelles. The correlation time of a E4C12/AOT (75/25 mol ratio) reverse micelles is about 
2.3 ?10?7  s (calculated from the hydrodynamic radius of the E4C12/AOT reverse micelles, 
rH = 8 ± 0.5 nm, which was determined by dynamic light scattering), which is one order of 
magnitude to slow to obtain 
1
H-NMR spectroscopic resolution.  
 
A?(1-40) in reverse micelles 
In an early study we encapsulated the A?(1-40) peptide in pure AOT reverse micelles. 
Encapsulation of A?(1?40) into AOT reverse micelles dissolved in isooctane can only be 
evidenced by CD spectroscopy since the absorption at 280 nm is too low due to the lack of 
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aromatic amino acids in the sequence of A?(1?40). In turn, the molar ellipticity given in 
figure 2b for A?(1?40)  encapsulated in 50 mM pure AOT reverse micelles dissolved in 
isooctane (dotted line) was calculated from the applied amount of A?(1?40) and an 
encapsulation efficiency of 20 %. The encapsulation efficiency was estimated from 
previous experiments with (KIGAKI)3 peptides in pure AOT reverse micelles. Therefore, 
the final concentration within the sample was about 10 μM. Further, figure 2b shows a CD 
spectrum of A? bound to POPG/POPC SUVs. Secondary structure calculations for A?(1-
40) in both media are given in table 1. NMR spectroscopy could not be performed due to 
the low peptide concentration. 
 
Discussion 
So far, the use of reverse micelle systems for protein structure determination has been only 
validated for ubiquitin
14
. Indeed numerous problems are encountered, especially i) low 
encapsulation efficiency and ii) denaturation of the native protein upon encapsulation
27
. In 
view of the peptide encapsulation efficiency for KIGAKI peptides we found that pure 
AOT reverse micelles have a 10 to 15 fold lower encapsulation efficiency than reverse 
micelles composed of C4E12/AOT (75/25 molar ratio). Explained is this finding by former 
results on proteins. The efficiency to encapsulate proteins within reverse micelles tends to 
decrease with increasing ionic strength
20, 28
. Thus it is most likely that the lower surface 
charge density in C4E12/AOT reverse micelles has the same effect on the encapsulation 
efficiency for peptides. However, the negatively surface charge is from importance for the 
encapsulation efficiency as it is demonstrated by using reverse micelles composed of only 
C4E12, where no peptide could be encapsulated.   
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Denaturation of proteins upon encapsulated in AOT reverse micelles is caused by 
adsorption of the protein to the surfactant-water interface. The adsorption process is driven 
by strong electrostatic interactions between the AOT polar head groups and the charged 
residues of the guest molecules
29, 30
. This disadvantage for structure determination of 
proteins in reverse micelles can be turned into an advantage for membrane-associated 
peptides, since electrostatic adsorption to the interface is often required for the structural 
transition. The electrostatic attraction to the membrane surface is in particular from 
importance for the random coil to ?-sheet transition of the (KIGAKI)3 and A?(1-40) 
peptides.  
The presented CD spectra of peptide 1 and 2 revealed that upon encapsulation in 
C4E12/AOT reverse micelles both peptides adopted a ?-sheet structure. Thus it can be 
concluded that peptide 1 and 2 are bound to the reverse micelle membrane surface and are 
not dissolved in the water pool within the reverse micelle. Further we found that the 
secondary structure of peptide 1 and 2 is in good agreement with the secondary structure 
of the peptides at biological relevant phospholipid membranes. Although AOT exhibits a 
negatively charged sulfate head group instead of a phosphate head group, as it is found in 
the abundant biological negatively charged POPG, the influence on the peptide 
conformation at the membrane surface of peptide 1 and 2 is the same. Furthermore, it 
demonstrates that interaction of (KIGAKI)3 with negatively charged lipid membranes is 
unspecific.  
The first 
1
H-NMR results of the C4E12/AOT reverse micelle phase with encapsulated 
KIGAKI peptides have shown the suitability of the reverse micelle system for future NMR 
applications on peptide aggregates. For peptide 2 we clearly observed natural abundance 
Chapter 6   
 
 
109 
proton resonances of the ?-sheet aggregated form, when encapsulated in reverse micelles. 
For the larger or more extended ?-sheet aggregates of peptide 1, the reverse micelles 
system has to be improved. At the current stage NMR spectroscopic resolution for peptide 
1 is properly lost due the slow tumbling rate of the reverse micelles and still a low peptide 
encapsulation efficiency. In an ongoing study we are trying to reduce the reverse micelles 
size (lower water content) and labeling isotopic the peptide to increase the NMR 
sensitivity. 
Apart of the artificial KIGAKI peptides we could show that it is possible to encapsulate 
the A?(1?40)  peptide in pure AOT reverse micelles. Similar to the KIGAKI peptides 
adopted A?(1-40) a ?-sheet structure within the reverse micelles. However, the ?-sheet 
structure of A?(1-40) within the reverse micelles is more complicated to explain as for the 
KIGAKI peptides. A?(1-40) can adopt a ?-sheet conformation upon binding to negatively 
charged lipid membranes
8
 or upon self-aggregation. Self-aggregation starts in water at 
A?(1-40) concentrations above 25 μM and low salt conditions31. Therefore, it is not clear 
if A?(1?40) adopted its ?-sheet structure upon adsorption to the AOT-water interface or 
by self-aggregation due to the high local A? concentration within the reverse micelles. 
Nevertheless, the secondary structure of A? within the AOT reverse micelles resembles 
the structure determined for A?(1?40) at POPC/POPG (75/25 mol/mol) membrane 
surfaces at a lipid to peptide ratio of 20:1. ?-helical structure elements observed at 
POPG/POPC lipid membranes at lipid to peptide ratios of 50:1 are not observed in AOT 
reverse micelles. 
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Conclusion 
Our results show the suitability of the NMR technique to investigate peptide aggregates in 
reverse micelles. The (KIGAKI)3 and Alzheimer peptide(1-40) adopt a ?-sheet structure 
upon encapsulation in AOT reverse micelles, which is comparable to the aggregated 
bound form of the peptides at the surface of phospholipid membranes. With this we 
demonstrated that the negatively charged surfactant (AOT)-water interface of reverse 
micelles is a biologically relevant environment for peptide aggregation. The presented CD 
and NMR data of all encapsulated peptides in reverse micelles are promising results for 
future NMR studies, to gain high-resolution structure information of peptide aggregates in 
a membrane environment. 
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Figure Captions 
 
Figure 1. AOT Reverse micelle with encapsulated peptide.  
 
Figure 2. A) CD spectra of peptide 1 and 2 bound to SUV (solid lines) and incorporated in 
reverse micelles (dashed dotted lines). The SUVs contained POPE/POPG/mPEG-2000-PE 
in a molar ratio of 45/50/5 and the molar ratio of peptide to lipid is 1:50. The reverse 
micelles are formed out of 100 mM surfactant C4E12/AOT in a molar ratio of 75/25 in 
isooctane with w0~10. The final peptide concentration in both media was about 50 μM. B) 
CD spectra of A? bound to small unilamellar phospholipid SUVs (solid line) and 
incorporated in pure AOT reverse micelles (dashed dotted lines). The SUVs contained 
POPC/POPG in a molar ratio of 75/25 at a peptide to lipid ratio is 1:20. AOT reverse 
micelles were formed out of 50 mM AOT in isooctane with a w0~12. For buffer conditions 
see material and methods. 
 
Figure 3. A and B shows the 
1
H-NMR spectrum of peptide 1 and 2 encapsulated in 
reverse micelles formed by 100 mM C4E12/AOT in a molar ratio of 75/25 in isooctane at 
298 K and w0=10, respectively. The aqueous solution used for the sample preparation 
contained 20 mM HEPES pH 7.2, 25 mM NaCl. The final peptide concentration for 
peptide 1 and 2 was 70 and 180 μM, respectively. Figure 3C shows a control sample of 
reverse micelles under the same conditions without encapsulated peptides. Spectra are 
plotted with an offset of 0.2 ppm.  
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Tables 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1 
 
 
Table.1 Secondary structure comparison between peptide 1, 2 and A?(1-40) encapsulated in AOT 
reverse micelles and bound to phospholipids vesicles.  
 Phospholipid vesicles
   AOT reverse micelles 
 
random coil ?-sheet ?-turn   random coil ?-sheet ?-turn 
Peptide 1 0.02
* 
0.98
* 
-   0.06 0.94 - 
Peptide 2 0.36
* 
0.64
* 
-   0.33 0.77 - 
A?(1-40) 0.44** 0.34** 0.22**   0.39 0.41 0.19 
*values are taken from reference
21
. 
** values are determined from the CD spectra measured within reference
8
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7.1 – Summary: Interaction between Xenon and Phospholipid 
Membranes studied by 
129
Xe/
2
H-NMR 
 
The most pronounced pharmacological property of the inert noble gas xenon is its ability 
to induce general anesthesia. It is a long lasting question if direct xenon-lipid interactions 
are involved in the mechanism of inducing general anesthesia. The question arose from the 
correlation between the potency of general anesthetics and their solubility in organic 
solvents (Meyer-Overton rule). It has been proposed that such correlation is founded on 
either an interaction of the anesthetic with the lipid bilayer of neuronal membranes or with 
the hydrophobic region of a protein contained in the membrane, so that partitioning of the 
anesthetic component into the lipid membrane is regarded as a pivotal step in mediating 
general anesthesia. In contrast to the commonly used anesthetics xenon is of special 
interest because of its small size and neutral charge. Further the chemical shift of the 
isotope 
129
Xe is governed by its environment and can thus be exploited for monitoring 
lipid partitioning directly by NMR. We describe a fast method to obtain xenon gas/lipid 
partition coefficients based on the chemical shift properties of 
129
Xe. The presented 
method can be applied to biological membrane samples, like tissue and blood samples. 
Furthermore, the results lead to a full thermodynamic characterization of the partitioning 
process of xenon in 1-palmitoyl-2-oleoyl-sn-glycero-3-phosphocholine (POPC), the major 
lipid component of neuronal membranes. 
With respect to the anesthetic mechanism, we revealed that xenon is not altering the 
structural properties of lipid bilayers upon partitioning. Therefore we labeled phospholipid 
molecules at specific segments with deuterium and determined their order parameters. The 
resultant unchanged deuterium order parameter profile is unique among general 
anesthetics and suggests that structural changes of the lipid molecules are not necessary to 
mediate anesthesia. Although structural changes of the lipid molecules are not observed, 
interactions between xenon and the lipid molecules are evidenced by depression of the 
phase transition temperatures of 1,2-dipalmitoyl-sn-glycero-3-phosphocholine (DPPC) 
lipid bilayers. 
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7.2 – Manuscript: Interaction between Xenon and Phospholipid 
Membranes studied by 
129
Xe/
2
H-NMR 
 
Introduction 
The most pronounced pharmacological property of the inert noble gas xenon is its ability 
to induce general anesthesia
1
. Although it has been revealed that xenon inhibits directly 
the excitatory NMDA (N-methyl-D-aspartate) membrane receptor channel
2
, it is still a 
matter of debate if direct xenon-lipid interactions are involved in the mechanism of 
inducing general anesthesia. In this view, the classical argument for assuming 
hydrophobic interactions to be involved in the mechanism of general anesthesia is based 
on the correlation between the potency of general anesthetics and their solubility in 
organic solvents
3
 (Meyer-Overton rule). Such correlations arise either from an interaction 
with the lipid bilayer region of neuronal membranes or with the hydrophobic region of a 
protein contained in the membrane, so that partitioning of the anesthetic component into 
the lipid membrane is regarded as a pivotal step in mediating general anesthesia. In 
addition to the partitioning of the anesthetic molecule into the membrane, structural and 
dynamical changes of the lipids in the membrane are most likely involved in the anesthetic 
response. Here, structural data of lipid molecules upon membrane partitioning of xenon 
are unknown, but are of importance, because xenon differs distinctively in size and in its 
dipole moment from other general anesthetics. 
It is also indispensable to gain knowledge of xenon-lipid interactions, because of the broad 
application range of xenon in medicine. Apart from its use as anesthetic, it serves as 
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nuclear magnetic resonance probe for tissue and blood, as contrast agent in magnetic 
resonance imaging, and in its polarized state as NMR signal enhancer (for a review see
4
). 
So far, only a few studies report on the xenon-lipid interactions
5-7
. For example, water-
lipid partition coefficients of xenon have been determined by volumetric experiments for 
phosphatidylcholine vesicles
8, 9
. Ostwald’s solubility coefficients of xenon were also 
determined for olive oil by radioactivity measurements
10
. Early NMR spectroscopic 
studies reported chemical shifts of 
129
Xe in dimeristoyl lecithin, egg lecithin/cholesterol 
mixture, and biological membranes isolated from T.californica
11
. 
Within the present work, we provide a simple and fast method to determine lipid partition 
coefficients of xenon by exploiting its very sensitive chemical shift dispersion. For this 
purpose, the chemical shift of 
129
Xe was measured in pure buffer, hydrated lipid POPC 
bilayers and in POPC suspensions at various concentrations. By monitoring the chemical 
shift of 
129
Xe in dependence of the lipid concentration, a partition coefficient could be 
determined for the temperature range between 280 and 325 K. The results lead to a full 
thermodynamic characterization of the xenon partitioning in lipid bilayers composed of 1-
palmitoyl-2-oleoyl-sn-glycero-3-phosphocholine (POPC), which is the major lipid 
component of neuronal membranes. Further we demonstrate by deuterium and phosphorus 
NMR that hydrated POPC bilayer conserve their structural properties upon partitioning of 
xenon. Although structural changes of the lipid molecules are not observed, interactions 
between xenon and the lipid molecules are evidenced by depression of the phase transition 
temperatures of 1,2-dipalmitoyl-sn-glycero-3-phosphocholine (DPPC) lipid bilayers. 
 
Chapter 7   
 
121 
Materials and Methods 
1,2-dipalmitoyl-sn-glycero-3-phosphocholine (DPPC) and 1-palmitoyl-2-oleoyl-sn-
glycero-3-phosphocholine (POPC) were purchased from Avanti Polar Lipids (Alabaster, 
AL). Deuterated lipids were synthesised as described previously12, 13. Deuterium labels 
were attached separately either at the headgroup of ?- or ?-choline (-POC?H2C?H2N-) of 
DPPC and POPC, or at the cis-double bond segment of the oleic acyl chain (carbon atoms 
C-9', C-10') of POPC. For preparing multilamellar vesicles (MLV), defined amounts of 
lipid were dissolved in chloroform and then dried with a stream of N2 and then over night 
at high vacuum. Subsequently, buffer solution was added to the lipid film, and the mixture 
was vortexed extensively. Small unilamellar vesicles (SUVs) were prepared from MLV 
suspensions by sonication. All experiments were performed in 25 mM sodium phosphate 
(pH 7.4) buffer containing 100 mM NaCl. 
 
129
Xe NMR 
Xenon was purchased from Carbagas (Switzerland). Experiments were carried out using a 
sapphire high pressure NMR tube (Saphicon). Details of the tube are given elsewhere14. 
The xenon pressure within the NMR tube was always adjusted to 0.9 MPa using the 
reducing valve of the gas tank. Observed resonance frequencies were referenced to a 
sample of pure xenon gas at 0.9 MPa. The chemical shifts are reported in ppm downfield 
of the frequency of the pure gas phase at ambient pressure15. Chemical shift measurements 
were generally performed with a 30° pulse (9 μs) and a repetition time of 2 s, with the 
exception of figure 1 (repetition time of 150 s). The T1 relaxation time of 
129Xe was 
determined with the inversion recovery experiment in the temperature range between 280 
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and 320 K. In buffered solution and under the given conditions, the T1 relaxation time of 
xenon was found to follow the equation ln(T1 / s) = ?1.16 ? (1000 / T / K( ) + 7.79  and in 50 
mM POPC SUV solution ln(T1 / s) = ?1.79 ? (1000 / T / K( )) + 9.35 , where T is the 
temperature in K. All 129Xe experiments were performed on a Bruker Avance 400 MHz 
wide bore DRX spectrometer. Temperature correction of the chemical shift data was 
achieved by measuring glycerol contained within the sapphire tube. The absolute error in 
temperature was estimated to be ± 0.2 °C. 
 
2
H NMR 
Solid-state NMR tubes (O.D. 0.5 mm) were filled with ~50 to 100 mg of dry lipid and 
buffer was added to a final 1:2 wt ratio. Next, the samples were extensively vortexed and 
subjected to several freeze-thaw cycles to produce MLVs. The NMR-tubes were sealed 
with a rubber septum and evacuated before being pressurized by xenon or nitrogen. The 
Xe pressure was always adjusted to 0.6 MPa using the reducing valve of the gas tank. All 
2H-NMR experiments were performed on a Bruker Avance 400 MHz spectrometer. 2H-
NMR spectra were recorded with a quadrupole echo sequence (90x-?-90y-?)16 with a echo 
time of ? = 60 μs, a ?/2 pulse length of 4.6 μs and a recycling time of 200 ms. Typically, 
8-K data FIDs were accumulated. The absolute error in temperature was estimated to be ± 
0.5 °C. 
 
Differential Scanning Calorimetry 
DSC measurements were made with a VP-DSC calorimeter (MicroCal; Northampton, 
USA) equipped with a pressure perturbation unit that was used to regulate the xenon 
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pressure. MLV samples were degassed and incubated for 24 hours under a xenon pressure 
of 0.4 MPa and then filled into in the calorimeter cell. To provide a pure xenon 
atmosphere above the sample, the calorimeter cell was flooded several times with xenon 
before the xenon pressure was increased to 0.4 MPa. The DSC measurements were started 
after an equilibration period of 30 minutes. Reference samples were degassed and 
measured under a 0.4 MPa nitrogen atmosphere. All samples were measured with two 
different scan rates, 0.7 K/min and 1 K/min. 
 
Theory of lipid partitioning 
The affinity of xenon for the lipid membrane will be quantified in terms of a partition 
coefficient, 
KXe =
nXe
L ?VW +Xe
nXe
W ?V L+Xe ?
nXe
L ?VW
nXe
W ?V L  (1) 
where KXe is the partition coefficient, nXe
W  and nXe
L  are the moles of xenon in the water and 
in the lipid membrane phase, respectively. The total volume of the water phase, VW +Xe , 
and the lipid phase, V L+Xe , which is the volume of the solvents plus the volume of xenon, 
was approximated by the volume of the pure solvent only, VW and V L . The volume of the 
lipid membrane phase was calculated with the help of the specific volume of the lipid 
molecule, ?L  (for POPC 0.996 ml/g 17), the molar amount of lipids in the membrane 
phase, nL , and the molecular weight of the lipid, ML 
 
(2) 
Substitution of nL  by the lipid concentration, cL, leads to 
KXe =
nXe
L ?VW
nXe
W ?nL ??L ?ML
  Chapter 7 
 
124 
 
(3) 
where ?  is the lipid volume fraction. Quantitative knowledge of the partition coefficient, 
KXe, is gained from the chemical shift of xenon, which is governed by the xenon 
environment only
18
. The observable chemical shift of xenon in lipid suspension, ?Xeobs , can 
be described by 
?Xeobs = XW ??XeW + XL ??XeL  (4) 
where ?XeW , ?XeL  are the chemical shifts and XW , XL  the mole fractions of xenon in the 
water and lipid phase, respectively. The model is valid under the conditions of fast 
chemical exchange of the xenon atoms between the water and lipid phase in the lipid 
suspension which has been shown previously
11
. XL  is given by the mass conservation 
?Xeobs = XW ??XeW + 1? XW( ) ??XeL  (5) 
Deriving XW  from equation 3 leads to the expression 
XW =
1
KXe ?? +1
 (6) 
which can be substituted in equation 5 and leads to the fit function of the observable 
chemical shift of 
129
Xe, ?Xeobs , 
?Xeobs = 1KXe? +1 ??Xe
W
+
KXe?
KXe? +1
??XeL  (7) 
A van’t Hoff analysis of the partitioning constant yielded from equation 7 was carried out 
to determine the thermodynamic partitioning parameters of xenon to POPC membranes. 
Therefore the partitioning data were fitted to 
KXe =
nXe
L
nXe
W
? 1
cL ??L ?ML =
nXe
L
nXe
W
? 1?
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lnKXe = ? ?H
0
R
1
T
? 1
T 0
?
??
?
?? +
?CpT 0
R
1
T
? 1
T 0
?
??
?
?? +
?Cp
R
ln
T
T 0
?
??
?
?? + lnKXe
0  (8) 
where R is the gas constant, T 0 is the reference temperature (297 K) in degrees Kelvin; 
KXe
0
 and ?H 0  are binding constant and enthalpy change at the reference temperature, 
resepectively, and ?Cp  is the heat capacity change of the partitioning reaction. 
 
Results 
Determination of the xenon-lipid partition coefficient from the 
129
Xe chemical shift  
For lipid suspensions, 
129
Xe spectra were recorded as a function of the POPC 
concentration and temperature at a xenon pressure of 0.9 MPa. A single resonance line 
(line width ?  8 Hz) was observed for all POPC concentrations below 100 mM. Figure 1 
shows 
129
Xe-NMR spectra recorded for various POPC suspensions at 321 K. 
 
Figure 1 
 
Additionally, a single broad 
129
Xe resonance signal (line width ~500 Hz) was found for 
more concentrated POPC lipid bilayers (water to lipid ratio 2:1) at 0.6 MPa (top spectrum 
in figure 1). It is obvious that the chemical shift of 
129
Xe changes upon increasing the lipid 
concentration.  
Beside of this, the chemical shift of 
129
Xe changes also with temperature. Figure 2 shows 
the obtained chemical shifts of 
129
Xe for buffered aqueous solution, POPC suspensions 
(representative for 15 and 50 mM POPC) and hydrated POPC bilayer for the temperature 
range between 280 and 325 K.  
  Chapter 7 
 
126 
 
Figure 2 
 
In buffered aqueous solution (25 mM NaPO4, 100 mM NaCl, pH 7.4), the chemical shift 
of
 129
Xe was found to describ a hyperbolic progression in the investigated temperature 
range with a maximum at 318 K, which is consistent with an earlier report
19
. Minor 
changes of the chemical shift of 
129
Xe in pure water and buffer are due to the present of 
buffer ions
20
. For hydrated lipid bilayers the chemical shift of 
129
Xe showed a linear 
temperature dependency close to reported 
11
 chemical shift values of 
129
Xe in olive oil 
(figure 2). 
The change of the chemical shift in dependence of the POPC concentration and 
temperature can be used to determine the partition coefficients of xenon for POPC 
membranes. This is because the chemical shift of 
129
Xe is governed by its environment 
only and therefore reflects the xenon distribution between the lipid and aqueous phase in 
the POPC suspension. By assuming the chemical exchange rate of xenon between the two 
phases is fast and independent of the POPC concentration, it is possible to describe the 
chemical shift of 
129
Xe by equation 7. For this the chemical shift of 
129
Xe in pure POPC 
lipid membranes is approximated by the chemical shift of 
129
Xe in hydrated POPC 
bilayers. In figure 3 we plotted the chemical shift of 
129
Xe in dependence of the POPC 
concentration for three temperatures.  
 
Figure 3 
 
Chapter 7   
 
127 
The solid lines are the best theoretical fit to equation 7. For the characteristic temperatures 
of 298 K and 310 K, we determined partition coefficients of 12.1 and 25.5 respectively. 
Figure 4 shows the resulting xenon/POPC partition coefficients in dependence of the 
temperature. 
Figure 4 
 
A vant’t Hoff analysis of the partitioning coefficient was carried out to determine the 
thermodynamic partitioning parameters of xenon. The solid line in figure 4 corresponds to 
the best theoretical fit (equation 8) to the experimental data. The calculated enthalpy, heat 
capacity and standard free energy of xenon partitioning from the aqueous to the POPC 
bilayer was found to be ?HXe0 = -3.75 kcal/mol, ?Cp = -95 ± 12 cal/molK, and ?GXe0 = -4.2 
kcal/mol at 298 K, respectively. ?GXe0 was calculated as ?G0 = ?RT ln K ?55.5M( ) , where 
RT is the thermal energy and the factor 55.5 is the molar concentration of water and 
corrects for the cratic contribution. 
A different behaviour of the chemical shift of 
129
Xe was found for POPC suspensions 
above 120 mM. Figure 5 shows the 
129
Xe NMR spectra for a POPC suspension of 150 
mM, recorded in the temperature range between 300 K and 325 K. 
 
Figure 5 
 
At 301 to 305 K, a line broadening of the 
129
Xe signal was observed. Above that 
temperature, the broadening of the 
129
Xe resonance got more pronounced and a splitting of 
the resonance line occurred. The line broadening and splitting of the 
129
Xe resonance can 
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only be explained by a decrease of the rate constant of the chemical exchange between the 
water and lipid phase. By comparison of the chemical shift of the arising 
129
Xe peak at the 
high field site with the above determined chemical shift values, we assigned the signal to 
xenon dissolved in water. As judged from the partition coefficient, the downfield peak 
corresponds to xenon dissolved in the POPC membrane. Direct determination of the 
xenon-lipid partitioning coefficient from the intensities of the 
129
Xe spectra at POPC 
concentrations higher than 100 mM and temperatures above 305 K are not possible, due to 
inadequate resolution of the resonance signals for line fitting. 
 
Structural changes of the lipid bilayer upon partitioning of xenon as monitored by 
deuterium and phosphorus NMR 
2
H-NMR spectra were obtained with hydrated POPC bilayers (water to lipid ratio 2:1) 
composed of POPC, deuterated at the ?-segment of the choline moiety or carbon double 
bond segment of the oleic acyl chain and measured at 310 K and 0.6 MPa xenon pressure. 
The xenon concentration within such an hydrated lipid bilayer sample can be 
approximated by taking the Ostwald solubility coefficient of xenon in olive oil (1.8 at 310 
K)
9
, that is the ratio of the volume of gas absorbed to the volume of the absorbing liquid 
measured at the same temperature, and the xenon density of 31 kg/m
3
 at 310 K. As a 
result, we approximate a xenon concentration of 25-30 mol% with respect to the POPC 
molecules.  
The quadrupole splittings of the deuterons at the head group and double bond segment 
were not changed upon the partitioning of xenon (0.6 MPa) for the temperature range 
between 280 and 330 K. As a reference for the splitting, we used the same lipid sample 
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under 0.6 MPa N2 pressure. All deuterons showed a single quadrupole splitting in the 
NMR spectra. To test if a higher xenon concentration within the POPC bilayer perturbs 
the POPC structure, we saturated a POPC bilayer sample (water to lipid ratio 4:1) at 
ambient pressure for 4 h with xenon and measured the quadrupole splitting again at the 
head and tail position under a xenon pressure of 0.6 MPa. In this experiment, the 
quadrupole splitting was identical to the first experiment. Apparently, the mobility of 
xenon in the POPC membrane is fast, and the residence time of xenon at an individual 
lipid segment must be shorter than the time scale of a deuterium NMR experiment (10
-5
s). 
Phosphorus-31 NMR spectra of the POPC bilayer were recorded, to confirm an intact 
POPC bilayer structure upon xenon partitioning (0.6 MPa) at 280 and 325 K. All 
phosphorus-31 NMR spectra were similar, showing the typical signature of the bilayer 
phase
12
 with a chemical shielding anisotropy of 47 ppm (spectra not shown).  
To generalize these results, we measured 
2
H-NMR spectra of deuterium labelled DPPC 
hydrated bilayer (water to lipid ratio 2:1) under a xenon pressure of 0.6 MPa. DPPC was 
labelled separately at the ?- and ?-segment of the choline moiety. In contrast to the POPC 
bilayer, the DPPC bilayer displays a phase transition at 41 °C. Figure 6A shows the 
quadrupole splittings, ?vQ, of the ?- and ?-deuterons in dependence of the temperature 
under 0.6 MPa xenon and nitrogen pressure. The influence of xenon on the pre (Tp=37°C) 
and main (Tm=41°C) phase transition temperatures of DPPC is obvious. In general, in 
going through the phase transition from the gel to the liquid crystalline phase the 
conformational motion of DPPC molecules become less restricted.  
 
Figure 6 
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This leads to an observable reduction of the quadrupole splitting at the phase transition 
temperatures
13, 21
 as compared to POPC bilayers. The reduction of quadrupole splittings of 
the ?- and ?-deuterons attached to DPPC due to the phase transition is considerably 
different between the reference sample (0.6 MPa N2 pressure) and xenon pressurized 
sample (0.6 MPa). Tm of the DPPC bilayer in presence of xenon is reduced by 1±0.5 °C 
from 41°C to 40°C, whereas Tp is reduced by 1.5±0.5 °C from 36.5 to 35 °C. Tp was only 
evaluated for the ?-deuterons, because the ?-deuterons of DPPC are less sensitive and are 
not responding to the pre transition
13
. The quadrupole splittings of the choline head group 
deuterons of DPPC above and below the phase transition temperature are not changed due 
to the presence of the xenon atoms. We also measured the phase transition temperatures of 
DPPC under xenon saturated conditions, where Tp and Tm are reduced by 3±0.5 and 
2.5±0.5 °C. 
To confirm these results, we recorded DSC thermograms of a 10 mM DPPC MLV 
solution under 0.4 MPa xenon and 0.4 MPa nitrogen pressure (shown in Figure 5b). 
Xenon decreased the Tm of DPPC by 0.5 °C and increased the Tp by 0.3 °C. A quantitative 
evaluation of the DSC experiment is not possible since mixing, transfer, and equlibration 
of the DSC samples with xenon proved to vary throughout our experiments. Nevertheless, 
deuterium NMR and DSC experiments reveal both a reduction of the main phase 
transition of DPPC in presence of xenon. Differences in DSC and NMR samples such as 
the higher xenon pressure and vesicle form explain differences in the strength of the 
temperature depression. We also monitored the chemical shift and T1 relaxation times of 
129
Xe in DPPC suspension. Both parameters were insensitive to the phase transition of 
DPPC. 
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Discussion 
Thermodynamics of xenon partitioning 
The presented work reports a full thermodynamic characterization of the xenon 
partitioning into POPC lipid bilayers. Lipid-water partition coefficients of xenon varied 
from 12 to 24.2 in the temperature range of 280 to 325 K. In comparison to literature 
values of lipid-water partition coefficients of xenon determined by volumetric and 
radioactivity methods, we find excellent agreement, with a faster and more quantitative 
method. For example, Smith et al. reported for phosphatidylcholine vesicle suspensions 
KXe values of 13 and 15.1 at 283 K and 298 K respectively. For olive oil KXe values of 
14.6, 19.3, 22.5, and 23.9 at 277, 293, 300, and 310 K were determined, respectively (all 
KXe values are translated from Oswald’s solubility coefficients). 
The free energy, enthalpy and the heat capacity changes for the partitioning process of 
xenon from the water to the lipid phase were -4.2 kcal/mol (at 298 K), -3.75 ± 0.5 
kcal/mol and -95 ± 12 cal/molK, respectively. It has been shown that the heat capacity 
change ?Cp can be empirically related to the change in hydrophobic and hydrophilic 
solvation
22
. Therefore, ?Cp can be assumed to reflect changes in the exposure of 
hydrophobic surface of xenon to water. Taking into account a water accessible apolar 
surface area (ASAap) of 156 Å
2
 for xenon
23
, and a change in heat capacity of -0.45 
cal/KmolÅ
2 22
, a theoretical ?Cp of -70 cal/molK is calculated. The experimental error and 
uncertainties in the ASAap value of xenon might explain the difference of 25 cal/molK 
between the experimental and theoretical ?Cp value. Additional contributions to ?Cp, as 
for example changes in the water accessibility of the lipid surface, cannot be ruled out, but 
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are small in comparison to the contribution of the burial of water-accessible apolar surface 
from xenon. 
 
NMR spectroscopic behaviour of 
129
Xe in lipid suspenion 
The systematic determination of the temperature and lipid concentration dependency of 
the chemical shift of 
129
Xe in phospholipid suspensions exemplifies for the first time some 
general behaviour of 
129
Xe in lipid solution. A linear temperature dependence of the 
129
Xe 
chemical shift is mostly found for xenon dissolved in organic solvents
24
, which is in line 
with the findings of
 129
Xe dissolved in hydrated lipid bilayer. For POPC SUVs we 
observed that the chemical shifts of 
129
Xe were in the range of 
129
Xe resonances found in 
buffered aqueous solution and in hydrated POPC bilayer. Additionally, the appearance of 
only one resonance signal for 
129
Xe dissolved in POPC suspension below 100 mM leads to 
the conclusion that xenon is in fast chemical exchange between the lipid and water phase. 
As a result, the exchange rate of xenon kXe between the two phases must be faster than 
?XeM ? ?XeW( ) / 2? 2  25, where ?XeW  and ?XeM  are the resonance frequencies of 129Xe in 
buffered aqueous solution and in hydrated POPC membrane, respectively. At higher 
POPC (>100 mM) concentration and temperatures above 305 K, we observed a line 
broadening of the 
129
Xe resonance, which can be interpreted as a decrease of the exchange 
rate below 40 s
-1
. In analogy, Miller et al. observed for ~130 mM DMPC at 308 K a clear 
peak separation between the lipid and water resonances of 
129
Xe, whereas one broad 
129
Xe 
resonance was yet again observed at 325 K. The merged lipid and water 
129
Xe resonance 
with increasing temperature was taken to reflect an increasing exchange rate of xenon in 
the lipid suspension with temperature. In contrast, present work suggests that the chemical 
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shift of 
129
Xe decreases concomitantly with increasing temperature. Therefore, the 
appearance of one broad xenon signal at higher temperature is more likely caused by the 
overlap of the 
129
Xe water and lipid signals rather than due to a fast chemical exchange. 
The increase of the residence time of xenon in the lipid bilayer at higher POPC 
concentration and temperature, and thus the line broadening, could be explained the 
formation of multilamellar vesicles. Accordingly, the chemical exchange by with 
multilmellar bilayers would increase the exchange rate. As a consequence, the exchange of 
xenon in hydrated lipid bilayer is slow and must lead to a splitting of the 
129
Xe resonances. 
However, this was not observed experimentally due to the limited resolution in the solid 
state NMR samples. 
 
The structural behaviour of the lipid membrane upon xenon partitioning 
Xenon has shown not to alter the structure and dynamics of the POPC molecules upon 
partitioning into POPC lipid bilayers under the observed conditions. This property 
distinguishes xenon from other gaseous anestetics as halothane, enflurane and isoflurane. 
For these anestetics, an increase of the order parameter for POPC segments near the 
interface and a decrease of order for those POPC segments within the hydrophobic region 
of the membrane at anestetic concentrations of 25 mol% has been reported
26
. In these 
experiments, however, the anestetic concentration greatly exceeded those used clinically. 
Likewise, the xenon concentration in present investigation exceeded the clinically relevant 
xenon concentration; but even at such saturation conditions of xenon in the POPC lipid 
membrane, no changes in the lipid structure and dynamics of the POPC bilayer could be 
observed. The absence of structural perturbation of the membrane upon xenon partitioning 
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can be explained by the three to five time smaller accessible surface area of xenon 
compared to gaseous anesthetics as halothane or enflurane. Additionally, xenon exhibits 
only a residence in the millisecond range in the membrane, where the time scale of a 
deuterium NMR experiment cannot resolve smaller differences. 
The distribution of the anaesthetic component within the lipid membrane is closely related 
to the order parameter profile of the membrane. Here conflicting results were reported. For 
example, Xu et al. revealed for xenon a preferential location at the head group region of 
phosphatidylcholine lipid bilayers by measuring site-selective intermolecular 
129
Xe-{
1
H} 
nuclear Overhauser effects between xenon and head group protons of phosphatidylcholine 
in sonicated unilamellar vesicles at 298 K
6
. The opposite result was found in molecular 
dynamic simulation of the xenon partitioning process in a DPPC bilayer
27
. Therein it was 
postulated that xenon is directed more to the hydrophobic core of the bilayer than to the 
head group region. Present results cannot clarify this dispute, but the unchanged 
quadrupole splittings of the deuterium labels attached to both the head group and double 
bond segment within the hydrophobic core of the POPC and DPPC bilayer arguments 
against a strong local preference of the xenon atoms in the phosphatidylcholine bilayer. 
This is also supported by considering that xenon exhibits no dipole moment, which could 
align with the dipole of the POPC molecules in the bilayer. In particular, present findings 
cannot support the MD simulation, because they predicted changes of the averaged order 
parameter of the DPPC molecules of about 0.003 (translates into a change of the 
quadrupole splitting constant of 0.4 kHz) upon xenon partitioning of 25 mol% in the 
DPPC bilayer which was not observed in present results. 
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Even though xenon molecules obviously do not perturb the structure of the lipid molecules 
of the bilayer, we found evidence that xenon interacts with the lipid molecules of the 
bilayer. Accordingly, xenon affected the thermotropic behaviour of DPPC mulilamellar 
vesicles. In detail, xenon decreased the Tm and Tp of the DPPC bilayer under the presented 
conditions of about 1 and 0.5 °C, respectively. The reduction of the phase transition 
temperature was found to be dependent on the amount of added anesthetic molecules
28
. In 
comparison, halothane and enflurane reduced Tm of DPPC by about 6.4 ° and 3.3 °C 
respectively under a partial pressure of 0.15 atm
29
. Only under xenon saturation conditions 
we observed phase transition temperatures of DPPC in the same order as for halothane and 
enflurane, which is reasonable since both have higher partition coefficients and smaller 
maximum alveolar concentrations (MAC value) required for anesthesia compared to 
xenon. Many suggestions have been made to explain the depression of the phase transition 
temperature of DPPC due to anesthetic partitioning, but the mechanism is still not clear, 
but present results demonstrate for the first time that lipid structural changes cannot 
account for the depression of the phase transition. 
 
Conclusion 
A new method for the rapid measurement of the xenon partition coefficients was presented 
exploiting the sensitive chemical shift of 
129
Xe. The main advantage of measuring the 
partition coefficient of xenon by 
129
Xe-NMR is its simplicity as compared to volumetric 
and radioactivity methods. Furthermore, the 
129
Xe-NMR characterization of the 
partitioning process of xenon provides important insights into the behaviour of xenon in 
lipid suspensions, which is of importance for its medical applications. With respect to the 
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anesthetic mechanism, we revealed that xenon is not altering the deuterium order profile 
of the lipid membrane under conditions used for anesthesia. This suggests that structural 
changes of the lipid molecules are not necessary to mediate anesthesia. 
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Figure Captions 
 
Figure 1. 
129
Xe-NMR spectra of various POPC SUV solutions at 321 K. Top spectrum 
corresponds to xenon dissolved in hydrated POPC bilayer (lipid to water ratio 1:2) at 321 
K. The two 
129
Xe resonances in the top spectrum are assigned to xenon dissolved in the 
lipid bilayer (193.05 ppm) and xenon in the gas phase above the bilayer (3.1 ppm). The 
xenon pressure in the lipid solution was adjusted to 0.9 MPa and in the hydrated lipid 
bilayer sample to 0.6 MPa. 
 
Figure 2. Upper panel: Chemical shift of 
129
Xe in buffered solution (?), in POPC SUV 
suspension with 15 (?), 50 (?) mM and in hydrated POPC bilayer (?) (lipid to water 
ratio 1:2) as function of the temperature. Additionally, the chemical shift of 
129
Xe in olive 
oil (?) is shown. Lower panel: To illustrate the effect of the lipid POPC phase on the 
chemical shift of 
129
Xe, we referenced the chemical shift of 
129
Xe to the chemical shift of 
129
Xe in water. The labels denote for the same solution as in (A). 
 
Figure 3. Chemical shift of 
129
Xe as function of the POPC concentration at 321 K (?), 
313 (?), and 297 K (?). The solid lines correspond to the best fit of the experimental 
data to equation 7. 
 
Figure 4. Partition coefficient of xenon into POPC SUV vesicles in dependence of the 
temperature. The solid line corresponds to the best fit of the experimental data to the van’t 
Hoff equation (equation 8). 
 
Figure 5. NMR spectra of 
129
Xe dissolved in 100 mM POPC SUV solutions (25 mM Tris, 
pH 7.4, 0.1 M NaCl) in dependence of the temperature. The applied xenon pressure was 
0.9 MPa. Numbers above the xenon resonances assign for the temperature in K. 
 
Figure 6. Upper panel: Quadrupole splittings, ??Q, of deuterium atoms attached to DPPC 
at the ?? (squares) and ?? (circles) segment of the choline head group in dependence of 
the temperature. The coarsed liposomes of DPPC (water to lipid ratio 1:2) were 
pressurized either with 0.6 MPa xenon (closed symbols) or with 0.6 MPa nitrogen (open 
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symbols). Lower panel: DSC heating thermograms of 10 mM DPPC MLV suspension 
under 0.4 MPa Xe (red line) and 0.4 MPa N2 (black line) pressure. 
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8. Summary 
 
This thesis aimed at improving our understanding of the thermodynamic and structural 
aspects of peptide aggregation processes at membrane surfaces. For this purpose we 
investigated a class of model peptides, which form a ?-sheet structure upon binding to 
membrane surfaces. Binding of peptides with the repeating sequence of KIGAKI to 
anionic membrane surfaces was chosen as model system to characterize the transition 
from a random coil to ?-sheet structure. Evidence is brought that the process of 
intermolecular ?-sheets formation by the KIGAKI peptides is a suitable model system for 
a peptide aggregation process at membrane surfaces.  
In order to understand this aggregation process, thermodynamic parameters of (KIGAKI)3 
binding to lipid membranes were determined directly by isothermal titration calorimetry. 
For a description of the peptide binding data a theoretical binding model was developed 
and evaluated with the drug verapamil. It is shown that the binding model, which is based 
on the Gouy-Chapman theory, can be used in a general way to describe electrostatic 
attraction and repulsion of charged molecules to lipid membranes under a variety of 
environmental conditions. Nevertheless, binding of peptides to lipid membranes is more 
complex as simply considering electrostatic attraction of the peptide to the membrane. 
Thermodynamic binding parameters of (KIGAKI)3 to lipid membranes, obtained by ITC, 
combines mainly two reactions, the intrinsic binding and ?-sheet folding process. 
Separation of both subprocesses from the overall thermodynamic binding process could be 
achieved by varying the extent of ?-sheet formation due to substitution of two adjacent D 
amino acids within the peptide sequence. Double D amino acid substitution leads to a 
local disturbance of the ?-sheet structure, where the extent of the ?-sheet formation is 
dependent on the number and position of the double D amino acid substitution. With this 
approach it was possible to determine for the first time a full thermodynamic profile of the 
random coil to ?-sheet transition for a peptide in a membrane environment and 
concomitantly these parameters are the first clearly defined parameters of a peptide 
aggregation reaction. 
Beta sheet folds in proteins tend to be distinctively smaller than current models predict for 
?-sheets in protein and peptide aggregates. To reveal differences between the ?-sheet 
folding reaction in a native and aggregated protein, we extended the study and determined 
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the length dependence of the ?-sheet folding reaction. Thermodynamic parameters of the 
?-sheet folding reaction for KIGAKI peptide with different lengths were determined in 
analogy to (KIGAKI)3. A linear length stabilization effect could be demonstrated for 
KIGAKI ?-sheet structure. Furthermore, for ?-sheets shorter than 10 residues the folding 
reaction is driven by entropy, whereas for longer ?-sheets the folding reaction is driven by 
enthalpy. Underlying length dependence of the thermodynamic driving forces of ?-sheet 
folding reaction is therefore the most important finding of this work since it reveals an 
important difference in the folding reaction between native and aggregating ?-sheets. 
Furthermore, the double D amino acid substitution strategy opens a new way to 
systematically resolve the characteristic ?-sheet-aggregation at membrane surfaces, as for 
example for the Alzheimer peptide. 
Beside thermodynamics of the ?-sheet folding process we also studied the dynamics and 
size of the extended ?-sheet structure of KIGAKI at the membrane surface by deuterium 
solid state NMR. It is revealed that the ?-sheet structure formed by the (KIGAKI)3 peptide 
is large and rigid and therefore inevitably extended at the membrane surface. Perturbation 
of the membrane integrity, due to peptide binding and ?-sheet formation are not observed. 
In turn, these findings weaken the theories that peptide aggregates at the membrane 
surface mediating cell death by disrupting the cell membrane. 
As a new approach to study extended ?-sheet structures at membrane surfaces, the 
(KIGAKI)3 and Alzheimer peptide were encapsulated in reverse micelles and dissolved in 
a low viscosity solvent. Within the reverse micelles KIGAKI peptides adopted their 
characteristic ?-sheet structure. Promising NMR results show that the reverse micelles 
technique is an interesting alternative for the structure analysis of membrane peptide and 
protein aggregates. 
The last part of this thesis dealt with the partitioning process of xenon in lipid membranes. 
NMR spectroscopic analysis of the chemical shift behavior of 
129
Xe in lipid suspension 
offered a new method to determine partitioning coefficients of xenon in lipid membrane 
samples, like blood and tissue samples, which are of particular interest for various medical 
applications of xenon. Additionally, our data provide new aspects of the anesthetic 
properties of xenon. In particular, we demonstrated that lipid molecules maintained their 
structure upon xenon partitioning, which suggests that structural changes of the lipid 
molecules are not necessary to mediate anesthesia. 
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